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Abstract
Premature birth, defined as a gestational period less than 37 weeks, occurs in 8% of infants
born in Canada. These births are associated with a higher risk of developing neurological
complications. Infants born with very low birth weights (VLBW, < 1500 g) experience
cognitive or behavioural deficits at a rate of 40-50%, while a further 5-10% develop major
disorders such as cerebral palsy. The likelihood of injury increases with a shorter gestational
period and/or a lower birthweight. Intraventricular hemorrhaging (IVH) occurs in 20-25% of
VLBW infants, characterized by bleeding in the germinal matrix and surrounding white matter.
This highly vascularized region is particularly susceptible to bleeds due to underdeveloped
cerebrovascular structures. Severe IVH causes an inflammatory response and subsequent
obstruction of cerebrospinal fluid (CSF) drainage, resulting in enlargement of the brain’s
ventricles, referred to as post-hemorrhagic ventricular dilatation (PHVD). PHVD increases
intracranial pressure and can result in compression/damage of brain tissue.
Diagnosis of IVH and PHVD is regularly performed using cranial ultrasound. Clinicians can
visually assess and grade hemorrhaging/ventricle dilatation. Ultrasound, however, is limited in
its ability to continuously monitor and only detects irreversible damage. NNeMo (Neonatal
NeuroMonitor) is a hybrid optical device combining diffuse correlation (DCS) and nearinfrared spectroscopy (NIRS) to simultaneous monitor cerebral blood flow (CBF) and
metabolism at the bedside. DCS analyzes light scatter from red blood cells to infer their motion
and calculate CBF while NIRS exploits light absorption properties to quantify changes in
oxidized cytochrome c oxidase (oxCCO), a direct marker of energy metabolism. System
validation was presented in a piglet model of neonatal hypoxia-ischemia. Clinical translation
of NNeMo was demonstrated in PHVD infants during ventricular taps (i.e., CSF drainage).
Changes in perfusion and metabolism are presented in premature infants at high risk of IVH
within the first 72 hours of life. Lastly, NNeMo was translated to the cardiac operating room,
in patients undergoing surgery with cardiopulmonary bypass, to observe metabolic response
to large intraoperative changes in CBF. Optical measures of perfusion and metabolism show
potential to act as prognostic markers of injury and could aid clinicians in patient management
before significant damage persists.
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Summary for Lay Audience
A full-term pregnancy is approximately 40 weeks in duration. Infants born within 37 weeks
are defined as premature and often experience inadequate brain growth and underdeveloped
cerebrovascular structures, which are necessary to maintain an adequate supply of blood and
oxygen to the brain. As a result, premature infants are at a higher risk of developing a brain
injury, which further increases with a shorter gestational period or a lower weight at birth. A
common injury is intraventricular hemorrhaging (IVH), which describes bleeding in and
around the ventricles of the brain. IVH has been found to occur in up to 25% of infants
weighing less than 1500 g at birth and 45% in those less than 1000 g, with most cases appearing
within the first 48 hours of life. Furthermore, severe cases of IVH can result in improper
draining of cerebrospinal fluid (CSF) from the brain’s ventricles. This leads to increased
intracranial pressure and ventricle volume, described as post-hemorrhagic ventricular
dilatation (PHVD), which can compress brain tissue and result in long-term cognitive deficit.
In today’s neonatal intensive care unit (NICU), brain monitoring is limited to infrequent
imaging using cranial ultrasound. While ultrasound can accurately diagnose bleeding/ventricle
enlargement, it cannot continuously monitor and can only image damage that has already
occurred. This dissertation explores the use of biomedical optics to monitor potential
physiological markers of brain injury before significant damage occurs. NNeMo (Neonatal
NeuroMonitor) is a non-invasive optical device developed to continuously monitor cerebral
blood flow (CBF) and metabolism at the bedside. This was achieved by combining diffuse
correlation spectroscopy to characterize CBF with broadband near-infrared spectroscopy to
monitor cerebral metabolism. NNeMo demonstrated changes in CBF and metabolism prior to
the onset of brain injury in an animal model. The system was translated to the NICU to monitor
PHVD infants during CSF drainage and preterms at risk of IVH soon after birth. Lastly, the
relationship between CBF and metabolism as indicators of potential injury was investigated in
patients undergoing cardiac surgery with cardiopulmonary bypass. Real-time monitoring of
cerebral perfusion and metabolism has potential to aid in patient management and improve
clinical outcome.
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Chapter 1

1

Introduction

Advancements in the modern neonatal intensive care unit (NICU) have greatly improved
outcomes of premature infants and those with complications at birth. With increasing
survival rates across NICU patients, clinical efforts have shifted to quality of life following
patient

discharge.

A

notable

area

of

focus

is

in

neurodevelopment

and

prevention/mitigation of long-term cognitive deficit. This dissertation explores
development of optical technologies to aid in the diagnosis and management of premature
brain injury with the goal of improving clinical outcomes.

1.1 Clinical Rationale
1.1.1

Premature Brain Injury

Premature birth, defined as a gestational period lasting fewer than 37 weeks, is a common
occurrence with 8% of infants in Canada born prematurely [1]. The shorter the gestational
age (GA) at birth and the less these infants weigh, the higher the risk of neurological
complications. Very low birth weight (VLBW; < 1500 g) infants experience behavioural
or cognitive deficits at a rate of 25-50%, with a further 5-10% developing major motor
disorders such as cerebral palsy [2]. These rates are more severe in extremely low birth
weight (ELBW; < 1000 g) infants, with apparent and significant long-term deficits [3,4].
Intraventricular hemorrhaging (IVH), is a common injury following premature birth and is
characterized by bleeding in the germinal matrix and surrounding white matter. The
germinal matrix is a highly vascularized region in the brain, comprised of glial and
neuronal precursor cells, and is particularly susceptible to hemorrhaging within the first 48
hours following birth [5]. Substantial bleeding in this area can cause a rupture of the
ependyma (ventricle lining) and result in blood entering the ventricles. IVH has been found
to occur in 20-25% of VLBW infants [6] and in 45% of ELBW infants [7]. Periventricular
leukomalacia (PVL) is another common injury characterized by ischemic damage to
periventricular white matter. PVL has been found in up to 50% of VLBW infants and can
take the form of a focal cystic injury embodying tissue necrosis or a diffuse non-cystic
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injury vulnerable to ischemia, with the latter being far more prevalent in preterms [2,8]. In
severe cases of cerebral hemorrhaging, an inflammatory response, followed by fibrosis,
can obstruct the drainage of cerebrospinal fluid (CSF) in the brain’s ventricles and lead to
post-hemorrhagic ventricular dilatation (PHVD) [9,10]. PHVD is a common complication
of high-grade IVH and can result in CSF accumulation, increased intracranial pressure, and
compression/damage of brain tissue.
The pathogenesis of IVH and PVL is multifaceted. The shortened gestation of a premature
birth prevents adequate development of cerebrovascular structures (i.e., vascularization of
the germinal matrix). In addition to an immature cerebrovascular system, poor regulation
of cerebral blood flow (CBF) is believed to contribute to injury as evident by the prevalence
of impaired cerebral autoregulation (CA; i.e., the ability to maintain CBF despite changes
in blood pressure) in this population [5,11,12]. In addition, preterms have a significantly
lower basal CBF compared to adults (<10 ml/100 g/min in preterms versus
50 ml/100 g/min in adults), and are therefore less tolerant of any disturbance in flow [13].

1.1.2

Clinical Diagnosis and Neuromonitoring

Considering the incidence of IVH and PVL following birth increases the risk of long-term
neurological complications, early characterization of injury is paramount [4]. Many infants
with brain injury are asymptomatic. Diagnosis is based on screening, most commonly with
cranial ultrasound (cUS). Cranial US is a non-invasive, bedside imaging technique that can
detect and grade IVH, identify PVL, and gauge ventricular dilatation [10,14]. Routine
monitoring with cUS is employed in standard practice in most centers with all infants
admitted to the NICU receiving a scan within the first week of life and a second at 36-40
weeks postmenstrual age (PMA) [15]. Imaging with ultrasound has two notable limitations.
Firstly, cUS cannot provide continuous monitoring, as it only captures a single snapshot of
the brain. Timely diagnosis, therefore, relies on frequency of imaging. In addition, brain
injury as observed by cUS is based on structural damage that has already occurred. It is of
note that magnetic resonance imaging (MRI) can also provide high resolution imaging to
accurately diagnose injury but, in addition to similar limitations as ultrasound, is costly and
not deployable at the bedside [16]. At the point of imaging, in both techniques, any damage
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identified is irreversible and clinical decision making seeks to manage the injury and
prevent further damage.
Recent work has looked into physiological precursors of brain injury. More specifically,
CBF has been measured as a potential marker of damage. The approaches and technologies
implemented to make this measurement have varied greatly over the years. Early work by
Volpe et al. in 1983 used positron emission tomography (PET), with oxygen-15 labelled
water as a radiotracer, to measure CBF in premature infants with IVH [17]. In this study,
significant reductions in CBF were found in areas of the brain impacted by hemorrhaging.
The study concluded that a drop in flow was principally responsible for successive
neurological deficits. In 1986, Greisen implemented a 133-Xenon clearance method to
measure CBF in premature infants soon after birth [18]. In this study, an arterial injection
of 133-Xenon was used while monitoring activity over the brain with a sodium-iodide
crystal detector. A lower-than-expected CBF was found in infants requiring ventilation.
While PET and 133-Xenon clearance approaches provide a fairly robust measure of CBF,
the radiation exposure required is a significant drawback.
Several studies have implemented transcranial Doppler ultrasound (TCD) to measure CBF
non-invasively. TCD operates by emitting an acoustic wave and monitoring changes in
frequency of reflected waves scattered from red blood cells (RBC). The difference in
frequency between incident and reflected wave is referred to as the Doppler shift and is
directly proportional to RBC velocity [19]. In premature infants, some studies have shown
strong correlations between TCD-measured CBF and the development of cerebral
hemorrhages [20]. However, a recent systematic review by Camfferman et al. reports a
high variability across studies, speculating that measurement frequency may be a limitation
in correlating flow measurements to the onset of injury [21]. While a continuous measure
of CBF by TCD is possible, ultrasound equipment is bulky, requiring a transducer
immediately above the site of interest, and impractical for longitudinal monitoring. Similar
doppler ultrasound-based techniques have also been implemented to measure CBF
indirectly via extracerebral feeding arteries. Studies have investigated early changes in
cerebral blood volume (calculated from CBF) in preterms during the first weeks of life [22]
and have found strong relationships between superior vena cava flow (measured as a
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reflection of CBF) and the onset of IVH [23,24]. Additional limitations of TCD include its
operator

dependence,

requiring

substantial

understanding

of

the

underlying

cerebrovascular structures in order to obtain an adequate measure, and its ability to measure
only large basal arteries, which describes global changes in flow [19].
A further consideration when relying on perfusion monitoring is to understand that CBF is
not a wholistic marker of cerebral health. Dynamic changes in CBF are generally managed
by brain homeostasis. So, when do changes in CBF become clinically significant? This
question can be addressed through a measure of oxygen utilization (i.e., cerebral
metabolism) as a biomarker of potential injury [25]. When the brain has a limited oxygen
supply, or is inefficient in metabolizing the oxygen available, there is an impact on energy
production which can lead to cell death. In the healthy brain, fluctuations in CBF are
compensated for by changes in the amount of oxygen extracted from the blood, known as
the oxygen extraction fraction (OEF). Only with extreme changes in flow, at which point
this compensatory mechanism fails, do changes in metabolism persist (Figure 1.1).
Metabolism has therefore proven a more direct marker of tissue viability [26]. Approaches
for monitoring cerebral metabolism in the newborn are limited; disregarding techniques
that require radiation exposure, magnetic resonance spectroscopy (MRS) is the most
notable. MRS is capable of directly measuring the concentrations of metabolites in brain
tissue, which have been shown to correlate with injury in infants with asphyxia [27] and
hypoxia-ischemia [28]. However, MRS is inconvenient for routine monitoring and poses a
practical challenge for use on premature infants.
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Figure 1.1: Oxygen extraction and metabolic response to changes in CBF.
Limited availability of robust and convenient bedside technologies has sparked the
development of optical techniques to provide a safe, non-invasive approach to
neuromonitoring. This dissertation describes the technology and clinical translation of
optical techniques to monitor cerebral tissue saturation, blood flow, and metabolism at the
bedside. Continuous bedside monitoring of physiological precursors has potential to alter
patient management and improve clinical outcomes associated with premature brain injury.

1.2

Near-Infrared Spectroscopy

Near-infrared spectroscopy (NIRS) is a non-invasive optical technique used to measure the
concentrations of light-absorbing molecules, termed chromophores, in living tissue. By
interrogating tissue with non-ionizing light within the near-infrared spectral range, light
absorption can be characterized and related to the in vivo concentration of chromophores.
NIRS was introduced by Frans Jöbsis in 1977 who discovered that NIR light could
penetrate the skull, providing a promising in-situ technique to monitor hemoglobin content
and oxygen utilization through photo-transmission [29]. Jöbsis observed an optical window
from 650-950 nm where light absorption from endogenous tissue chromophores is
relatively small, allowing for deeper photon penetration [30]. The most prevalent
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chromophores in tissue within this range are oxy-hemoglobin (HbO2), deoxy-hemoglobin
(Hb), and water. Wavelengths immediately above and below this region are highly
absorbed by water and Hb, respectively. Similar optical windows of lower absorption also
exist between 1100–1350 nm and 1600–1870 nm [31]; however, light sources in these
ranges have traditionally been power inefficient or not cost-effective for bedside
monitoring. Figure 1.1 shows the absorption spectra of HbO2, Hb, and water in the NIR
optical window where distinct spectral features between chromophores are apparent.

Figure 1.2: Optical window in the near-infrared.
By interrogating tissue with light at various wavelengths, the proportion absorbed by each
chromophore can be determined and related to their respective concentrations. A measure
of tissue oxygen saturation (StO2) can be calculated as follows:
[𝐻𝑏𝑂2 ]
2 ]+ [𝐻𝑏]

𝑆𝑡𝑂2 = [𝐻𝑏𝑂

(1.1)

This section will elaborate on the analytical basis of NIRS and the principles of converting
light absorption into chromophore concentrations.

1.2.1

Physical Principles of NIRS

Light incident on any media will be attenuated by two primary interactions: absorption and
scattering. When a photon strikes a medium it is absorbed if the frequency of the incoming
light is equivalent to the energy required to excite the molecule to a higher energy state.
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The loss of intensity as light travels through a non-scattering medium was first described
as absorption by Pierre Bouguer in 1729. Johann Heinrich Lambert, in 1760, expanded this
idea to describe absorption (A) in a homogenous material as proportional to the length of
sample through which the light passes:
𝐼

𝐴 = − log (𝐼 ) = 𝜇𝑎 𝑙
0

(1.2)

where I/I0 is the proportion of light absorbed, µa is the absorption coefficient representing
the inverse of the average distance that a photon is likely to travel before an absorption
event, and l is the thickness of a sample. August Beer, in 1852, determined that light
absorption is proportional to the concentration of the solution in which light is travelling.
This relationship between absorption and concentration is commonly referred to as the
Beer-Lambert law:
𝐴 = 𝜀𝑐𝑙

(1.3)

where 𝜀 is the molar extinction coefficient, an intrinsic property specific to each species,
and c is the concentration of the solution. In a sample consisting of numerous absorbers,
this law can be expanded to account for all constituents:
𝐴 = ∑𝑖 𝜀𝑖 𝑐𝑖 𝑙

(1.4)

The Beer-Lambert law, however, is only satisfied in a non-scattering medium. Within the
NIR window, light scatter is the most dominant interaction in tissue [32,33]. Rayleigh
scattering can occur when light interacts with particles smaller than the incident
wavelength, and Mie scattering when particles are much larger; the latter is more common
in tissues with the abundance of larger bodies such as nuclei and mitochondria. Scattering
via Fresnel Reflections is also common, occurring at an index of refraction. To account for
the influence of scatter, a modified Beer-Lambert law was introduced by Delpy et al. in
1988 [34]. Firstly, equation 1.3 can be adapted to describe intensity loss due to light
scattering as follows:
𝐼 = 𝐼0 𝑒 −𝜇𝑠 𝑙

(1.5)

where µs represents the inverse distance that a photon is likely to travel before it is
scattered. Similar to absorption, the behaviour of light scatter varies across different media.
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The Henyey-Greenstein Phase Function, described in 1941, is a probability density
function which describes the likelihood of light scattering at an angle 𝜃 given the scattering
anisotropy factor, g [35],
1

𝑝(𝜃) = 4𝜋

1−𝑔2
3

(1.6)

(1+𝑔2 −2𝑔 𝑐𝑜𝑠 𝜃)2

where g is intrinsic to the media and describes the likely direction of a scattered photon.
This metric can range from -1 to 1 as the mean cosine of the scatter angle; a value of 0
represents isometric scattering. Most tissue types have a g of approximately 0.9, which
means that light is mostly forward scattered. However, due to the high prevalence of
scattering events relative to absorption, directionality is quickly lost in tissue and photon
propagation resembles a photon cloud. As a result, scatter is assumed to be isotropic and
non-directional. In highly diffuse media such as tissue, scattering is commonly
characterized by the reduced scattering coefficient, µs′:
𝜇𝑠′ = 𝜇𝑠 (1 − 𝑔)

(1.7)

where 1/µs′ describes the average distance that a photon travels before its movement can
be modelled as a random walk or diffusion-like process. The change in µs′ with respect to
wavelength can be modelled using a power law:
𝜆 −𝛼

𝜇𝑠′ (𝜆) = A (𝜆 )
0

(1.8)

where α is the scattering power and A is the µs′ value at λ0, both of which can be determined
experimentally. For biological tissue, scattering is a combination of Mie and Rayleigh
effects with α between 3 and 5.5 [36]. The Beer-Lambert law can be modified to account
for the effects of scattering:
𝐴(𝜆) = 𝐷𝑃(𝜆) ∑𝑖 𝜀𝑖 𝑐𝑖 + 𝐺(𝜆)

(1.9)

where G is wavelength dependent scalar term, describing the proportion of light not
detected due to scatter, and the DP is the differential pathlength characterizing the distance
that light travels following multiple scattering events. In order to quantify chromophore
concentrations, these scattering dependent metrics must be determined in addition to
absorption information. Section 1.2.2 elaborates on modelling light propagation in a highly
scattering media.
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1.2.2

Light Propagation in Tissue

The behaviour of electromagnetic radiation is governed by Maxwell’s equations; however,
modelling this becomes exceedingly complex within a highly scattering and heterogeneous
medium such as tissue. Instead, the radiative transfer equation (RTE) can be used as a
simplification, describing light as discrete photons which undergo absorption and elastic
scattering events while conserving energy.
1 𝛿

[𝑣 𝛿𝑡 + 𝑠̂ ⋅ 𝛻 + 𝜇𝑎 + 𝜇𝑠 ] 𝐿(𝑟, 𝑡, 𝑠̂ ) = 𝜇𝑠 ∫4𝜋 𝐿(𝑟, 𝑡, 𝑠̂ )𝑃(𝑠̂ , 𝑠̂ ′ ) ⅆ𝛺 ′ + 𝑆(𝑟, 𝑡, 𝑠̂ ) (1.10)
where L(r,t,ŝ) is the radiance at position r in the direction defined by the vector ŝ at time t.
P(ŝ,ŝ′) is the scattering phase function which describes the probability of scattering to from
direction ŝ to ŝ′, S(r,t,ŝ) is the source term and 𝑣 is the speed of light in the medium. The
RTE can be greatly simplified for light propagation through a diffuse medium considering
the directionality of light quickly becomes isotropic due to the far greater number of
scattering events compared to absorption. For a source-detector distance (SDD)
significantly larger than µs′, the radiance becomes equivalent to the isotropic fluence and a
directional flux.
1 𝜕𝛷(𝑟,𝑡)
𝑣

𝜕𝑡

+ 𝛻 ⋅ 𝐽⃗(𝑟, 𝑡) + 𝜇𝑎 𝜙(𝑟, 𝑡) = 𝑆(𝑟, 𝑡)

(1.11)

where fluence, 𝛷 = ∫ 𝐿(𝑟, 𝑡, Ω)ⅆΩ and the flux, 𝐽⃗(𝑟, 𝑡) = −𝐷∇𝛷(𝑟, 𝑡). This can be further
simplified to the diffusion approximation (DA) as follows,
1 𝛿

(𝑣 𝛿𝑡 − 𝐷𝛻 2 + 𝜇𝑎 ) 𝜙(𝑟, 𝑡) = 𝑆(𝑟, 𝑡)

(1.12)

where D is the diffusion coefficient defined as follows:
1

𝐷 = 3[(1−𝑔)𝜇

𝑠 +𝜇𝑎 ]

= 3[𝜇

1
𝑠′ +𝜇𝑎 ]

(1.13)

Given certain boundary conditions and geometries, analytical solutions to the diffusion
approximation can be derived, which can be used to determine tissue optical properties
(i.e., µa and µs′). Section 1.3 elaborates on NIRS techniques that have been developed for
brain monitoring and approaches used to separate the effects of light scattering from
absorption.
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1.3

In vivo NIRS Techniques

The fundamental understanding of light interaction with tissue described above is utilized
in various approaches to quantify chromophore concentrations in vivo for a wide range of
clinical applications. These methods characterize absorption and scattering effects through
interrogating an area of interest with NIR light and analyzing changes in light intensity,
frequency, wavelength, time, and location. This section will describe the different NIRS
approaches investigated, the technology involved, and touch upon several applications of
these techniques in neuromonitoring with particular focus on the premature brain. Studies
involving hybrid/multi-modal devices will be discussed in section 1.5.

1.3.1

Continuous-wave NIRS

Continuous-wave (CW) NIRS systems utilize light sources that are constant in intensity
and implement a minimum of two wavelengths to characterize absorption changes related
to the concentrations of HbO2 and Hb. These devices are advantageous due to their high
temporal resolution, cost-effectiveness, and portability [37]. System components include
light sources, often either laser diodes or light-emitting diodes (LED), optical fibers to
direct and capture light, and photon detectors which vary across different optical
techniques. Most detectors rely on the photoelectric effect (PE) where a photon generates
a charge carrier and electrical current. This can occur ‘externally’, such as in photomultiplier tubes (PMT), where an incident photon liberates an electron, is accelerated in an
electric field, and causes a cascade of electrons ejections resulting in a signal amplification
[38]. The PE can also occur ‘internally’ as an absorbed photon creates an electron-hole
pair, produces a photocurrent, and is detected as an electrical signal. An example of the
internal PE is in the common photodiode, prevalent within CW-NIRS systems, where the
output voltage is proportional to the power of incident light. Further advances have led to
the avalanche photodiode (APD) which utilizes the internal PE, as in photodiodes, but
generates electron cascades to improve signal amplification similar to PMTs [38,39]. The
portability of sources and detectors, and their ability to effectively shield from ambient
light, have allowed for bedside monitoring and even wireless/wearable devices [37,40].
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CW-NIRS operates under the assumption that scattering is unchanged over the course of a
measurement. By analyzing only changes in intensity, without characterizing the optical
properties, only relative values of hemoglobin and StO2 can be acquired. While relative
measures can be valuable for tracking longitudinal changes, they are limited for
establishing clinical thresholds or comparing measures between subjects. Another set-back
of many CW-NIRS system is depth sensitivity, as they are unable to differentiate between
brain tissue and extra-cerebral layers (scalp and skull) [41]. This is less of an issue within
neonatal applications due to the thin skull thickness in the newborn [42].

1.3.1.1

Spatially Resolved Spectroscopy

Spatially resolved spectroscopy traditionally utilizes CW-NIRS techniques while
quantifying optical properties by implementing multiple light source-detector distances
(SDD). In 1989 Patterson et al. proposed that the effective attenuation coefficient (µeff)
could be measured by acquiring intensity information as a function of distance from the
light source [43]. Equation 1.15 defines µeff, and simplifies it given that µs >> µa:
𝜇𝑒𝑓𝑓 = √3𝜇𝑎 (𝜇𝑎 + 𝜇𝑠′ ) ≅ √3𝜇𝑎 𝜇𝑠′

(1.14)

Through modelling the diffusion approximation (described in section 1.2.2) for a semiinfinite geometry, while assuming the SDD, ρ >> 1/µs′, light reflectance can be described
as follows:
𝑅(𝜌) ∝

exp−𝜇𝑒𝑓𝑓
𝜌2

(1.15)

Taking a natural logarithm, the reflectance can be modelled as a linear equation with µeff
as the slope:
ln(𝜌2 𝑅(𝜌)) = −𝜇𝑒𝑓𝑓 𝜌 + 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡

(1.16)

By acquiring data at multiple distances, µeff can be determined. To quantify µa, an estimate
of µs′ is required [44]. Some work has utilized calibrated reflectance measurements to solve
for the intercept of the linear equation and estimate µs′ [45]. SRS was first demonstrated
by Matcher et al. in 1995 to provide absolute hemoglobin concentrations and saturation
values comparable to blood-gas analysis [46]. This technique is the basis for most
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commercially available NIRS devices. Section 1.3.1.2 elaborates on the clinical application
of commercial CW-NIRS systems implementing SRS technology.

1.3.1.2

Commercial CW-NIRS Devices

CW-NIRS has proven extremely useful in brain monitoring studies involving premature
infants, a very fragile patient population, due to its safe and non-invasive approach.
Compared to other techniques for examining the brain (described in section 1.1.2), NIRS
allows for continuous monitoring, requires minimal handling, and can be implemented
without

disrupting

clinical

care

(i.e.,

x-ray

imaging,

ventilation

equipment,

electroencephalography (EEG) monitoring, etc.). NIRS was first implemented on
newborns to monitor cerebral oxygen levels in vivo in 1985 by Brazy et al. [47]. Since
these preliminary reports, optical neuromonitoring with NIRS has been implemented
around the world to investigate the developing brain. Numerous commercial systems using
SRS technology have been developed for neonatal brain monitoring. Several groups have
compared the robustness of systems available and the clinical relevance of their measures
[48–52]. Generally, NIRS monitoring of StO2 has proven robust in characterizing trends
but absolute values have varied depending on the device and sensors used. Saturation
differences as large as 14% have been reported with neonatal sensors [53]. Notably, work
by Kleiser et al. compared measurements with five commercially available oximeters on a
phantom model of a neonatal head. Both system brand and sensor type were determined to
influence StO2 measures but values were found to be linearly related, allowing for
comparison across devices [54].
Despite these differences, the SafeBoosC Phase II randomized clinical trial was
implemented to determine the benefit of CW-NIRS measures of StO2 in extremely preterm
infants by developing a treatment guideline to manage deviations from an expected range
(55–85%) [55]. This study accepted a handful of NIRS devices that produced absolute StO2
values, allowing only a 5% deviation from the INVOS oximeter (Medtronic) and an
absolute repeatability of at least than 6% [56]. With these criteria, across 166 preterm
infants, the trial found that NIRS monitoring resulted in a significantly reduced burden of
hypoxia within the first 72 hours of life [57]. Without a gold-standard technique to provide
a robust absolute measure, establishing clinical guidelines for StO2 to gauge brain
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development or indicate injury remains a challenge. The following sections elaborate on
advanced NIRS techniques that have been investigated to provide more robust
measurements or more sensitive biomarkers of development/injury.

1.3.1.3

Broadband NIRS

Broadband NIRS (B-NIRS) is a CW-NIRS technique which analyzes absorption as a
function of wavelength across the entire optical window. An estimate of DP can be derived
using the absorption spectrum of water, which has distinct spectral features. This approach
was first reported by Matcher et al. in 1993 who calculated DP as the quotient of the
apparent water concentration, determined using the measured amplitude at 970 nm, divided
by an assumed water concentration for brain tissue [58]. Light attenuation is also
influenced by a DC scattering component (the G term from the modified Beer-Lambert
law, equation 1.9). By taking the second derivative of the reflectance spectrum, the
influence of scattering can be considered negligible due to its weak wavelength
dependence. Derivatives of G can therefore be omitted by assuming wavelength
independence over this range. The second derivative of the attenuation is modelled as
follows:
𝜕2 𝐴(𝜆)
𝜕𝜆2

= 𝐷𝑃 ∑𝑖

𝜕 2 𝜀𝑖 (𝜆)
𝜕𝜆2

𝐶𝑖

(1.17)

where terms are defined as in equation 1.9. The water feature can be characterized by
performing a least-squares fit between the second derivatives of the measured and ground
truth water absorption spectra. The DP can be determined by scaling this factor by an
assumed brain water concentration [58].
Derivative spectroscopy has since been extended to solve for absolute concentrations of
hemoglobin by fitting the first and second derivatives of solutions for the diffusion
approximation to the first and second derivatives of the measured reflectance data
(Figure 1.3) [59–61].
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Figure 1.3: Extinction coefficient, 1st, and 2nd derivatives for HbO2, Hb, and water.
In this approach, light propagation is modelled via a steady-state solution to the diffusion
approximation with reflectance given by [62]:
1

1

𝑅(𝜌) = 4𝜋 [𝑧0 (𝜇𝑒𝑓𝑓 + 𝑟 )]
1

𝑒

(−𝜇𝑒𝑓𝑓 𝑟1 )

𝑟12

1

+ (𝑧0 + 2𝑧𝑏 ) (𝜇𝑒𝑓𝑓 + 𝑟 )
2

𝑒

(−𝜇𝑒𝑓𝑓 𝑟2 )

𝑟22

(1.18)

where r1= [ρ2 + z02]1/2 and r2 = [ρ2 + (z0 + 2zb)2]1/2. The effective depth is represented by
z0 = 1/µs′, while zb = 2D(1+Reff)(1-Reff)-1 is the extrapolated boundary [63] with
Reff = 0.493 as the effective reflection coefficient for tissue and air refractive indices [64].
The impact of scatter (described by equation 1.8) is characterized by solving for the
scattering terms A and α using a least-square minimization algorithm. The introduction of
a derivative analysis has the added benefit of minimizing the influence of DC noise from
ambient light sources. However, the fitting algorithms involved have proven to be
computationally heavy and require too much time to allow for real-time monitoring. Recent
work has combined the derivative approach to quantify chromophores at baseline with
relative models using the Beer-lambert Law to provide continuous absolute monitoring at
high temporal resolutions:
(𝐻𝑏𝑂 𝑏 +∆𝐻𝑏𝑂 )

2
2
𝑆𝑡 𝑂2 = (𝐻𝑏𝑏+∆𝐻𝑏)+(𝐻𝑏𝑂
𝑏 +∆𝐻𝑏𝑂
2

2)

(1.19)
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where the superscript ‘b’ indicated absolute values measured at baseline and variables
preceded by Δ indicate relative changes [65].
In addition to measuring StO2, B-NIRS is capable of monitoring cerebral metabolism. This
is achieved through the metabolic marker cytochrome c oxidase (CCO), an enzyme in the
mitochondria’s electron transport chain vital to oxidative phosphorylation. CCO is the final
electron accepter that becomes oxidized, reducing oxygen to water. This exchange builds
on an electrochemical gradient which ultimately drives ATP synthesis. A reduction in CCO
may signal subsequent damage; significant reductions in energy production can lead to cell
death and tissue damage [66]. To meet high energy demands, the brain has a relatively
higher concentration of mitochondria compared to the skin and muscle that comprises the
extra-cerebral layers, making CCO a more brain-sensitive marker of metabolism. Similar
to hemoglobin, oxygenated and deoxygenated CCO have distinct absorption spectrum in
the NIR (Figure 1.4).

Figure 1.4: Absorption spectra of oxCCO
The total concentration of CCO in the brain is stable; however, its oxidization is dynamic
[67]. A relative change in metabolism can therefore be determined by comparing the
interchange between oxidation states. This is achieved using B-NIRS by analyzing the
oxidized-reduced difference spectrum to indicate changes in the oxidized state of CCO
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(oxCCO). Analytically, a modified Beer-Lambert law (similar to equation 1.9), developed
by researchers at University College London, includes oxCCO as a chromophore [68]:
−1

𝜀𝐻𝑏𝑂2 (𝜆1 ) 𝜀𝐻𝑏 (𝜆1 ) 𝜀𝑜𝑥𝐶𝐶𝑂 (𝜆1 )
∆𝐻𝑏𝑂2
1
⋮
⋮
⋮
[ ∆𝐻𝑏 ] = 𝐷𝑃 [
]
(𝜆
)
(𝜆
)
(𝜆
)
𝜀
𝜀
𝜀
∆𝑜𝑥𝐶𝐶𝑂
𝐻𝑏𝑂2 𝑛
𝐻𝑏 𝑛
𝑜𝑥𝐶𝐶𝑂 𝑛

∆𝐴(𝜆1 )
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An in vivo measurement of CCO has been sought since the conception of NIRS [29]. With
a concentration less than 10% of hemoglobin’s, accurate measures of CCO have proven
challenging and controversial with traditional NIRS technology [68–71]. The more recent
use of spectral analysis has allowed for robust measures, characterizing oxCCO’s broad
absorption feature [72,73]. Optical measurements of oxCCO were found consistent with
metabolic measures from cerebral microdialysis [74] and MRS [75]. To confirm signal
contribution from cytochrome, equation 1.20 can be solved both with (3-component model)
and without (2-component model) the inclusion of ΔoxCCO. The resulting concentrations
can then be used to back-calculate the attenuation from which a residual difference between
calculated and measured attenuation can be determined. The incorporation of oxCCO as a
chromophore can be justified by noting that the 2-component residual resembles the
absorption spectra of oxCCO, suggesting a missing chromophore in the fit, while the 3component residual is approximately zero across all wavelengths [67].
B-NIRS achieves hyperspectral analysis by implementing a ‘white-light’ halogen bulb as
a source, which emits throughout the NIR, and a spectrometer employing a diffraction
grating to separate incoming light as a function of wavelength. In the spectrometer, light is
detected by a charged couple device (CCD) which operates using the internal PE (described
in section 1.3.1). In comparison to APD or PMT technology, CCDs collect spatial
information along an array of pixels. B-NIRS systems, in comparison to other advanced
NIRS approaches (discussed in sections 1.3.2 and 1.3.3), are simple in their design and are
cost-effective [76]. While B-NIRS is able to acquire metabolic information, it is limited in
depth sensitivity, similar to traditional CW-NIRS approaches.
B-NIRS measures of StO2 and oxCCO have been acquired in several relevant animal
models and neonatal studies. Early work investigating cytochrome using discrete
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wavelength CW-NIRS systems have reported conflicting and inconsistent measures. Given
these discrepancies, only recent applications utilizing B-NIRS systems will be discussed
(for a detailed history of CCO measures see the recent review by Bale et al. [67]). Within
a piglet model of neonatal hypoxia-ischemia (achieved through reducing inspired oxygen
and occluding carotid arteries), Bainbridge et al. reported a correlation between oxCCO
and clinical outcome at 48 hours post-injury [75]. In a similar animal model, measures of
oxCCO were able to gauge injury severity [77]. In this study, controlled anoxia events prior
to and following injury were monitored while injury severity was confirmed using MRS.
In 2014, Bale et al. monitored cerebral saturation and metabolism in six infants with
neonatal encephalopathy for over 200 hours in the NICU [73]. This work demonstrated the
feasibility for longitudinal optical monitoring while observing 236 desaturation events. A
significant similarity between oxCCO and MRS biomarkers of injury severity was
reported. McLachlan et al. utilized a B-NIRS system to monitor StO2 nine infants with
PHVD receiving a ventricular tap and demonstrated the potential of optical monitoring in
gauging intervention efficacy. A significant increase in post-operative StO2 was found
compared to a control group. In addition, preliminary work in a neonatal piglet model
manipulated cerebral metabolism through inducing ischemia and using an anaesthetic to
reduce oxygen demand. This work compared oxCCO and calculated measures of
metabolism based on oxygen utilization, finding a temporal delay in the latter [78]. Further
work is required to elucidate the difference between the two metabolic measures.

1.3.2

Time-resolved NIRS

Time-resolved NIRS was first introduced in 1988 by Chance et al. and Delpy et al. to
characterize the DP using time-of-flight information as photons traverse tissue [34,79]. TRNIRS utilizes a light source with extremely short laser pulses, on the order of picoseconds.
High temporal resolution detectors and electronics generate histograms of incoming
photons as a function of arrival time, referred to as temporal point spread functions (TPSF,
Figure 4).
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Figure 1.5: Time-resolved NIRS with pulse of intensity I0(t) is incident on tissue,
producing a TPSF with intensity I(t).
By modelling the TPSF by the DA, the optical properties can be quantified and, in turn,
used to determine absolute chromophore concentrations. The time dependent solution of
the DA for semi-infinite geometry can be given as follows [80]:
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(1.21)

Time-of-flight information provides the added benefit of increased depth sensitivity. Later
arriving photons, depicted by the tail-end of each TPSF, can be separately binned to isolate
light that has travelled deeper within tissue [81]. Recent studies have demonstrated the
impact of analyzing these photons to differentiate between signal contribution from the
brain versus extra-cerebral layers [82]. Depth sensitivity can also be achieved through
calculating the statistical moments, with higher moments more sensitive to the latter end
of the histogram representing later arriving photons [83,84].
To achieve high temporal resolution measures, TR-NIRS systems utilize pulsed lasers
operating on the order 80 MHz and quick detectors such as PMTs coupled to a photon
counting module to generate TPSFs. These components are costly and bulky compared to
other NIRS approaches, making TR-NIRS challenging for bedside monitoring with few
commercial TR-NIRS systems available, most notably is the TRS device by Hamamatsu
Photonics, Japan. Many recent studies have worked to minimize the size of TR-NIRS
equipment and develop portable systems [85,86]. Multi-channel devices have also been
developed for complete brain mapping and optical tomography [87,88]. The UCL group
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has utilized their 32-channel system, dubbed MONSTIR, to generate three-dimensional
images of the premature brain with IVH. Measured absorption and cerebral blood volume
(CBV) was consistent with the asymmetry expected from the hemorrhaged area [89]. In
neonatal animal models, TR-NIRS measurements of venous oxygenation (calculated from
StO2) were shown to agree with values obtained from directly from sagittal sinus blood
[90]. However, in a neonatal piglet model of hyper/hypoxia, measures of StO2 with TRand B-NIRS devices produced strong a correlation but discrepancies between absolute
values persisted, with B-NIRS reporting significantly higher measures [91]. Experiments
in phantom and animal models have also demonstrated the ability of TR-NIRS to monitor
deep brain temperature by analyzing shifts in the water absorption peak [92].
TR-NIRS was first used on newborn infants by Van der Zee et al. in 1992 to characterize
the DP as a function of depth [93] and similar devices have since been translated to the
clinic in a number of exploratory studies. In 2005, Ijichi et al. measured optical properties,
StO2, and CBV as a function of GA in term infants admitted to the NICU [94]. This study
demonstrated the feasibility for bedside neuromonitoring in the NICU while reporting a
positive correlation of µs′ and CBV and a negative correlation of StO2 with increasing GA.
Following this, a number of clinical studies have implemented Hamamatsu’s TRS devices
in neonatal populations. Using the TRS-10 system, Koyano et al. found significant
increases in CBV and decreases in StO2 in infants with high Hb levels prior to blood
transfusion. This work demonstrated the potential of TR-NIRS monitoring to guide the
decision to transfuse in VLBW infants [95]. Using the TRS-20 system, Ishii et al. reported
significantly higher StO2 and lower OEF in infants small for their GA compared to infants
of an appropriate size [96]. In similar measurements, Fujioka et al. compared premature
infants to those born at term, within the first three days of life, and found similar StO2
values but significantly increased CBV in the full-term group [97].

1.3.3

Frequency-domain NIRS

Frequency domain NIRS (FD-NIRS) was proposed in 1990 as an alternative approach for
quantifying tissue optical properties using a radiofrequency modulated light source [98–
100]. By altering the emission-source intensity, light interrogating tissue will reach the
detector with a change in phase proportional to the distance travelled (Figure 7). By
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acquiring both the light attenuation and phase shift, the DP and optical properties can be
determined and used to quantify chromophore concentrations [32].

Figure 1.6: Frequency domain NIRS, phase modulated light source with intensity I0
is incident on tissue resulting in an intensity change (I1) and change in phase (𝜱).
The intensity collected at the detector can be represented by [101]:
𝐼 = 𝐼𝐷𝐶 + 𝐼𝐴𝐶 𝑠𝑖𝑛(2𝜋𝑣𝑡 − 𝜙)

(1.22)

where IDC is the average detected intensity, IAC is the amplitude of the frequency dependent
intensity, v is the modulating frequency, and 𝛷 is the phase shift. The DP can then be
calculated as 𝐷𝑃 = 𝛷c𝑣 /2π𝑣𝑛𝑡 [101]. By assuming the modulating frequency is
significantly smaller than frequency of scattering events, a solution to the diffusion
approximation exists for a semi-infinite homogeneous medium. In 1993, Fishkin and
Gratton [102] derived expressions for the measured phase (F 𝛷), AC (FAC), and DC (FDC)
signals which can be summarized as follows [103]:
𝐹𝜑 (𝜑, 𝜌, 𝜔, 𝜇𝑎 , 𝜇𝑠′ ) = 𝑆𝜑 (𝜔, 𝜇𝑎 , 𝜇𝑠′ )𝜌 + 𝐾𝜑−𝑆𝑜𝑢𝑟𝑐𝑒 + 𝐾𝜑−𝐷𝑒𝑡𝑒𝑐𝑡𝑜𝑟

(1.23)

𝐹𝐴𝐶 (𝐷𝐶, 𝜌, 𝜔, 𝜇𝑎 , 𝜇𝑠′ ) = 𝑆𝐴𝐶 (𝜔, 𝜇𝑎 , 𝜇𝑠′ )𝜌 + 𝐾𝐴𝐶−𝑆𝑜𝑢𝑟𝑐𝑒 + 𝐾𝐴𝐶−𝐷𝑒𝑡𝑒𝑐𝑡𝑜𝑟

(1.24)

𝐹𝐷𝐶 (𝐷𝐶, 𝜌, 𝜇𝑎 , 𝜇𝑠′ ) = 𝑆𝐷𝐶 (𝜇𝑎 , 𝜇𝑠′ )𝜌 + 𝐾𝐷𝐶−𝑆𝑜𝑢𝑟𝑐𝑒 + 𝐾𝐷𝐶−𝐷𝑒𝑡𝑒𝑐𝑡𝑜𝑟

(1.25)

where ρ represents the SDD and ω is the angular modulation frequency of the source. SDC,
SAC, and Sφ represent the slopes of these linear functions and the K terms embody
instrumental factors intrinsic to the source and detector [103]. While the latter terms are
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unknown, SRS techniques can be used to acquire measurements at multiple distances and
determine the optical properties from a calculated slope as follows:
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(1.26)
(1.27)

where S denotes the slope for equations 1.24-1.26. With data acquired from a minimum of
two wavelengths, absolute concentrations of Hb and HbO2 can be determined [101].
Single-distance approaches to quantify FD-NIRS measures has also been achieved by using
a calibration phantom with known optical properties to determine K terms (in equations
1.23-1.25) or by using a multi-frequency measurement with the modulation frequency (ω)
as the independent variable opposed to the SDD (ρ) [103].
While FD-NIRS systems are more complex than CW-NIRS techniques, they are simpler
and more cost-effective compared to TR-NIRS. Sources often exist as laser diodes
alternately driven at frequencies on the order of 100 MHz and fast detectors, such as PMTs,
operating in heterodyne mode. Compared to TR-NIRS devices, FD-NIRS requires multidistance or multi-frequency measurements to quantify tissue chromophores. Alternatively,
FD-NIRS requires the inclusion of a calibration measurement, prior to monitoring, in order
to characterize the power of different sources and gains of detectors [104]. Despite the
ability of FD-NIRS to characterize the DP, a study by Binzoni et al. compared the depth
sensitivity between FD and CW-NIRS approaches and reported a similarity when
modulation frequencies were < 200 MHz [105]. A study by Dehaes et al. found a major
source of error with FD-NIRS measures, determined through Monte Carlo simulations, to
be the significant curvature of the neonatal head relative to the typical source-detector
distance since FD-NIRS are typically calibrated assuming a planar geometry. In this study
optical absorption in the neonatal brain was retrieved with an error of 8–24% [106].
FD-NIRS was first implemented on newborn infants in 1995 by Duncan et al. to
characterize optical pathlength [107], and in 1998 ISS Inc. (Champaign, IL) developed
Oxiplex, the first commercial FD-NIRS system. Today it remains as one of the few
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commercially available devices. In 2007, Franceschini et al. implemented FD-NIRS to
monitor early brain development [108]. Here, StO2, CBV, and CMRO2 were calculated
from measurements of hemoglobin concentrations and agreed with previously described
developmental milestones from PET and EEG studies. A strong correlation was also found
between changes in CBV/CMRO2 measures and neonatal brain injury [109]. Recent work
by van Essen et al. compared StO2 measurements acquired using the Oxiplex FD-NIRS
and the INVOS CW-NIRS (Medtronic) systems in premature infants within the first 15minutes of life [110]. Significantly higher saturation values resulted using the Oxiplex
system, suggesting persistent inconsistencies between optical techniques. Comparing
preterm to term infants, Arri et al. found no significant difference between mean StO2
values, similar to the study by Fujioka et al. using TR-NIRS [97], but reported
measurement precision greater in infants at term due to changes in tissue homogeneity with
development [33]. Roche-Labarbe et al. acquired optical measures of CBV and StO2 using
FD-NIRS in combination with CBF from TCD to calculate CMRO2 in premature infants
within six weeks following birth [111]. CBV was found to increase with GA, similar to
reports using TR-NIRS [94]; however, no change in StO2 was noted. This study found a
significant discrepancy between CMRO2 calculated using estimated and direct measures
of CBF and emphasized the benefit of combining NIRS approaches with CBF monitoring.
Section 1.4 describes optical techniques to measure CBF and section 1.5 elaborates on the
development of hybrid systems.

1.4

Optical Blood Flow Monitoring

NIRS measurements of StO2 have been used to describe oxygen content in the newborn
brain during various stages and abnormalities. This metric has acted as a surrogate marker
of cerebral hemodynamics and metabolism, due to a lack of adequate technology to provide
more direct measures, but has proven limited in indicating adverse cerebral events or in
predicting clinical outcomes [49,50,112]. Emerging optical techniques have proven
capable of measuring blood flow in cerebral macro and microvasculature. This section will
elaborate on approaches to directly measure CBF in the premature brain and their clinical
applications.
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1.4.1

Dynamic Contrast-Enhanced NIRS

NIRS is capable of quantifying blood flow using both endogenous [113,114] and
exogenous [115–117] contrast agents. The former approach is based on the Fick principle
and work by Kety and Schmidt who, in 1945, utilized nitrous oxide gas inhalation and brain
uptake to provide the first quantitative measure of cerebral perfusion in humans [118].
NIRS can similarly use light absorption from HbO2 as a flow tracer and has demonstrated
comparable CBF measures with 133Xe clearance techniques in premature infants [119,120].
Dynamic contrast-enhanced (DCE) NIRS instead utilizes an intravenous injection of the
light absorbing dye indocyanine green (ICG) to act as an intravascular contrast agent. This
exogenous tracer has a stronger and more distinct absorption peak in the NIR. DCE-NIRS
can quantify CBF through a tracer kinetics model [121–123]:
𝐶𝑏 (𝑡) = 𝐶𝐵𝐹 ∙ 𝑅(𝑡) ∗ 𝐶𝑎 (𝑡)

(1.28)

where Cb is the ICG concentration in brain tissue measured using NIRS and Ca is the
arterial concentration acquired using a dye densitometer. R(t) is the impulse residue
function which describes the fraction of dye in the tissue at time t following a bolus
injection at t = 0. CBF can be solved by deconvolution since R(0) ≡ 1. Absolute measures
of CBF have been validated in piglets against measurements obtained with computed
tomography (CT) perfusion [115,124] and in adults against arterial spin labelling (ASL)
MRI [125]. DCE-NIRS has shown strong agreement when using both CW- and TR-NIRS
techniques [116]. In addition, multi-distance NIRS has allowed for depth-resolved flow
measurements [126,127]. The use of ICG to monitor CBF was demonstrated in infants by
Patel et al. in 1998 who found good agreement with NIRS measures of flow using HbO2
as an endogenous marker [128]. DCE-NIRS measures of CBF have been combined with
StO2 from standalone NIRS to calculate CMRO2 in piglet models of neonatal hypoxia
ischemia [129,130] and in infants with patent ductus arteriosus [131] and post-hemorrhagic
hydrocephalus [132]. The development and clinical translation of hybrid systems to acquire
metabolic information is the focus of section 1.5. Due to the need for a contrast agent,
DCE-NIRS is a minimally invasive technique but is only able to provide discrete
measurements of CBF. More recent advancements in optical technology have provided a
means of continuous non-invasive monitoring of CBF at the bedside.
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1.4.2

Diffuse Correlation Spectroscopy

Diffuse correlation spectroscopy (DCS) is a technique gaining significant popularity in
recent literature which can continuously acquire microvascular CBF without the use of
contrast. DCS, similarly to NIRS, utilizes light in the NIR range, but focuses on
characterizing scattering events caused by red blood cells (RBC). When interrogating a
region with light, constructive and destructive interference of light electric fields will be
apparent at the site of the detection fiber as dynamic bright and dark spots; this is referred
to as a speckle pattern. Speckle intensity analysis was originally investigated to determine
the size and structure of large molecules [133] and, under various names, has shown
potential in flow monitoring [134,135]. More recently, Boas et al. set the ground work in
developing DCS as a potential tool for measuring cerebral perfusion [136,137]. Since RBC
are the primary moving light scatterers in tissue [138], the faster they move in vasculature
the quicker the speckle intensity will fluctuate. By analyzing these temporal fluctuations
with an autocorrelation, RBC motion can be related to correlation decay and, in turn, to
blood flow. For an electromagnetic field in a highly scattering medium, the field
autocorrelation function G1(𝜌,𝑡) can be given by:
𝐺1 (𝜌, 𝜏) = 〈𝐸(𝜌, 𝜏) ∙ 𝐸(𝜌, 𝑡 + 𝜏)〉

(1.29)

where E(𝜌,𝑡) is the electric field at SSD (𝜌) and time (t), 𝜏 is the delay time, and angle
brackets denote temporal averages. The normalized field autocorrelation function can then
be represented as:
𝑔1 (𝜌, 𝜏) =

〈𝐸(𝜌,𝜏)∙𝐸 ∗ (𝜌,𝑡+𝜏)〉
〈|𝐸(𝜌,𝑡)|2 〉

(1.30)

DCS monitors speckle light intensity at high temporal resolutions, from which a
normalized intensity autocorrelation function can be determined:
𝑔2 (𝜌, 𝜏) =

〈𝐼(𝜌,𝜏)∙𝐼(𝜌,𝑡+𝜏)〉
〈|𝐼(𝜌,𝑡)|2 〉

(1.31)

where I(ρ,t) is the detected light intensity at an SDD ρ and time t. The normalized intensity
and electric field autocorrelation function are related via the Siegert relationship [139]:
𝑔2 (𝜌, 𝜏) = 1 + 𝛽|𝑔1 (𝜌, 𝜏)|2

(1.32)
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where β is the coherence factor dictated by the number of speckles detected and laser
properties (i.e., coherence length and stability). G1 satisfies the diffusion equation and,
assuming a point source and semi-infinite homogenous geometry, can be solved for using
the correlation diffusion equation (CDE) [137]. Similar to the RTE (Equation 1.10) which
assumes energy conservation with photon scatter, the CDE describes a transfer of
correlation, in that it accumulates a correlation decay with scattering events. The DA
(equation 1.12), simplified from the RTE, can instead be modelled as the CDE [136]:
[𝐷(𝑟, 𝑡)𝛻 2 − 𝑣𝜇𝑎 (𝑟, 𝑡) − 𝑘𝐷2 (𝜏)] ⋅ 𝐺1 (𝑟, 𝑡) = −𝑣𝑆(𝑟)

(1.33)

where D is the diffusion coefficient (equation 1.13) and kD2 represents a correlation decay
caused by the motion of scatterers.
𝑘𝐷2 (𝜏) = 3𝜇′𝑠 𝜇𝑎 + 𝛼𝜇′2𝑠 𝑘02 〈𝑟 2 (𝜏)〉

(1.34)

where alpha is the ratio of moving scatterers to all scatterers, 𝑘0 = 2𝜋𝑛/𝜆 is the light
wavenumber (with λ as the wavelength and n as the refractive index), and <Δr2(τ)> is the
mean-square displacement of the scatterers over delay time τ. To model flow in
vasculature, the Brownian diffusion model assumes incoherent motion and is given by:
〈∆𝑟 2 (𝜏)〉 = 6𝐷𝐵 𝜏

(1.35)

where DB is the effective diffusion coefficient. Applying Brownian motion to the equation
kD2 gives:
𝑘𝐷2 = 3𝜇′𝑠 𝜇𝑎 + 6𝜇′2𝑠 𝑘02 𝛼𝐷𝐵 𝜏

(1.36)

where the collective term αDB (in units cm2/s) represents an index of blood flow (BFI)
[140,141]. To solve for aDB, G1 must first be calculated, which is achieved through an
analytical solution to the CDE (equation 1.33) [62,142]:
𝐺1 (𝜌, 𝜏) =

3𝜇′𝑠 𝑒 −𝑘𝐷 (𝜏)𝑟1
4𝜋

[

𝑟1

−

𝑒 −𝑘𝐷 (𝜏)𝑟2
𝑟2

]

(1.37)

where r1= [ρ2 + z02]1/2 and r2 = [ρ2 + (z0 + 2zb)2]1/2.. The effective depth is represented by
z0 = 1/µs′, while zb = 2D(1+Reff)(1-Reff)-1 is the extrapolated boundary [63] with
Reff = 0.493 as the effective reflection coefficient for tissue and air refractive indices [64].
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Figure 1.7: Normalized intensity autocorrelation function showing correlation decay
at varying flowrates
To isolate speckle intensity fluctuations from RBC motion, DCS employs a continuouswave long-coherence laser. A coherence length (>5 m) significantly larger than the photon
pathlength (<1 m) is required to ensure that the light interrogating tissue remains in-phase
despite the large pathlength travelled. Any decay in the correlation can then be attributed
to the movement of scatterers opposed to fluctuations from the source itself. Most
commonly, DCS utilizes a laser within the first optical window (e.g. 785 nm). Recent work
has shown that longer wavelengths (>1000 nm) have SNR advantages [143]. When
collecting light, implementing a single-mode detection fiber (core radius ~2-8 µm)
improves speckle contrast by allowing only a single scattered electric field component.
However, the small amount of light collected from the small core greatly reduces SNR.
The use of few-mode fibers has been shown to improve upon this by increasing the number
of photons collected while suffering only a slight decrease in speckle contrast [144–146].
To monitor CBF at high temporal resolutions, single-photon avalanche photodiode (SPAD)
detectors are utilized. Coupled with a counting board, these detectors can achieve a high
SNR. To calculate an autocorrelation curve, incoming photons are binned as a function of
time. Traditionally, this is achieved using a multi-tau hardware correlator board with set
delay times, ranging from µs to s. Improving upon this, Baker et al. found a selection of
delay times to increase temporal resolution and SNR [147]. Modifying delay times also has
potential to improve depth sensitivity, as fitting earlier delay times represents longer photon
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pathlengths and increased brain signal contribution [148]. Further, Wang et al. showed the
development of a software correlator to digitally bin photons for calculation of the
autocorrelation curve, allowing increased selectivity of the delay time range [149]. High
temporal resolution flow measurements achieved using software correlators have proven
capable of monitoring CBF pulsatility [149,150]. In comparison to NIRS, DCS has
improved depth sensitivity, showing a three-fold increase in brain-to-scalp signal
contribution, making it ideal for bedside neuromonitoring [148]. Multi-layer models have
been implemented to differentiate between scalp and brain flow in both animals and
humans [147,151]. Signal contribution from the brain has been further investigated with
the development of time-domain (TD) DCS systems. Similar to TR-NIRS approaches, TDDCS acquires a temporal point spread function, while simultaneously measuring the
autocorrelation function, and through time-gating can differentiate photon pathlengths and
ultimately depth penetration [152].
A large number of studies in animal models, adults, and neonates have reported strong
correlations of BFI (measured in cm2/s) with CBF (measured in traditional units of
mL/min/100 g) using numerous techniques including Doppler ultrasound [153], DCEultrasound [154], TCD [155], Xenon-CT [156], DCE-NIRS [60,157], phase-contrast MRI
[158], and ASL-MRI [140,159–162]. DCS has generally been used to track relative
measures of CBF, as quantification requires measuring the optical properties
[157,163,164]. BFI’s relative measure of flow has been implemented alongside DCE-NIRS
techniques to quantify CBF [157,165]. Recently, a stand-alone DCS system was shown to
capable of providing absolute CBF through multi-distance DCE measurements, finding a
strong correlation with DCE-NIRS measures of flow [141].
DCS systems have been implemented to monitor the premature brain in a number of studies
and are often combined with other NIRS techniques to provide both perfusion and
metabolic information. Section 1.5 outlines the benefits of hybrid optical systems in
acquiring these metrics and elaborates on the clinical applications of both CBF and
metabolic neuromonitoring in the NICU.

28

1.5

Hybrid Optical Systems

Limitations in the clinical relevance of StO2 alone, and the more recent emergence of DCS
measures of flow, has prompted the development of hybrid NIRS/DCS devices to acquire
both cerebral perfusion and metabolism concurrently [25]. A bedside measure of
metabolism has potential in providing a more direct marker of injury. It can provide context
to fluctuations in CBF and indicate when changes are significant enough to impact oxygen
utilization. When cells are not sufficiently metabolizing oxygen to create energy, it can
result in cell death and subsequent brain damage. Metabolism is most commonly calculated
as CMRO2, a conservation equation based on the Fick principle, which determines oxygen
consumption in units of O2/100 g/min by measuring cerebral blood flow and the
arteriovenous oxygen difference [90,118,140]:
𝐶𝑀𝑅𝑂2 = 𝐾 × 𝑡𝐻𝑏 × 𝐶𝐵𝐹 × (𝑆𝑎𝑂2 − 𝑆𝑣𝑂2 )

(1.38)

where K is the oxygen carrying capacity of hemoglobin (1.39 mL of O2 per g of Hb [166]),
tHb is the total hemoglobin concentration, SaO2 is the arterial oxygen saturation, and SvO2
is the venous oxygen saturation. When applied to NIRS, SvO2 is determined from StO2 by
assuming a fixed ratio of arterial-to-venous blood:
𝑆𝑣𝑂2 =

𝑆𝑡𝑂2 −𝑆𝑎𝑂2 (1−𝑓𝑣 )
𝑓𝑣

(1.39)

where fv is the venous volume fraction (0.75) [167]. Equation 1.38 can then be simplified
as follows:
𝐶𝑀𝑅𝑂2 =

𝐾×𝑡𝐻𝑏×𝐶𝐵𝐹
𝑓𝑣

× (𝑆𝑎𝑂2 − 𝑆𝑡𝑂2 )

(1.40)

By combining NIRS measures of StO2 and DCS measures of CBF, CMRO2 can be
determined. This combination was first demonstrated by Cheung et al. in 2001 and has
since evolved in highly sophisticated and commercially available devices [142]. This
section elaborates on the development of systems combining the NIRS techniques
described in section 1.3 with DCS to monitor the newborn brain.
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1.5.1

Frequency-domain NIRS and DCS

The first hybrid system presented by Cheung et al. utilized multi-distance FD-NIRS and
DCS technology to collect optical data from four different positions on a rat’s brain [142].
The system was adapted to monitor CBF and CMRO2 during ischemia in a similar animal
model [168] and soon after in the adult brain [169]. This device acquired FD-NIRS and
DCS information in succession and reported a 2.5-minute temporal resolution for a full
data set. Since this work, significant improvements have been made to system SNR,
temporal resolution, and depth sensitivity. Advancements have allowed for robust
monitoring and translation of technology to the NICU to monitor perfusion and metabolism
at the bedside [104]. A notable milestone was the development of the MetaOx described
by Carp et al. in 2017, the first commercially available FD-NIRS/DCS device [170]. This
system can acquire data at 10 Hz, enabling pulsatile measurements, and can analyze
collected data in real-time. By implementing a short-pass filter to block DCS light from
FD-NIRS PMT detectors, it allows for a truly simultaneous measure of perfusion and
metabolism. Validation of the system demonstrated similar results to stand-alone devices.
Recent work has also introduced motion correction algorithms for CBF and CMRO2
measures [171].
Both research and commercial FD-NIRS/DCS systems have been translated to the NICU
to investigate perfusion and metabolic change during early stages of brain development. In
2010, Roche-Labarbe et al. monitored CBF and CMRO2 in preterm infants during the first
six weeks of life. In this study StO2 measures steadily decreased during this period, while
CBF and CMRO2 increased, with the latter increasing 40% [111]. This group also observed
changes in CBF and CMRO2 as a function of brain development, finding both to positively
correlate with post-menstrual age [172]. Recent work has also found correlations between
CBF and malnutrition impeding adequate development [173]. Significantly reduced CBF
and CMRO2 values have been reported in extremely low GA (24-28 weeks gestation)
infants with IVH compared to those without hemorrhages [174]. Regional changes in CBF
and CMRO2 in both preterm and term infants have also been investigated, finding
significantly increased values in the right hemisphere [175,176]. In age-matched groups,
males were found to have higher CBF in most regions, a higher CMRO2 in the frontal
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region, and more prominent hemispheric asymmetry [104,176]. Such a discrepancy was
expected since newborn males are generally more susceptible to white matter injury,
hypoxic-ischemic injury, and cerebral palsy than females [177,178].
Similar FD-NIRS/DCS systems have been utilized to investigate a wide range of neonatal
brain injuries. Several studies have monitored CBF and CMRO2 in infants with complex
congenital heart disease (CHD). Durduran et al. investigated cerebrovascular reactivity
(i.e., changes in CBF in response to change in partial pressure of CO2), which has been
associated with adverse neurodevelopment, finding minimal influence of hypercapnia on
flow/metabolic measures in term infants [179] while differences in CBF and CMRO2 were
found in CHD patients compared with controls [180]. Severe forms of CHD were found to
produce CBF and CMRO2 values similar to expected values for preterms and showed a
strong correlation to MRI-measured values when infants were at rest and hypercapnic
[161]. In infants with ventricle lesions undergoing neonatal cardiac surgery, no correlation
was found between changes in CBF/CMRO2 and duration of deep hypothermic circulatory
arrest [181]. In infants with hypoxic-ischemic encephalopathy decreases in both metrics
were found when undergoing therapeutic hypothermia [182]. Optical measures of
perfusion and metabolism have also been used as a marker of functional activation in
preterm infants [183].

1.5.2

Time-resolved NIRS and DCS

Similar to devices described in section 1.5.1, hybrid systems combining TR-NIRS and DCS
techniques offer continuous and robust measurements of CBF and CMRO2. Due to the
complexity of TR-NIRS devices (as described in section 1.3.2) studies combining these
approaches are limited. In 2010, Diop et al. first utilized TR-NIRS in conjunction with
DCS to quantify the relative measures of CBF using a DCE-NIRS approach [157]. The
device’s ability to monitor flow and metabolic information was demonstrated in a neonatal
piglet model of brain injury by manipulating metabolism using anaesthetics and sodium
cyanide [90]. The system’s ability to accurately monitor optical properties and CBF was
demonstrated in a phantom model along with the depth sensitivity of acquired measures
[184]. Recent iterations of this device employed optical filters to allow NIRS and DCS
technique to run truly simultaneously [185].
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More recent work by Giovannella et al. presented a commercial-grade hybrid TRNIRS/DCS device called the BabyLux [186]. This system also utilizes optical filters to
acquire simultaneous NIRS and DCS data at a temporal resolution of 1 s, while avoiding
crosstalk between signals. System stability was demonstrated, and in-vivo measurements
were conducted on the adult brain. The accuracy and precision of this device was described
using phantoms and piglet models in comparison to expected values from simulated data
[187]. Concurrent measures of cerebral oxygenation and blood flow were demonstrated in
healthy term infants, reporting an improved intra-subject variability in oxygenation values
compared to commercial NIRS devices [188].

1.5.3

Broadband NIRS and DCS

While hybrid systems using FD- and TR-NIRS can provide concurrent measures of CBF
and CMRO2, the latter is a calculated metric based on the former. As such, any error in the
CBF measure is also reflected in CMRO2. As discussed in section 1.3.1.3, B-NIRS has the
advantage of acquiring a measure of oxCCO, a direct marker of cerebral metabolism, in
addition to CMRO2. While a comparison between oxCCO and CMRO2 is limited,
preliminary work reports a slight discrepancy [78]. Compared to other NIRS approaches,
B-NIRS devices have the added benefit of simplicity and cost, requiring only a halogen
bulb and spectrometer. A study utilizing both B-NIRS and DCS was presented, but
continuous measurements of both techniques had not been achieved. In premature infants
receiving an indomethacin infusion (a vasoconstrictor) as treatment for patent ductus
arteriosus, Diop et al. monitored CBF and CMRO2 surrounding the intervention using BNIRS and DCS [60]. This study reported a significant reduction in StO2 and CBF, with no
change in CMRO2. Measurements in this work were non-continuous, and simultaneous
acquisitions of oxCCO and CBF had yet to be reported.

1.6

Research Objectives

The goals of my doctoral research were to develop a hybrid optical system to provide a
continuous measure of cerebral perfusion and metabolism, via the marker oxCCO, in
infants at risk of brain injury. A non-invasive technique to characterize these metrics has
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potential to aid in early detection and clinical management of IVH and PHVD. These goals
have been addressed through the following aims:
1. Develop and validate a hybrid B-NIRS and DCS neuromonitor to simultaneously
acquire CBF and oxCCO at the bedside.
2. Assess system feasibility in PHVD infants in the neonatal intensive care unit.
3. Investigate cerebral perfusion and metabolic stability during early brain
development in premature infants soon after following birth.
4. Investigate the impact of significant changes in CBF on cerebral energy
metabolism.
Chapters two through five address these goals in order.

1.7

Thesis Outline

This dissertation includes six chapters. Chapters two to four were adapted from published
work. Chapter five presents the first application of CBF and oxCCO measures in premature
infants immediately following birth. Chapter 7 summarizes the advancements presented in
this body of work.

1.7.1

Development of a hybrid broadband NIRS and DCS device for
concurrent measurements of cerebral perfusion and
cytochrome c oxidase (Chapter 2)

The development of a novel system combining B-NIRS and DCS is described. The
system’s ability to acquire oxCCO and CBF is demonstrated in a piglet model of neonatal
hypoxia-ischemia. This chapter is based on a publication titled “Simultaneous monitoring
of cerebral perfusion and cytochrome c oxidase by combining broadband near-infrared
spectroscopy and diffuse correlation spectroscopy,” published in Biomedical Optics
Express in 2018 by Ajay Rajaram, Gemma Bale, Matthew Kewin, Laura B. Morrison, Ilias
Tachtsidis, Keith St. Lawrence, and Mamadou Diop [65].
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1.7.2

Monitoring changes in cerebral blood flow and metabolism in
infants with post-hemorrhagic ventricular dilatation during
ventricular taps (Chapter 3)

NNeMo (Neonatal Neuromonitor) a clinical B-NIRS/DCS system is presented. System
feasibility is demonstrated in infants with post-hemorrhagic ventricular dilatation (PHVD)
to monitor hemodynamics and metabolism during the surgical removal of cerebrospinal
fluid. This chapter is based on a publication titled “Perfusion and metabolic
neuromonitoring during ventricular taps in infants with post-hemorrhagic ventricular
dilatation,” published in Brain Sciences in 2020 by Ajay Rajaram, Lawrence C. M. Yip,
Daniel Milej, Marianne Suwalski, Matthew Kewin, Marcus Lo, Jeffrey J. L. Carson, Victor
Han, Soume Bhattacharya, Mamadou Diop, Sandrine de Ribaupierre, and Keith St.
Lawrence [189].

1.7.3

Monitoring cerebral hemodynamic, oxygenation and
metabolic stability in premature infants following birth using a
hybrid broadband NIRS/DCS optical brain monitor (Chapter
4)

NNeMo was utilized to monitor premature infants with the first 72 hours of life, starting
soon after birth. Spontaneous and dynamic changes in CBF and metabolism are reported
during this early period. A publication titled “Monitoring cerebral hemodynamic and
metabolic stability in premature infants following birth using NNeMo (Neonatal
NeuroMonitor) a hybrid broadband NIRS/DCS optical brain monitor,” which elaborates
on the data presented in this section is in preparation by Ajay Rajaram, Daniel Milej, Lilian
Kebaya, Matthew Kewin, Lawrence C. M. Yip, Marianne Suwalski, Sandrine de
Ribaupierre, Soume Bhattacharya, Mamadou Diop, and Keith St. Lawrence.

1.7.4

Changes in cerebral blood flow and metabolism in response
to hypoperfusion events in adults during surgery with
cardiopulmonary bypass (Chapter 5)

Successful preliminary results in the NICU prompted translation of NNeMo to monitor
CBF and metabolism in adults undergoing surgery with cardiopulmonary bypass. While
this study investigates a very different patient population, the underlying pathophysiology
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and development of brain injury is similar. The relationship between cerebral perfusion
and metabolism is demonstrated during extreme hypoperfusion events and transitions
on/off cardiopulmonary bypass. This chapter is based on a publication titled “Optical
monitoring of cerebral perfusion and metabolism in adults during cardiac surgery with
cardiopulmonary bypass,” published in Biomedical Optics Express in 2020 by Ajay
Rajaram, Daniel Milej, Marianne Suwalski, Lawrence C. M. Yip, Linrui R. Guo, Michael
W. A. Chu, Jason Chui, Mamadou Diop, John M. Murkin, and Keith St. Lawrence [150].

1.7.5

Conclusion and Future Directions (Chapter 6)

This section summarizes the main findings of all work presented and elaborates on future
directions for optical neuromonitoring in the newborn. Final conclusions and closing
remarks are discussed.
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Chapter 2

2

Simultaneous monitoring of cerebral perfusion and
cytochrome c oxidase by combining broadband nearinfrared
spectroscopy
and
diffuse
correlation
spectroscopy

This chapter has been adapted from the publication titled “Simultaneous monitoring of
cerebral perfusion and cytochrome c oxidase by combining broadband near-infrared
spectroscopy and diffuse correlation spectroscopy” published in the journal Biomedical
Optics Express in 2018 by Ajay Rajaram, Gemma Bale, Matthew Kewin, Laura B.
Morrison, Ilias Tachtsidis, Keith St. Lawrence, and Mamadou Diop, volume 9, issue 6.

2.1 Abstract
Preterm infants born with very low birth weights are at a high risk of brain injury, in part
because the premature brain is believed to be prone to periods of low cerebral blood flow
(CBF). Tissue damage is likely to occur if reduction in CBF is sufficient to impair cerebral
energy metabolism for extended periods. Therefore, a neuromonitoring method that can
detect reductions in CBF, large enough to affect metabolism, could alert the neonatal
intensive care team before injury occurs. In this report, we present the development of an
optical system that combines diffuse correlation spectroscopy (DCS) for monitoring CBF
and broadband near-infrared spectroscopy (B-NIRS) for monitoring the oxidation state of
cytochrome c oxidase (oxCCO) – a key biomarker of oxidative metabolism. The hybrid
instrument includes a multiplexing system to enable concomitant DCS and B-NIRS
measurements while avoiding crosstalk between the two subsystems. The ability of the
instrument to monitor dynamic changes in CBF and oxCCO was demonstrated in a piglet
model of neonatal hypoxia-ischemia (HI). Experiments conducted in eight animals,
including two controls, showed that oxCCO exhibited a delayed response to ischemia while
CBF and tissue oxygenation (StO2) responses were instantaneous. These findings suggest
that simultaneous neuromonitoring of perfusion and metabolism could provide critical
information regarding clinically significant hemodynamic events prior to the onset of brain
injury.
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2.2

Introduction

An estimated 15 million babies are born prematurely each year and those with very low
birth weights (VLBW < 1500 g) are at a high risk of neurodevelopmental impairment [1].
Among the 63,000 VLBW infants born annually in the United States, 5-10% develop major
disabilities such as cerebral palsy and 25-50% show other cognitive and behavioural
deficits [2,3]. Although other factors contribute to perinatal brain injury, alterations in
cerebral blood flow (CBF) are believed to play a significant role due to the immaturity of
the cerebral vascular system and complications associated with premature birth, such as
poor cardiac and lung function, which can impede blood flow and oxygenation [4]. In
addition, changes in brain tissue metabolism are likely to precede structural abnormalities
associated with injury [5]. In term infants, metabolite ratios measured by magnetic
resonance (MR) spectroscopy have shown high accuracy in predicting adverse
neurodevelopmental outcome [6,7] and have potential in guiding clinical management.
Despite this, applications of MR methods for routine brain monitoring are clearly
impractical. Cranial ultrasound remains the first-line option in the neonatal intensive care
unit (NICU), particularly for monitoring intraventricular haemorrhage. However,
ultrasound is used to detect brain damage that has already occurred, rather than detecting
pathophysiological events that are indicative of oncoming injury. This speaks to the need
for bedside methods capable of detecting CBF and metabolic fluctuations which could act
as prognostic markers of brain injury.
Advancements in biomedical optics have provided cost-effective alternatives for
monitoring the brain with the aim of detecting hemodynamic/metabolic events that may
precede brain injury. In particular, near-infrared spectroscopy (NIRS) – a safe, quantitative,
and portable technology – is widely used to obtain estimates of cerebral oxygen saturation
(StO2), which has been used as a surrogate marker of CBF in the clinic [8]. NIRS can also
directly measure CBF, either by dynamic contrast-enhanced (DCE) methods [9,10], or by
diffuse correlation spectroscopy (DCS). DCS has been extensively validated against other
perfusion techniques and it has the advantage of providing continuous monitoring [11].
The combination of NIRS and DCS has the potential to further enhance brain monitoring
by combining flow and oxygenation measurements to determine the cerebral metabolic
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rate of oxygen (CMRO2) [8,12–15], which is a more sensitive marker of tissue viability
[16]. Consequently, monitoring CMRO2 could help identify clinically significant changes
in CBF considering the fact that only flow reductions large enough to exhaust the
compensatory increase in oxygen extraction will have an impact on energy metabolism [9].
However, a potential challenge with continuous monitoring of CMRO2 is that it requires
the combination of a number of parameters: CBF, StO2, and arterial oxygen saturation
(SaO2) – which have proven challenging to measure during asphyxia [16]. Furthermore,
CMRO2 computation relies on assuming a fixed arteriovenous blood volume ratio, which
may vary under pathological conditions [17–19].
A direct measure of cerebral energy metabolism can be obtained by measuring changes in
the oxidation state of cytochrome c oxidase (CCO) – a key element in oxidative metabolism
– which is directly related to mitochondrial ATP production [20]. CCO is the terminal
electron acceptor in the electron transport chain (ETC): the final stage of oxidative
metabolism. A unique copper dimer (Copper A) in the enzyme has an absorption peak
around 835 nm in its oxidized form (oxCCO), but not in its reduced state. A change in the
redox state represents a change in oxidative cellular metabolism. To accurately resolve
changes in oxCCO, many wavelengths (broadband) are required as the concentration of
CCO is 10% of the in vivo hemoglobin concentration. Previous studies have shown that
broadband NIRS (B-NIRS) measured oxCCO changes are associated with acute changes
in metabolism following hypoxia-ischemia (see Bale et al. for a detailed review [20]). As
well, changes in oxCCO measured by B-NIRS showed strong correlation with measures of
cellular metabolism from magnetic resonance spectroscopy [21] and microdialysis [22].
Simultaneous monitoring of perfusion and oxygen metabolism, through combining DCS
and B-NIRS, could therefore provide a valuable tool for neuromonitoring in the NICU.
This report presents the development a hybrid B-NIRS/DCS system for real-time
monitoring of StO2, CBF, and ΔoxCCO. The ability of the instrument to capture dynamic
oxygenation, blood flow, and metabolic changes was demonstrated in an animal model of
neonatal hypoxia-ischemia that has been shown to cause rapid reductions in cerebral blood
flow and oxygenation [15].
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2.3
2.3.1

Methods
Instrumentation

The light source of the B-NIRS subsystem, a 20 W halogen lamp (Ocean Optics Hl-2000HP), was high-pass filtered at 500 nm to remove ultraviolet light and directed towards the
tissue by an optical fiber bundle (3.5 mm active diameter, 30-μm core, 0.55 numerical
aperture). Light diffusely reflected from the tissue was collected with an identical fiber
bundle, placed at 30 mm away from the emission probe (see Fig. 1), and directed to a
custom-made spectrometer (iDus Andor camera, Oxford Instruments; 548-1085 nm
bandwidth; 1.65 nm resolution; P&P Optica, ON, Canada). The light source of the DCS
was a long coherence length, continuous-wave laser emitting at 785 nm (DL785-100s,
CrystaLaser, NV) and was coupled into a 400-μm diameter fiber. Light from the tissue was
collected with a few-mode fiber (SMF-28e+, 8 µm core; few-mode at 785 nm) placed 20
mm from the DCS emission probe and coupled to a single-photon counting module
(SPCM-AQR4C, Excelitas, QC, Canada). The output of the SPCM was fed into a correlator
board (Flex033LQ-1, Correlator.com, NJ) to generate normalized intensity autocorrelation
curves. Note that in some of the phantom experiments, a single-mode fiber (S630 Nufern,
6 µm core) was used instead of the few-mode fiber.
Operating the two subsystems simultaneously would result in significant crosstalk since
the DCS laser is powerful enough to saturate the spectrometer’s CCD detector. As well,
the presence of incoherent light from the broadband light source alters the autocorrelation
curves acquired while the B-NIRS light is on. To avoid crosstalk, a shutter-based
multiplexing approach was used to alternatively collect measurements from each
subsystem (i.e., B-NIRS and DCS). Fig. 2.1 shows a schematic of the hybrid B-NIRS/DCS
device.
Optical fibers were discontinuous on the NIRS emission and detection ends, with shutters
placed at these junctions. Signal loss was minimized by securing the probes in close
proximity to the shutter, using an optical breadboard. A shutter was also placed in front of
the DCS laser, and another in front of the single-photon counting module. The latter was
equipped with a light collimator and a coupling lens to maximize the signal-to-noise ratio
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(SNR). A dual DC power supply was used to operate the multiplexer: a high voltage (24 V)
was sent to rapidly open the shutter, immediately followed by a lower voltage (10 V) to
maintain the open state. These voltage values were chosen to minimize shutter blade
transition time and digital modules (NI 9477, National Instruments, TX) were utilized to
cycle between the voltage outputs. Opening and closing of the shutters were alternated to
allow for sequential acquisition and were controlled using a field programmable gate array
(FPGA) card (PCI-7811R, National Instruments). Digital modules (NI 9401, NI) were also
used to control and monitor shutter states, which were synchronized by in-house software
written in LabVIEW FPGA, as detailed in [23]. B-NIRS and DCS measurements were
analyzed using a customized MATLAB script to yield cerebral oxygen saturation,
perfusion, and metabolism.

Figure 2.1: Simplified schematic of B-NIRS/DCS system with the shutter-based
multiplexer. Red dots: B-NIRS emission and detection probes; blue dots: DCS
emission and detection fibers.
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2.3.2
2.3.2.1

System demonstration
Phantom Experiments

To investigate the potential impact of the B-NIRS light on the DCS measurements,
autocorrelation curves were acquired while the broadband light source remained on. Data
were collected on a liquid phantom consisting of a mixture of Intralipid and India ink that
provided a reduced scattering coefficient of 1.0 mm-1 and an absorption coefficient of 0.01
mm-1; values were chosen to mimic tissue based on previous reports [24]. In the first set of
measurements, the emission probe of the B-NIRS was positioned 30 mm away from the
detection fiber of the DCS system, and the level of light contamination experienced by the
DCS was varied by modulating the intensity of the B-NIRS light using its built-in aperture.
This test was repeated with a 10-mm distance between the B-NIRS emission probe and
DCS detection fiber to further increase the intensity of B-NIRS light collected by the DCS
system.

2.3.2.2

Hypoxia-ischemia Model

The ability of the hybrid B-NIRS/DCS device to monitor dynamic changes in CBF and
oxCCO was demonstrated in an animal model of hypoxia-ischemia (HI) involving newborn
piglets aged 10-40 hours. This model was chosen because it results in rapid changes in
blood flow and oxygen supply to the brain [15]. Piglets were anesthetized under 3%
isoflurane during preparatory surgery (2% post-surgery), tracheotomized, and
mechanically ventilated on an oxygen-medical air mixture. Incisions were made lateral to
the trachea and vascular occluders (In Vivo Metric, CA) were placed around the carotid
arteries posterior to the clavicle. Catheters were inserted into an ear vein for injections and
into a femoral artery to monitor vitals (SurgiVet, Smiths Medical, MN), as well as to collect
arterial blood samples for gas and glucose analyses. Arterial oxygen saturation (SaO2) was
measured via a pulse oximeter attached to the piglet’s right forelimb. Piglets were placed
in the prone position and the B-NIRS and DCS probes were secured to the left side of the
head, avoiding the sagittal sinus, using an in-house 3D-printed probe holder.
HI insult was induced by first inflating the occluders around the carotid arteries, followed
by reducing the inspired oxygen from 21% to 8%. B-NIRS and DCS data were acquired
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continuously throughout the insult, starting 5 minutes prior to carotid clamping to acquire
baseline measurements. The real-time DCS blood flow index was used to confirm
successful clamping, i.e., an immediate drop in CBF. Following this confirmation, inspired
oxygen concentration was reduced and the HI insult was maintained for a minimum
duration of 10 minutes once the blood flow index reached its nadir. At the end of the HI
insult, recovery was initiated by deflating the carotid occluders and returning oxygen
supply to baseline levels. Two control animals experienced identical procedures, excluding
inflation of the occluders and reduction in inspired oxygen, to confirm the stability of the
optical measurements during the experiment.
The continuous recording of B-NIRS and DCS data were set on a 14-s cycle. That is, 12 BNIRS spectra were acquired over 3 s, followed by 2 DCS measurements over the following
10 s, with a 0.5-s delay both preceding and following each technique. Data were
continuously saved and imported into MATLAB for real-time update of the DCS blood
flow index and relative oxCCO. The final step in the experiment was to calibrate the DCS
data by measuring absolute CBF with DCE-NIRS following the 90-minute recovery (i.e.,
post HI insult) period [25]. The DCE-NIRS protocol consisted of a bolus injection of
indocyanine green (ICG, 0.1 mg/kg) into a cannulated vein. The passage of ICG through
the brain was captured by continuously recording B-NIRS data at a temporal resolution of
400 ms. The time-varying arterial ICG concentration was concomitantly measured by a
dye densitometer (DDG 2001, Nihon Kohden, Japan) attached to a front paw.
This study was approved by the Animal Use Subcommittee of the Canadian Council on
Animal Care at Western University (London, Ontario).

2.3.3

Data Processing

2.3.3.1
2.3.3.1.1

Quantification of Tissue Chromophore Concentrations and
StO2
Broadband Fitting for Absolute Concentrations

Before the start of each study, the spectrometer was wavelength calibrated using a neon
light source and a dark-noise signal was also acquired. Thereafter, a reference spectrum
was acquired – using a pinhole attenuator, which provided uniform attenuation while
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avoiding detector saturation – to account for the spectral properties of the light source and
the spectrometer. A de-noising algorithm was subsequently applied to the data to reduce
the measurement noise as described previously [26]. The baseline reflectance spectrum
R(λ) was then computed from the spectrum measured on the piglet’s head, the dark-noise
signal of the spectrometer, and the reference spectrum as follows:
𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚 − 𝑑𝑎𝑟𝑘

𝑅(λ) = 𝑙𝑜𝑔10 (𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒λ − 𝑑𝑎𝑟𝑘λ )
λ

λ

(2.1)

The 1st and 2nd derivative of R(λ) was fit to the 1st and 2nd derivatives of the solution to the
diffusion approximation for a semi-infinite homogenous medium (i.e., the theoretical
model) [10], characterized by the reduced scattering (µs′) and absorption (µa) coefficients,
described respectively in equations (2.2) and (2.3) [27]:
𝜆

−𝛼

𝜇𝑠 ′ = A (800(𝑛𝑚))

(2.2)

where α is the scattering power, characterizing the wavelength dependence of the µs′, and
A is the µs′ value at a wavelength λ= 800 nm (in our analysis, but can be any wavelength
in the range where Eq. 2.2 is valid).
𝜇𝑎 (𝜆) = 𝑊𝐹 ∙ 𝜀𝐻2 𝑂 (𝜆) + 𝐻𝑏 𝑏 ∙ 𝜀𝐻𝑏 (𝜆) + 𝐻𝑏𝑂2𝑏 ∙ 𝜀𝐻𝑏𝑂2 (𝜆)

(2.3)

where WF is the tissue water fraction, ε is the extinction coefficient of the corresponding
chromophore, and Hbb and HbO2b are respectively the baseline concentrations of
deoxyhemoglobin and oxyhemoglobin in µM. CCO was not included in the baseline
analysis due to its relatively small concentration and lack of features in the derivative
spectra.
The baseline reflectance spectrum was analyzed using a three-step, multi-parameter fitting
algorithm, based on a constrained least-square minimization algorithm built with a custom
MATLAB function (fminsearchbnd) [10]. Firstly, the second-derivative of the reflectance
spectrum R(λ) was fit to the 2nd derivative of the theoretical model between 815 and 845
nm to obtain the tissue water fraction (WF). Although the fitting yielded estimates for all
the parameters listed in Table 2.1, we only consider WF to be reliably estimated from this
step because it has been previously shown that the 2nd derivative of the scattering
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coefficient and the other tissue chromophores do not have significant contribution in this
wavelength range [28]. Using the value of WF obtained in the first step as a known
parameter, the 2nd derivative fit was performed from 680 to 800 nm to obtain Hbb. The
WF and Hbb values were then used as known parameters in the fitting of the first derivative
of R(λ) from 680 to 845 nm to determine HbO2b, A, and α [10,26,28]. The upper and lower
bounds, as well as the initial values of the parameters used in the fitting routine are given
in Table 2.1.
Table 2-1: Initial values, lower and upper bounds of the fitting parameters.
Parameter

Initial value

Lower
bound

Upper
bound

WF
Hb (g/dL)
HbO2b(g/dL)
A (mm-1)

0.8
10
40
1

0.6
0
0
0

0.95
60
80
1.3



2.7

0.6

4.0

b

Baseline tissue oxygen saturation (StO2b) was computed using Hbb and HbO2b:
𝑆𝑡𝑂2 𝑏 =

2.3.3.1.2

𝐻𝑏𝑂2 𝑏
𝐻𝑏 𝑏 +𝐻𝑏𝑂2 𝑏

(2.4)

Derivative Spectroscopy for Differential Concentrations

Once the baseline StO2 was quantified, a modified Beer-Lambert Law approach was used
to analyze the complete set of B-NIRS spectra as it is considerably faster than the derivative
fitting which takes 84 ± 17 s per spectrum on an i7-4700MQ 2.40 GHz processor. The
UCLn algorithm was used to quantify changes in Hb, HbO2, and oxCCO concentrations
(units: µM) from changes in attenuation across 770-900 nm [29], using a dynamic
pathlength calculated by fitting the 2nd derivative of R(λ) to the second derivative of the
water absorption spectra [28] and correcting for the wavelength dependence of the
pathlength [30]. Tissue oxygen saturation at each time point was determined by combining
the relative changes derived from the values obtained with the UCLn algorithm with the
absolute baseline values obtained by the derivative fitting approach:
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𝑆𝑡𝑂2 =

(𝐻𝑏𝑂2𝑏 +∆𝐻𝑏𝑂2 )
𝑏
(𝐻𝑏 +∆𝐻𝑏)+(𝐻𝑏𝑂2𝑏 +∆𝐻𝑏𝑂2 )

(2.5)

where ΔHbO2 and ΔHb represent the relative changes in oxy/deoxy-hemoglobin.

2.3.3.2

Quantifying CBF

DCS data were analyzed by fitting the measured electric field autocorrelation function to a
solution to the diffusion approximation for a semi-infinite homogeneous medium [10].
Fitting was performed using the known source-detector distance (20 mm) and values of µa
and µs′ at 785 nm obtained from the B-NIRS analysis. Time varying changes in µa were
used along with the baseline µs′ [25] to fit the dynamic data. The fitting of the
autocorrelation curves yielded the correlation factor (β) and the blood flow index (BFi)
[25].
For the DCE-NIRS analysis, CBF was quantified by relating the time-varying arterial
concentration of ICG, Ca(t), to the corresponding brain concentration curve, Cb(t), using
the following equation [31]:
𝐶𝑏 (𝑡) = 𝐶𝐵𝐹 ∙ 𝑅(𝑡) ∗ 𝐶𝑎 (𝑡)

(2.6)

where R(t) is the impulse residue function and * refers to the convolution operation. The
product CBF • R(t) was extracted using a deconvolution algorithm [32], from which CBF
was determined by the initial value since R(t) by definition begins at a value of one. The
CBF measurement was then used to convert the DCS BFi time series into physiological
blood flow units (i.e., ml/100g/min) [25].

2.3.4

Error Analysis

Monte Carlo simulations were conducted to assess the accuracy of the 3-step, multiparameter fitting approach. Simulated spectra were generated using the semi-infinite
solution to the diffusion approximation with values of Hbb and HbO2b that corresponded to
an StO2 = 75.5% (all input parameters are given in Table 2.2). Poisson noise was added at
each wavelength, and the fitting routine used to obtain best-fit estimates of the
5 parameters. The same initial values and boundary conditions given in Table 2.1 were
used. Simulations were run 500 times to generate a distribution of estimates for each fitting
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parameter. As well, the entire analysis was repeated by averaging spectra over 8 to 512
repetitions to estimate the precision of the fitting parameters over a range of SNR.

2.3.5

Statistical Analysis

For the tissue phantom experiments, the influence of the NIRS broadband source on the
estimated diffusion coefficients was tested using a Student’s t-test.
For the HI experiments, individual CBF time series, from each animal, were normalized to
their corresponding baseline values. Thereafter, ten CBF values were extracted by dividing
the normalized time series into bins of successive 10% reductions in flow and averaging
within these bins. The corresponding oxCCO concentration changes were obtained for each
CBF interval. A multivariate ANOVA was conducted to determine which oxCCO values
were significantly different from baseline. The same approach was also applied to
investigate the relationship between CBF and StO2 during HI.

2.4
2.4.1

Results
Instrumentation

The experiments conducted with the tissue-mimicking phantoms showed a significant
effect of the broadband light source on the autocorrelation curves. Fig. 2.2 presents curves
acquired with the B-NIRS emission probe at 10 mm away from the DCS detection, along
with the corresponding best fit to the diffusion approximation. Note that a single-mode
fiber was used in this test to provide a wide dynamic range for the correlation factor, β.
The curves shown in Fig. 2.2 were acquired with the B-NIRS light off (A) or on (B).
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Figure 2.2: Autocorrelation functions (blue symbols) acquired with (a) DCS alone,
and (b) DCS in the presence of light from the B-NIRS source (10 mm). The red lines
in both figures are the best fit to the diffusion approximation.
As expected at this short distance between the B-NIRS emission and DCS detection, the
high intensity of incoherent light from the broadband source significantly reduced the SNR
of the acquired autocorrelation functions and the correlation factor β (y-intercept). The use
of a few-mode fiber in this test would produce even lower β values, by allowing the
propagation of more modes of light. A significant difference in the derived diffusion
coefficient was found between the two curves: 1.56 ± 0.05×10-8 cm2/s (DCS alone) and
1.82 ± 0.30×10-8 cm2/s (with broadband light source on) (p < 0.01). The broadband light
source also affected the estimated β value when using a few-mode fiber with a distance of
30 mm as shown in Fig. 2.3, A. However, in contrast to the data acquired at 10 mm, the
broadband light contamination did not significantly affect the values of the derived
diffusion coefficient when the B-NIRS emission probe was 30 mm away from DCS
detection (Fig. 2.3(B)).
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Figure 2.3: (A) DCS autocorrelation curves with B-NIRS light (30 mm from DCS
detection) at varying intensities, (B) diffusion coefficient values without (blue) and
with (red) the B-NIRS light; data were averaged over 10 acquisitions, error bars
represent standard deviation.
To demonstrate the robustness of the B-NIRS multi-parameter fitting, the algorithm
described was used to estimate the 5 fitting parameters from spectra of varying SNR
(obtained by averaging a varying number of spectra). The parameters obtained by fitting a
low SNR spectrum (obtained from one simulated spectrum with added Poisson noise, as
described above) and one high SNR spectrum (obtained by averaging 512 spectra low SNR
spectra) are displayed in Table 2.2, along with the resulting StO2 value. Note that the mean
and standard deviation displayed in Table 2. 2 were obtained by repeating the simulations
500 times (i.e., Monte Carlo type approach).
Table 2-2: Monte Carlo simulation of B-NIRS fitting algorithm.
Simulation parameter

Input Values

1 acquisition

512 averages

WF
Hbb(g/dL)
HbO2b(g/dL)
A (mm-1)

0.8
13
40
0.8
2.6

0.71 ± 0.13
12.0 ± 3.3
36.2 ± 9.4
0.93 ± 0.23

0.80 ± 0.04
12.9 ± 0.6
39.8 ± 1.7
0.81 ± 0.04

2.6 ± 0.3
75.0 ± 3.9

2.6 ± 0.03
75.5 ± 0.2


StO2 (%)

75.5

StO2 values obtained by using a varying number of averaged spectra are displayed in Fig.
2.4. The error bars represent the standard deviation over 500 simulations.
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Figure 2.4: Estimation of StO2 from simulated spectra of varying SNR (obtained by
varying the number of averaged spectra). The circles represent the mean and the
error bars are the standard deviation over 500 repetitions for each set of averaged
spectra.

2.4.2

Hypoxia-ischemia Insult

Experiments were conducted on eight piglets (2 female, mean age = 25 ± 10 h,
weight = 1.6 ± 0.3 kg). Of these, control experiments involving no HI insult were
conducted on two animals. Table 3 displays the average baseline values across all animals
for all 5 fitting parameters, cerebral oxygen saturation, and perfusion.
Table 2-3: Baseline fitting parameters, StO2, and CBF.
Parameter

Baseline value

WF

0.78 ± 0.02

b

Hb (g/dL)

18 ± 3

b

35 ± 13

HbO2 (g/dL)
-1

A (mm )

0.35 ± 0.11



3.3 ± 0.5

StO2 (%)

64 ± 13

CBF (ml/100g/min)

28 ± 7

B-NIRS spectra recorded at baseline and during the peak of HI insult are shown in
Fig. 2.5, A). An attenuation difference, calculated as the log of the ratio between these
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spectra, is displayed in black in Fig. 2.5 B. The fit of the attenuation by the concentrations
recovered from the Beer-Lambert algorithm are shown in blue and red. The blue curve
represents the fit of HbO2 and Hb (2-component model), while the red line represents the
fit of HbO2, Hb, and oxCCO (3-component model). It is clear that the addition of oxCCO
to the model improved the fitting; this is further demonstrated in Fig. 5, C which shows
residuals between measured and modelled attenuation. The 3-component model has a
smaller residual, randomly distributed around 0, whereas, the 2-component model had a
residual centered on a peak around 820 nm. This suggests that there is a missing
chromophore in the model with a peak at 820 nm, which is very similar to the oxCCO
difference spectrum [20].

Figure 2.5: Broadband NIRS analysis showing (A) raw intensity measurements at
baseline and during HI insult, (B) attenuation and best fit of the 2- (Hb and HbO2)
and 3-component models (Hb, HbO2, and oxCCO), and (C) and residuals between
measured and modelled attenuation, with CCO difference spectrum (ox-redCCO)
for comparison.
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A 5-s DCS acquisition period provided sufficient SNR with adequate temporal resolution
to discern physiological changes caused by HI. Specifically, various DCS acquisition times
were tested at baseline, and there was no statistically significant difference between the
BFi obtained at 5 and 15 s acquisitions over 30 cycles (difference = 3.2%, p=0.42). DCS
autocorrelation curves acquired at baseline, during HI insult, and following recovery are
displayed in Fig. 2.6. The CBF values derived by calibrating each BFi were 35.2 ± 0.8
ml/100g/min, 2.6 ± 0.1 ml/100g/min, and 32.5 ± 0.8 ml/100g/min respectively.

Figure 2.6: DCS autocorrelation curves measured in one piglet during (A) baseline
(CBF = 35.2 ± 0.8 ml/100g/min), (B) HI insult (CBF = 2.6 ± 0.1 ml/100g/min), and
(C) following insult recovery (CBF = 32.5 ± 0.8 ml/100g/min). The red lines
represent best fit to the diffusion approximation.
Fig. 2.7 presents StO2, CBF, and oxCCO time courses for three HI piglets and one control.
Region (i) in each graph corresponds to the brief period between inflating the carotid
occluders and reducing the inspired oxygen content. The combination of both components
of HI is represented by region (ii). For the controls, no significant changes in the any of the
parameters were detected. While StO2 and CBF responded immediately to occluder
inflation, oxCCO displayed a delayed response. As well, a continual reduction in oxCCO
persisted after CBF and StO2 had reached their nadir. This pattern was observable in all HI
experiments.
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Figure 2.7: Simultaneous monitoring of StO2, absolute CBF, and oxCCO in 3
hypoxia-ischemia (HI) animals (A, B, C) and a control piglet (D). The HI insult
began with clamping the carotid arteries (region (i)), followed by inducing hypoxia
by reducing the inspired oxygen fraction to 8% (region (ii)).
To further investigate the temporal relationship between CBF and metabolism during HI,
oxCCO and StO2 were separately correlated to incremental changes in CBF as described
in section 2.3.5. Data presented in Fig. 2.8(A) and Fig. 2.8(B) show oxCCO and StO2,
respectively, averaged across all animals and plotted against averaged changes in CBF
normalized to baseline values. Due to the rapid and large initial reduction in CBF caused
by carotid occlusion, the initial drop in CBF was greater than 40% in some experiments.
Consequently, CBF intervals with mean values of 0.62 and 0.76 show only data from two
and one animals, respectively.
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Figure 2.8: Correlation plots of a) oxCCO vs CBF, and b) StO2 vs CBF; * indicates a
significant change in either oxCCO or StO2 from baseline (p<0.05). Error bars
represent the standard error of the mean. CBF intervals with mean values of 0.62
and 0.76 show only data from two and one animals, respectively.

2.5

Discussion

In this article, we report on the development of a hybrid diffuse correlation spectroscopy
(DCS) and broadband near-infrared spectroscopy (B-NIRS) instrument capable of
simultaneous monitoring of cerebral blood flow (CBF) and changes in the oxidation state
of cytochrome c oxidase (oxCCO). This was achieved using a simple shutter-based
multiplexing method that allowed acquisition of DCS and B-NIRS measurements in quick
succession, thereby avoiding crosstalk between the two subsystems.
Although the importance of monitoring both CBF and metabolism has been long
recognized, StO2 is still the most widely used marker of cerebral health in the clinic, despite
its limited sensitivity to brain injury [8]. The lower sensitivity of StO2 is believed to be
related, in part, to the inability to separate blood flow and metabolic effects [8,33].
Hemoglobin difference (Δ[HbDiff] = Δ[HbO2] - Δ[Hb]) has been used as a surrogate
marker of CBF, but its relationship to flow also depends on oxygen metabolism [33].
Recent advancements have enabled direct CBF monitoring by DCS; however, monitoring
CBF alone may not be sufficient to capture the interplay between substrate delivery and
demand. To assess clinically significant changes in CBF, which could impact tissue
viability, measures of metabolism have been recently investigated. Conversely, monitoring
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CBF could help determine if metabolic reductions are due to limited oxygen delivery as
opposed to changes in demand.
The multiplexing approach presented here was necessary to avoid crosstalk between the BNIRS and DCS techniques as the DCS laser would saturate the B-NIRS detector if they are
operated simultaneously. As well, when the broadband source is used concurrently with
DCS measurements, the autocorrelation curves are altered, particularly at short distances
between the B-NIRS emission probe and DCS detection fiber. Even when a single-mode
DCS detection fiber was used, to maximize the dynamic range of the correlation factor, we
found that with a 10 mm distance between the B-NIRS source and the DCS detection,
incoherent light excited additional modes in the DCS fiber. This manifested as a much
lower β value in the autocorrelation curves (Fig. 2.2) and resulted in a significantly
different diffusion coefficient (p < 0.01), warranting the use of shutters. Fig. 2.3 A shows
that increasing the B-NIRS light intensity decreases the correlation factor (y-intercept).
However, the values of diffusion coefficients obtained by fitting the measured
autocorrelation curves in Fig. 2.3 A with the solution to the diffusion equation for a semiinfinite homogeneous medium [34] did not significantly differ, as shown in Fig. 2.3 B. This
shows that at larger distances, the B-NIRS light affects the correlation factors of the
autocorrelation curves but has no significant effect on the diffusion coefficient.
The SNR can be further increased by reducing the sampling rate; lengthening the shutter
cycle times allows for measures to be averaged over more acquisitions, but this would
increase the time between successive measurements. In its current configuration, the hybrid
B-NIRS/DCS device provided StO2, CBF, and oxCCO measurements every 14 s. This
sampling rate could likely be increased to every 3-5 s using new technologies such as the
DCS software correlator [35]. However, the speed of the current system was sufficient to
capture the dynamics of the CBF and oxCCO responses to HI, and therefore will likely be
sufficient for cerebral monitoring in the NICU.
StO2 was monitored by a combination of a spectral derivative fitting approach to determine
baseline StO2 and a faster linear algorithm based on the Beer-Lambert law to track
subsequent changes in HbO2 and Hb concentrations. The reproducibility of the baseline
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optical properties derived from the former was tested by conducting an error analysis
involving Monte Carlo simulations. Fig. 2.4 and Table 2-2 demonstrate the ability of the
fitting technique to extract parameter estimates with good precision and accuracy. These
estimates were found to be insensitive to the boundary conditions and initial values used
by the fitting routine (Table 2-1). Furthermore, the average baseline StO2 (64±13%) was
in good agreement with a previous study (StO2 = 69±2%) involving the same animal model
but using time-resolved NIRS to measure the optical properties [12]. Further validation
studies are on-going to assess the accuracy of this technique over a wide range of StO2
[36]; however, it is important to realize that the computational efficiency of the UCLn
algorithm is extremely valuable for real-time monitoring in clinical applications.
Source-detector distances of 3 cm for B-NIRS and 2 cm for DCS were chosen to probe the
piglet brain because it has been shown that in reflectance geometry, the penetration depth
is approximately the square root of the source-detector distance [37]. Considering that the
thickness of the extra-cerebral layers in newborn piglets is 2-3 mm [23], the brain can be
reliably probed using a source-detector distance of 2 cm or greater. Note that this approach
has been previously validated against CT perfusion measurements in a neonatal piglet
model [23]. In addition, the probe geometry depicted in Fig. 2.1 was designed to ensure
that DCS and B-NIRS probed overlapping brain regions. It is important to note that the HI
model causes global changes in cerebral blood flow and metabolism. Therefore, it is
expected that small differences in the tissue volumes interrogated by the two instruments
will not alter the relationship between the measured hemodynamic and metabolic changes.
There have been a number of previous studies combining B-NIRS and DCS [38–40]; in
particular Lee et al. recently presented a compact device for dual monitoring of tissue flaps.
However, the greater source-detector distances required for brain monitoring limits the
applicability of many of these approaches. Furthermore, a key novelty of our method is the
ability to continuously monitor StO2, absolute blood flow, and oxCCO, which has not been
previously reported. In terms of brain monitoring, a similar concept combining frequencydomain NIRS (FD-NIRS) and DCS [41] was recently reported. This device is capable of
simultaneous monitoring of StO2, CBF, and CMRO2, and has been used to investigate
neonatal hemodynamics. Instead of a 785-nm laser, a DCS laser emitting at 850 nm was
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used along with optical filters to prevent crosstalk between the two systems. An 850-nm
laser is outside of the spectral range used for broadband analysis of hemoglobin
concentration (680 to 845 nm), but more critically it is within the range of the CCO feature
(780 to 900 nm). Although there are long coherence lasers operating at wavelengths lower
than 680 nm, it is noteworthy that they have significantly lower power outputs. As well,
above 900 nm, SPCM detectors commonly used in DCS systems have lower quantum
efficiencies; both factors would reduce SNR. These limitations of current technology
restrict the feasibility of using optical filters for concurrent monitoring of CBF and oxCCO.
The HI piglet model produced rapid and dynamic changes in StO2, CBF, and oxCCO. More
importantly, the experimental results clearly demonstrated the unique individual responses
in oxygenation, flow, and metabolism (Fig. 2.7 and 2.8). These differences warrant the
inclusion of all three measures in order to understand the broader physiological impact of
HI. That is, StO2 and hemoglobin concentrations allow for monitoring of hypoxia, CBF
dynamics indicate ischemia, and changes in oxCCO relate to metabolic stress. Together,
these different perspectives describe the hemodynamic and metabolic environment that
surrounds and precedes brain injury.
In the 6 animals with HI injury, the decrease of oxCCO was delayed in comparison to CBF
and continued to decline even after CBF and StO2 reached their nadirs. A similar biphasic
relationship between oxCCO and HbDiff was found in piglets experiencing anoxia [42].
Group averages of time courses are not shown due to the temporal variability between
clamping carotid arteries and reducing oxygen content. The timing of the latter varied
because it was only executed once occluders were shown to produce a noticeable decrease
in CBF. Nevertheless, time courses across all experiments showed the direct effect of
decreased CBF on StO2 and a delayed oxCCO response. Reduced blood flow is likely met
by increased oxygen extraction in order to maintain oxidative metabolism, which is
consistent with previous reports between CBF and CMRO2 in piglets [33] and infants [9].
This compensatory mechanism may explain the delayed oxCCO response. However, the
relationship between oxidative metabolism and oxCCO is complex. Further investigation
into the interrelationship between these values and their physiological significance in
predicting brain injury will be the subject of future investigations.
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2.6

Conclusion

This article reports on the development of a novel optical system that combines DCS and
B-NIRS to enable continuous monitoring of absolute cerebral blood flow and changes in
the oxidation state of cytochrome c oxidase – two sensitive biomarkers of brain health. The
combination of the two subsystems was achieved through the use of a simple multiplexing
approach based on electromechanical shutters and can be easily implemented elsewhere.
In addition, the ability to simultaneously monitor CBF and oxCCO has led to a key finding;
that is, the response of cerebral oxygen metabolism is delayed in hypoxia-ischemia while
the CBF response is instantaneous. We anticipate that real-time monitoring of absolute
CBF and oxCCO will provide greater insights into hemodynamic events that precede brain
injury and could become valuable for guiding therapeutic interventions. Furthermore,
because the hybrid B-NIRS/DCS system is safe and portable, it could be easily deployed
in the NICU to monitor cerebral perfusion and metabolism at the bedside in early stages
following birth, with the goal of detecting significant hemodynamic events before brain
injury occurs.
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Chapter 3

3

Perfusion and metabolic neuromonitoring during
ventricular taps in infants with post-hemorrhagic
ventricular dilatation

This chapter has been adapted from the publication titled “Perfusion and metabolic
neuromonitoring during ventricular taps in infants with post-hemorrhagic ventricular
dilatation” published in Brain Sciences in 2020 by Ajay Rajaram, Lawrence C. M. Yip,
Daniel Milej, Marianne Suwalski, Matthew Kewin, Marcus Lo, Jeffrey J. L. Carson, Victor
Han, Soume Bhattacharya, Mamadou Diop, Sandrine de Ribaupierre, and Keith St.
Lawrence, volume 10, issue 7.

3.1 Abstract
Post-hemorrhagic ventricular dilatation (PHVD) is characterized by a build-up of
cerebrospinal fluid (CSF) in the ventricles, which increases intracranial pressure and
compresses brain tissue. Clinical interventions (i.e., ventricular taps, VT) work to mitigate
these complications through CSF drainage; however, the timing of these procedures
remains imprecise. This study presents Neonatal NeuroMonitor (NNeMo), a portable
optical device that combines broadband near-infrared spectroscopy (B-NIRS) and diffuse
correlation spectroscopy (DCS) to provide simultaneous assessments of cerebral blood
flow (CBF), tissue saturation (StO2), and the oxidation state of cytochrome c oxidase
(oxCCO). In this study, NNeMo was used to monitor cerebral hemodynamics and
metabolism in PHVD patients selected for a VT. Across multiple VTs in four patients, no
significant changes were found in any of the three parameters: CBF increased by 14.6 ±
37.6% (p = 0.09), StO2 by 1.9 ± 4.9% (p = 0.2), and oxCCO by 0.4 ± 0.6 µM (p = 0.09).
However, removing outliers resulted in significant, but small, increases in CBF (6.0 ±
7.7%) and oxCCO (0.1 ± 0.1 µM). The results of this study demonstrate NNeMo’s ability
to provide safe, non-invasive measurements of cerebral perfusion and metabolism for
neuromonitoring applications in the neonatal intensive care unit.
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3.2

Introduction

Premature birth, defined as a gestational period less than 37 weeks, occurs in 8% of infants
in Canada [1]. Those born with lower birthweights (<1500 g) are at an increased risk of
neurological complications, including deficits in cognition and behaviour as well as a
higher incidence of major motor disorders (e.g., cerebral palsy) [2]. The largest contributor
to preterm brain injury is intraventricular hemorrhaging (IVH). The pathogenesis of IVH
involves the combination of an immature cerebral vascular anatomy (i.e., a highly
vascularized germinal matrix) and poor cerebral blood flow (CBF) regulation [3,4]. It is
believed that IVH elicits an inflammatory response, followed by fibrosis and subsequent
obstruction of cerebrospinal fluid (CSF) drainage [5]. This can lead to accumulation of
CSF, increased intracranial pressure (ICP), and dilatation of the entire ventricular system,
referred to as post-hemorrhagic ventricular dilatation (PHVD).
PHVD is a major complication in severe cases of IVH (Grade III and higher), where more
than 50% of the lateral ventricles are experiencing a bleed [6,7]. Due to a progressively
increasing ICP, any delay in treatment can result in white matter atrophy and neurologic
deterioration [4,8]. Cranial ultrasound (cUS) is the current gold standard in diagnosing and
monitoring the progression of PHVD through ventricular measurements such as the
ventricular index, anterior horn width, and thalamo-occipital distance [9]. Given these
measures, there is still some debate over the timing of clinical intervention [10]. An early
approach used by many European centres relies on ventricular measurements before
patients are symptomatic. Intervention consists of a variety of techniques to drain CSF,
including external ventricular drains (EVD), lumbar punctures (LP), and ventricular taps
(VT), among others. [11]. In comparison, many North American centres employ a later
approach where treatment is initiated depending on the ventricular index and clinical signs
(e.g., increased ICP, head circumference, ventricle size, tense fontanelle, etc.) [12,13];
similar techniques are then implemented to drain CSF.
The discrepancy in the timing of clinical intervention is largely due to a lack of adequate
monitoring techniques to quantify PHVD progression and treatment efficacy. Recent work
has elucidated the benefits of hemodynamic and metabolic neuromonitoring surrounding
the development of PHVD [14,15]. These metrics have shown potential to act as prognostic
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markers of PHVD symptoms and could better indicate when to implement CSF drainage
strategies. Measurements of CBF by transcranial doppler (TCD) have proven robust in
premature infants; however, continuous monitoring is not ideal as TCD is operatordependent and only measures macrovascular changes in blood flow [16,17]. Biomedical
optics instead provide a safe, non-invasive technique ideal for longitudinal brain
monitoring at the bedside [3,18–20].
This study presents an in-house built brain monitoring system referred to as NNeMo
(Neonatal NeuroMonitor) that is capable of simultaneous measurement of cerebral
perfusion, tissue saturation, and oxygen metabolism at the bedside through combining two
optical techniques. Broadband near-infrared spectroscopy (B-NIRS) uses near-infrared
light to measure absorption properties of tissue that can be used to estimate the
concentrations of oxy and deoxyhemoglobin, from which the cerebral tissue saturation
(StO2) can be calculated [21]. B-NIRS can also provide a direct measurement of cerebral
metabolism by monitoring absorption changes in the oxidation state of cytochrome c
oxidase (oxCCO), which is directly related to mitochondrial ATP production in the electron
transport chain [22]. Diffuse correlation spectroscopy (DCS) is an emerging technique that
provides continuous monitoring of CBF by analyzing dynamic light scatter from red blood
cells [23]. DCS has been validated against multiple modalities, including dynamic contrastenhanced NIRS, Positron Emission Tomography with oxygen-15 (15O) labelled water, and
Arterial spin labelling MRI [24–26]. NNeMo combines B-NIRS and DCS technology to
simultaneously monitor CBF, StO2, and oxCCO.
This study presents the clinical translation of NNeMo to monitor PHVD infants in the
neonatal intensive care unit (NICU) undergoing CSF drainage via ventricular taps.
Previous work using contrast-enhanced NIRS reported a small increase in CBF after the
VT, but with no concurrent change in cerebral energy metabolism [14]. However, only
single time-point measurements before and after the procedure were acquired due to the
need to inject a contrast agent (indocyanine green). Here, we present continuous bedside
monitoring of cerebral perfusion and metabolism in PHVD patients undergoing a VT, with
the goal of assessing any potential treatment-related changes in CBF and oxCCO. Based
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on the magnitude of CBF changes previously reported [14], it was hypothesized that CSF
drainage would lead to a modest increase in CBF, but with minimal impact on oxCCO.

3.3
3.3.1

Materials and Methods
Patient Population

This study was approved by the Western University Health Sciences Research Ethics
Board (Project Identification Code: 17828), which adheres to the guidelines of the
Canadian Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans.
Patients with PHVD were enrolled after obtaining parental consent. The initial IVH was
diagnosed by cranial ultrasound (cUS) and graded according to the Papile scale [5]. The
decision to perform a ventricular tap was based on standard of care, including clinical
evidence (apnea, bradycardia, full fontanelles) and increased ventricle size as measured by
cUS.

3.3.2

Study Design

Infants receiving a VT were monitored throughout the procedure with NNeMo
(Figure 3.1 a). Prior to surgical setup, optical probes were placed on the infant’s scalp
above the frontoparietal cortex and held in place by a custom-built probe holder
(Figure 3.1b). Two optical probes (one for the B-NIRS and one for the DCS) delivered
light to the scalp. Source power levels were maintained within ANSI standards for skin
exposure. A common detection fiber bundle was used to collect diffusely reflected light
that had propagated through the head. The DCS and B-NIRS systems collected light at
source-detector distances (SDD) of 2 and 3 cm, respectively, to ensure adequate brain
interrogation (Figure 3.1 c). As an additional precaution, a phototherapy eye shield was
employed to avoid exposing the subject’s eyes to the light sources.
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(b)

(a)

(c)

Figure 3.1: (a) Neonatal NeuroMonitor (NNeMo) combining broadband nearinfrared spectroscopy (B-NIRS) and diffuse correlation spectroscopy (DCS)
techniques. (b) Optical fibers affixed to an infant’s head using a 3D-printed probe
holder. A phototherapy eye shield was used as a safety precaution. (c) Optical fiber
schematic showing two optical sources and a common detection fiber
(SDD: DCS 2 cm; B-NIRS 3 cm).
Following sterilization of the surgical site, a VT was performed by a pediatric
neurosurgeon. A needle was inserted into the lateral ventricles (Figure 3.2 a) to allow for
CSF drainage (Figure 3.2 b). Following sufficient CSF removal, as determined by the
clinician, the needle was removed and gentle pressure was applied to the needle insertion
site. Optical data were collected throughout the VT, extending a minimum of 10 min prior
to and following the procedure. B-NIRS and DCS data were acquired sequentially at a
sampling rate of 250 ms and each dataset was averaged to achieve a final temporal
resolution of 7 s.
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(a)

(b)

Figure 3.2: (a) Pediatric neurosurgeon inserting a needle into the ventricle and (b)
draining cerebrospinal fluid (CSF) from the patient. Optical probes were affixed to
the patient’s head throughout the procedure.

3.3.3

Instrumentation

NNeMo was constructed by combining B-NIRS and DCS modalities using a multiplexing
shutter system controlled by custom software developed in LabView (2017 SP1, National
Instruments, Austin, TX, USA) and MATLAB (R2018b, MathWorks, Natick, MI, USA)
[27]. The acquisition times of both the B-NIRS and DCS were set to 250 ms (4 Hz). The
shutter system cycled between the two subsystems in 3 s intervals. A total of 12 data points
were acquired in each interval and averaged for both B-NIRS and DCS measurements. A
0.5-s delay was added between the intervals to account for shutter transition times and to
avoid overlap between the B-NIRS and DCS data.
The B-NIRS light source was a 20-W halogen bulb (Hl-2000-HP, Ocean Optics, Delay
Beach, FL, USA) that was filtered from 600 to 1000 nm and coupled into a custom optical
fiber bundle (2.4 mm diameter, 30 µM core, 0.55 numerical aperture ((NA), Loptek,
Berlin, Germany) that directed the light to the head. Light from the interrogated tissue was
collected by 3 fiber bundles (2 mm diameter, 30 µm core, 0.55 NA, Loptek, Berlin,
Germany) that were linearly aligned at the entrance of the spectrometer (iDus 420, Andor,
Oxford Instruments, Abingdon, UK; 548–1085 nm bandwidth; 1.65 nm resolution; P&P
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Optica, Waterloo, ON, Canada). For DCS, light from a long coherence laser (DL785-100s,
CrystaLaser, Reno, NV, USA) was coupled into a fiber bundle (4 × 200 µm core diameter,
0.22 NA, Loptek, Berlin, Germany) and directed towards the head. Light was collected by
4 single-mode fibers (8 µm core diameter, 0.12 NA, Loptek, Berlin, Germany) and coupled
to a four-channel single photon counting module (SPCM-AQR-15-FC, Excelitas
Technologies, Montreal, QC, Canada). The output from each detector was fed into an edgedetecting counter on a PCIe-6612 counter/timer data acquisition board (National
Instruments) [28]. Photon counts were recorded and processed using in-house developed
software (LabVIEW, MATLAB) [29]. For each detector, the software generated intensity
autocorrelation curves at 50 delay times ranging from 1 µs to 1 ms.
For use in the NICU, the optical fibers were designed to be lightweight and flexible, with
a 90°bend at the patient end to further minimize weight on the infant. A 3D-printed fiber
probe holder (5 × 2 × 1 cm; Flexible Resin, Form 2, Formlabs, Somerville, MA, USA) was
designed to secure the three optical probes (2 emission, 1 detection) to the patient’s
forehead using a soft and flexible base material with a non-abrasive strap (Figure 1 b).

3.3.4
3.3.4.1

Data processing
NIRS Analysis: Quantifying StO2 and Changes in oxCCO
Concentration

Prior to clinical measurements, a reference spectrum was acquired using a pinhole
attenuator to characterize the spectral properties of the optical system. In addition, a
measurement of the dark noise was acquired to characterize ambient light conditions. For
the clinical NIRS data, each reflectance spectrum, R(λ), was corrected for the reference
and dark count spectra as follows:
𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚 − 𝑑𝑎𝑟𝑘

𝑅(λ) = 𝑙𝑜𝑔10 (𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒λ − 𝑑𝑎𝑟𝑘λ )
λ

λ

(3.1)

where spectrum λ refers to the clinical measurement at wavelength λ.
To quantify chromophore concentrations, while accounting for the contribution of light
scatter, a derivative approach was utilized [18,30,31]. First and second derivatives of R(λ)
were calculated and fit to the solution of the diffusion approximation for a semi-infinite
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homogeneous medium [19]. Light absorption (Equation (3.2)) and scattering (Equation
(3.3)) parameters were input into the solution as follows [30]:
𝜇𝑎 (𝜆) = 𝑊𝐹 ∙ 𝜀𝐻2 𝑂 (𝜆) + 𝐻𝑏 𝑏 ∙ 𝜀𝐻𝑏 (𝜆) + 𝐻𝑏𝑂2𝑏 ∙ 𝜀𝐻𝑏𝑂2 (𝜆)

(3.2)

where WF is the tissue water fraction, Hbb and HbO2b are baseline concentrations of
deoxyhemoglobin and oxyhemoglobin in µM, and ε refers to the unique extinction
coefficient for each chromophore.
𝜆

−𝛼

𝜇𝑠 ′ = A (800(𝑛𝑚))

(3.3)

where α is the scattering power and A is the μs′ value at λ = 800 nm. Reflectance spectra
measured at baseline were analyzed with a multi-parameter fitting algorithm based on a
constrained

least-square

minimization

using

a

custom

MATLAB

function

(fminsearchbnd). Briefly, second derivative R(λ) spectra were fit by the model between
815 and 845 nm to obtain WF. The WF value was incorporated into the second derivative
fit from 680 to 800 nm to determine Hbb. Lastly, WF and Hbb were used in the analysis of
the first derivative spectrum. The fitting procedure extended from 680 to 845 nm to obtain
an estimate of HbO2b [30].
Following baseline analysis, a modified Beer–Lambert law based on the UCLn algorithm
(Equation (4)) was used to calculate changes in hemoglobin and oxCCO concentrations
for the duration of the study [22].
−1

𝜀𝐻𝑏𝑂2 (𝜆1 ) 𝜀𝐻𝑏 (𝜆1 ) 𝜀𝑜𝑥𝐶𝐶𝑂 (𝜆1 )
∆𝐻𝑏𝑂2
1
⋮
⋮
⋮
[ ∆𝐻𝑏 ] = 𝐷𝑃 [
]
(𝜆
)
(𝜆
)
(𝜆
)
𝜀
𝜀
𝜀
∆𝑜𝑥𝐶𝐶𝑂
𝐻𝑏𝑂2 𝑛
𝐻𝑏 𝑛
𝑜𝑥𝐶𝐶𝑂 𝑛

∆𝐴(𝜆1 )
× [ ⋮ ]
∆𝐴(𝜆𝑛 )

(3.4)

where ΔHbO2, ΔHb, and ΔoxCCO are relative changes from baseline in oxy-hemoglobin,
deoxy-hemoglobin, and the oxidation state of cytochrome c oxidase. The differential
pathlength (DP) was set to 4.39 based on previous literature [32,33] and corrected for the
wavelength dependency of the pathlength [34]. ΔA represents the measured change in
attenuation. Relative and baseline measures of hemoglobin were combined to determine
the tissue saturation as follows [27]:
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(𝐻𝑏𝑂 𝑏 +∆𝐻𝑏𝑂 )

2
2
𝑆𝑡 𝑂2 = (𝐻𝑏𝑏+∆𝐻𝑏)+(𝐻𝑏𝑂
𝑏 +∆𝐻𝑏𝑂
2

3.3.4.2

2)

(3.5)

DCS Analysis: Relative Measure of CBF

Acquired normalized intensity autocorrelation data were converted to electric field
autocorrelation data following the Siegert relation [35,36]:
𝑔2 (𝜌, 𝜏) = 1 + 𝛽

|𝐺1 (𝜌,𝜏)|2
〈𝐼(𝜌,𝜏)〉2

(3.6)

where g2(ρ,𝜏) is the measured normalized intensity autocorrelation, β is the coherence
factor, G1(ρ,𝜏) is the electric field autocorrelation function, and <I(ρ,𝜏)> is the averaged
detected intensity. The parameter ρ refers to the SDD and 𝜏 is the correlation time. G1 was
modeled using the solution to the diffusion approximation for a semi-infinite homogenous
medium and assuming the motion of light scatterers can be characterized by a pseudoBrownian motion [35,37,38]. Fitting was conducted for ρ = 2 cm and using the dynamic
µa measurements obtained by B-NIRS. A constant value for μs′ of 8 cm−1 was used in
accordance with recent literature [39]. Fitting each autocorrelation curve provided an index
of cerebral blood flow (CBFi).

3.3.5

Statistical Analysis

All data are presented as mean ± standard deviation (range) unless otherwise noted. Since
the tapping duration varied between procedures, the perfusion, oxygen saturation, and
metabolic data collected for each VT were temporally normalized to the average tap
duration to obtain mean time courses. For pre- and post-VT statistics, data were limited to
two minutes prior to needle insertion and following needle removal to avoid motion
artifacts. To assess the overall change in CBFi, StO2, and oxCCO due to a VT, a one-tailed
paired t-test was used to compare pre- and post-VT measurements. Potential outliers were
identified as points greater than q3 + w × (q3 − q1) or less than q1 – w × (q3 − q1) in the
box plots, where w represents the whisker length and q indicates the quartile number.
Statistics were repeated excluding any outliers. A matched pairs power analysis was
conducted using the G*Power 3 software (v3.1.9.7, Düsseldorf, Germany) to calculate the
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total sample size required to achieve significance [40]. Statistical significance was based
on a p-value < 0.05; power was set to 0.8.

3.4

Results

Optical measurements were acquired during 14 ventricular taps across four patients (one
female, three males, gestational age 25.0 to 37.6 weeks, mean = 29.2 ± 5.6 weeks). Data
from four events were excluded due to excessive patient motion. A further three B-NIRS
datasets were excluded due to ambient light contamination. DCS data acquired during these
periods were not impacted and remained in the analysis. A total of 10 ventricular taps were
analyzed for CBFi, and seven for StO2 and oxCCO. Clinical parameters are displayed in
Table 3.1.
Table 3-1: Clinical parameters for post-hemorrhagic ventricular dilatation (PHDV)
patients.
Gestational age at birth (weeks)
Birth weight (g)
Sex (n)
Apgar 1 min
Number of VT performed (n)
Age at first VT (weeks)
EVD (n)
VP shunt (n)
IVH Grade: Bilateral III
IVH Grade: III (R)/ IV (L)
IVH Grade: Bilateral IV

29.2 ± 5.6 (25–37 4/7)
1259.0 ± 746.7 (810–2376)
F = 1, M = 3
3.8 (1–8)
7.8 (5–10)
3.8 ± 2.1 (2.3–7)
2
3
2
1
1

EVD, external ventricular drain; VP ventriculoperitoneal; IVH, intraventricular hemorrhage.

Infants were monitored continuously throughout the ventricular tap, spanning needle
insertion and CSF drainage. Ventricular tap duration varied across the interventions with
an average duration of 16.1 ± 7.7 min (range: 8.75 to 29.25 min). Average time courses of
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CBFi, StO2, and oxCCO during the tapping procedure are displayed in Figure 3.3.

Figure 3.3: Change in cerebral blood flow index (ΔCBFi, n = 10), tissue saturation
(StO2, n = 7), and change in oxidation state of cytochrome c oxidase (ΔoxCCO,
n = 7) averaged across multiple trials over the course of ventricular taps (VT). Data
were temporally normalized to the averaged tap duration (16 min) and aligned to
VT start and end points. Each time course is displayed with its standard error
(shaded background).
The grey shaded regions in Figure 3.3 surrounding the CSF drainage period represent the
intervals used to calculate average pre- and post-VT values. Figure 3.4 presents the changes
in CBFi and oxCCO relative to baseline and pre- and post-VT StO2 values. The outliers
indicated on the plot borders corresponded to ΔCBFi changes of 122.0% and −25.0%, and
ΔoxCCO of 1.7 µM. Averaged values are displayed in Table 3-2 along with t-test and
power analysis results. Significance was not met for any of the parameters. Power analysis
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indicated that sample sizes of 29 and 18 for ΔCBFi and ΔoxCCO, respectively, would be
required to achieve significance. A significant increase was found for both ΔCBFi and
ΔoxCCO if outliers were excluded.

Figure 3.4: Boxplots showing changes in CBFi (a) and oxCCO (c) following
ventricular tap and StO2 (b) before and after the tap. Results are based on the
difference between pre- and post-VT measurements that were averaged over 2-min
periods. Individual data points are displayed; outliers are indicated by the crosses
on the borders and represent ΔCBFi values of 122% and −25% and ΔoxCCO of 1.7
µM.
Table 3-2: Average changes following VT relative to baseline, t-test, and power
analysis.
Statistical parameter
Average change

ΔCBFi (%)
14.6 ± 37.6

ΔStO2 (%)
1.9 ± 4.9

ΔoxCCO (µM)
0.4 ± 0.6

p-value

0.09

0.20

0.09

Required sample size for significance1

29

45

18

Average change excluding outliers

6.0 ± 7.7

-

0.1 ± 0.1

p-value excluding outliers

0.05

-

0.02

3.5

Discussion

The purpose of this study was to implement the recently developed Neonatal NeuroMonitor
(NNeMo) to assess cerebral hemodynamics and metabolism during ventricular taps in
patients with post-hemorrhagic ventricular dilatation. Compared with commercial NIRS
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devices that focus on monitoring StO2, the goal of implementing NNeMo was to assess the
direct impact of a VT on CBF, as measured by DCS, and cerebral oxygen metabolism, as
determined by monitoring oxCCO with B-NIRS. Both methods provide continuous
recordings, which enabled CBFi and oxCCO to be monitored throughout the tapping
procedure (Figure 3.3).
In hydrocephalus, decreases in cerebral perfusion are expected to precede changes in
metabolism and clinical symptoms [41]. In agreement with this concept, reductions in CBF
have been shown to impact metabolism only when CBF drops below a certain threshold
[27,42]. During a VT, as the ventricle volume and ICP decrease, perfusion is expected to
improve. The possibility of concurrent changes in metabolism would therefore depend on
the extent to which CBF is improved by the VT. A large increase in oxCCO following a
VT would suggest that the mitochondria were oxygen-limited prior to the procedure,
implying that the intervention could have been performed earlier [43]. In this study, it was
anticipated that a VT would improve CBF, but the magnitude of the perfusion increase
would likely not be sufficient to have an effect on oxCCO. Following 10 VTs, a nonsignificant increase was found in ΔCBFi (14.6 ± 37.6%, p = 0.09) and ΔoxCCO
(0.4 ± 0.6 µM, p = 0.09), while little change was observed in ΔStO2 (1.9 ± 4.9%, p = 0.2).
Power analysis indicated that achieving significance for these relatively small increases
would require a sample size of 29 for ΔCBFi and 18 for ΔoxCCO. Removing the outliers
in the ΔCBFi (n = 2) and ΔoxCCO (n = 1) datasets did result in significant increases in
both parameters; however, the average changes remained small (6.0 ± 7.7% for ΔCBFi and
0.1 ± 0.1 µM for ΔoxCCO).
Several studies have investigated the potential impact of CSF drainage on cerebral
hemodynamics in PHVD patients. An increase in CBF velocity was found by Doppler
ultrasound across seven patients [44], and stable oxCCO, as measured by NIRS, in
23 infants receiving a VT or lumbar puncture (LP) [45]. In an earlier study, Casaer et al.
reported that oxCCO increased in infants with grade 3 or 4 IVH who received an LP if
patients had clinical signs of elevated ICP (i.e., increased head circumference, bulged
fontanel, n = 4), but not if these symptoms were absent (n = 4) [46,47]. Similarly, elevated
cerebral oxygenation has been reported during cerebrospinal fluid removal, which was
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interpreted as evidence of increased CBF [45,48,49]. Previous work by our group measured
absolute CBF and the cerebral metabolic rate of oxygen (CMRO2) before and following a
VT using dynamic contrast-enhanced NIRS [14]. A significant increase in CBF (15.6%)
across 20 VTs was found with no change in CMRO2. In general, evidence of increased
CBF following CSF removal has been consistent across studies. The lack of a metabolic
response can be explained by the modest perfusion increase, indicating that the reduction
in CBF prior to the VT was not sufficient to impede oxygen delivery [18,31]. The results
of the current study complement these findings as the average increases in CBFi and
oxCCO were small and only reached significance after removing outliers. It is important
to note that the technologies used across studies to monitor cerebral perfusion and oxygen
metabolism are quite different, yet the findings are similar.
Compared with McLachlan et al. [14], the use of the hybrid B-NIRS/DCS system had the
advantages of not requiring an injection of an exogenous contrast agent to assess cerebral
perfusion and metabolism and providing continuous monitoring of these parameters
throughout the tapping procedure. The combination of B-NIRS and DCS in NNeMo was
achieved using a multiplexing shutter system to prevent crosstalk between the two
techniques. The intensity of the light from the DCS laser is large enough to easily saturate
the B-NIRS spectrometer, which impedes its ability to detect the relatively small spectral
features of oxCCO. Conversely, broadband light from the B-NIRS light source is highly
incoherent, which can degrade the temporal correlation of dynamic light scattering used by
DCS to measure CBFi [50]. These issues can be overcome by cycling data acquisition
between the two techniques. In this study, a sample rate of 4 Hz for both systems with an
overall cycling time of 7 s was considered sufficient, given the procedure was between 10
to 30 min in duration. It should be noted, however, that the multiplexing shutter system has
the flexibility to achieve higher temporal resolutions if required. Both systems are capable
of sampling rates up to 10 Hz, which could be used for instance to capture blood flow
pulsatility [28]. The minimum cycling time would be on the order of 300 ms, accounting
for shutter opening and closing times of less than 50 ms [51]. Alternately, truly
simultaneous measurements could be achieved using optical filters to selectively block BNIRS and DCS light sources from the opposing detectors. Recent works describing hybrid
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B-NIRS/DCS and time-resolved NIRS/DCS systems utilizing bandpass and notch filters
have been proposed [50,52,53].
In this clinical application, the two major sources of signal contamination were motion
artifacts and ambient light. Maintaining adequate probe contact with the scalp was
challenging on infants with PHVD as the head is distended due to the enlarged ventricles.
As CSF is drained during a VT, head circumference decreases, which can loosen the straps
holding the probes to the head. To mitigate this issue, the probes were placed on the
forehead above the frontoparietal cortex, where there is minimal change in head
circumference. In addition, the elastic property of the strap used to hold the probes in place
helped maintain good contact throughout the procedure. To minimize motion artifacts, an
NICU nurse gently restrained the patient’s head during the VT. Other sources of motion
were the repositioning of the infant in the cot for needle insertion and the application of
pressure to the head after the needle was retracted (Figure 3.2). As a result, data analysis
was limited to 2-min windows immediately prior to and following the VT. This short period
prevented monitoring for possible long-term changes after the VT, despite NNeMo’s
measurement stability over extended durations [27]. In three experiments, subjects were
located in an environment with excessive ambient light, as reflected by greater dark count
measurements acquired by B-NIRS. Since oxCCO only contributes approximately 10% of
the total spectral signal [22], it was necessary to remove B-NIRS datasets in which the dark
count was deemed excessive. In contrast, ambient light did not have the same impact on
the DCS measurements due to the stronger intensity of the laser and therefore these datasets
were included in the analysis.
Another potential source of error with optical neuromonitoring methods is the effect of
scalp contamination. The influence of the scalp is considerably less in infants compared
with adults, and within this study its effects were mitigated using appropriate sourcedetector distances for B-NIRS (SDD = 3 cm) and DCS (SDD = 2 cm) [54]. An additional
source of signal contamination unique to hydrocephalus is possible light loss in the
enlarged ventricle as the cortical mantle becomes increasingly thin. Our group
demonstrated that this effect could distort absorption spectra as the thickness of the cortical
mantle approaches 1 cm [14]. This likely did not have a significant effect on the CBFi
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measurements since the SDD was 2 cm. The NIRS spectra were, however, acquired with
SDD = 3 cm, which would increase the chance of light loss in the ventricles. The excellent
agreement in mean baseline StO2 values from the current and previous study – 58.4 ± 9.7%
compared to 58.9 ± 2.7% from reference [14] – indicates that cortical thickness did not
have a significant effect.
Future work will investigate a potential correlation of hemodynamic changes with
subsequent markers of brain injury. Comparison to clinical outcomes has the potential to
establish clinical thresholds of perfusion/metabolic change and could aid in describing VT
efficacy or in gauging brain injury severity during the progression of PHVD.

3.6

Conclusion

In summary, this feasibility study presents an optical system capable of providing real-time
monitoring of cerebral perfusion and oxygen metabolism in the NICU. In this application,
cerebral blood flow and metabolic changes monitored throughout VTs were small and only
reached significance after removing outliers. These results are in good agreement with
previous studies. Considering that the hybrid optical system is portable and completely
non-invasive, it is well suited for neuromonitoring in PHVD patients who may be suspected
of larger cerebral hemodynamic changes based on clinical symptoms.
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Chapter 4

4

Monitoring cerebral hemodynamic, oxygenation and
metabolic stability in premature infants following birth
using a hybrid broadband NIRS/DCS optical brain
monitor

This chapter features unpublished work in preparation for submission by Ajay Rajaram,
Daniel Milej, Lilian Kebaya, Matthew Kewin, Lawrence C. M. Yip, Marianne Suwalski,
Sandrine de Ribaupierre, Soume Bhattacharya, Mamadou Diop, and Keith St. Lawrence.

4.1 Introduction
As the perinatal period is a time of rapid neurodevelopment, a shortened gestation leaves
an immature and fragile cerebrovascular system vulnerable to damage that can lead to longterm cognitive dysfunction or life-long disability [1]. Premature birth is defined as a
gestational age (GA) less than 37 weeks and has shown to strongly correlate with the
development of adverse neurological outcomes, such as cognitive and behavioural deficits,
and more severe disorders, such as cerebral palsy. [2–4]. The duration of gestation and an
infant’s weight at birth are factors that influence the likelihood of adverse effects. Clinical
management (e.g. thermoregulation, respiratory management, etc.) during the first few
days following birth have proven critical in improving short and long-term outcome [5,6].
A common brain injury associated with preterm birth is intraventricular hemorrhaging
(IVH), which is characterized by bleeding in the germinal matrix and surrounding white
matter. IVH has been found to occur in 20-25% of preterms born with very low birth
weights (VLBW, <1500 g) and most commonly appears within the first 72 hours following
birth [7]. The pathogenesis behind IVH is multifactorial. However, contributing factors
include an unstable cerebral blood flow (CBF), resulting from an underdeveloped
cerebrovascular system, and having a limited ability to adequately perfuse distal whitematter regions [8]. This is exacerbated by the absence of intact cerebral autoregulation
(CA; i.e., the ability to maintain constant CBF during changes in blood pressure). In
addition, the premature brain likely has a minimal tolerance to reductions in CBF due to
the lower basal values compared to adults [9]. Diagnosis of IVH is achieved through
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imaging with cranial ultrasound (cUS) to visually assess and grade cerebral hemorrhages
at the bedside. In most centers, standard practice calls for imaging within the first week of
life and again within the first month [10]. A major drawback is that cUS is not a prognostic
technique as it can only indicate damage that has already occurred.
Recent work has demonstrated the value of optical devices to non-invasively monitor
physiological precursors of brain injury. Near-infrared spectroscopy (NIRS) utilizes light
in the near-infrared spectral range to determine cerebral tissue saturation (StO2) by
quantifying hemoglobin concentrations. Commercial NIRS devices have been utilized to
demonstrate the value of StO2 as a biomarker of cerebral hemodynamic stability in the
premature brain [11–14]. Notably, the SafeBoosC Phase II randomized clinical trial found
that neuromonitoring using NIRS within the first 72 hours resulted in a significantly
reduced burden of hypoxia [15]. While StO2 has become an accessible and robust marker
of cerebral oxygenation, the development of diffuse correlation spectroscopy (DCS) offers
a non-invasive approach to directly monitor CBF [16]. The index of cerebral blood flow
(CBFi) obtained by DCS has been validated against numerous gold-standard techniques,
such as arterial spin labelling MRI [17–21] and transcranial doppler ultrasound [22], and it
has proven useful in monitoring neonatal populations during various developmental stages
and clinical interventions. For example, CBF has been monitored in preterm infants during
the first six weeks of life and has shown to positively correlate with postmenstrual age
[23,24].
A measure of cerebral hemodynamics alone is likely insufficient for describing the risk of
injury since sufficient oxygen delivery can be maintained despite fluctuations in CBF due
to compensatory changes in the oxygen extraction fraction (OEF) [25,26]. If changes in
CBF are significant or persistent enough to exceed this compensatory mechanism, the
cerebral energy metabolism will be negatively impacted. Substantial drops in metabolism
often lead to cell death and subsequent tissue damage [27]. Recent work using broadband
NIRS (B-NIRS) to quantify light absorption over the NIR spectrum has allowed for robust
measurements of cytochrome c oxidase (CCO), a direct marker of cerebral oxidative
metabolism [28]. CCO is an enzyme in the mitochondria’s electron transport chain vital to
cellular energy production through oxidative phosphorylation. In the final step of this
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process, CCO becomes oxidized, which contributes to an electrochemical gradient driving
energy production. Similar to hemoglobin, changes in light absorption from the oxidation
state of CCO (oxCCO) can be quantified by B-NIRS. Changes in oxCCO during anoxia
events have shown to correlate severity of injury in animal models [29] and, in term infants
with hypoxic-ischemic encephalopathy, oxCCO has shown indicative of outcome [30].
NNeMo (Neonatal NeuroMonitor) is an in-house built hybrid B-NIRS/DCS device capable
of continuous bedside monitoring of cerebral perfusion and metabolism, via the marker
oxCCO. With a concurrent measure of metabolism, more physiological context can be
given to CBF monitoring by describing both oxygen supply and its impact on utilization.
This study aims to demonstrate NNeMo’s ability to characterize CBF and metabolic
stability within the first 72 hours of life in infants with an increased risk of developing IVH
(i.e., < 32 weeks GA and/or weighing < 1500 g). It is hypothesized that only significant
changes in CBF will impact metabolism. With a simultaneous acquisition of perfusion and
metabolism, the interrelationship of these metrics can be investigated and could provide
insight on hemodynamic instability during early brain development, the presence/absence
of CA, and potential links to the onset of IVH.

4.2
4.2.1

Materials and Methods
Patient Population

This study was approved by the Western University Health Sciences Research Ethics
Board, which adheres to the guidelines of the Canadian Tri-Council Policy Statement:
Ethical Conduct for Research Involving Humans. Subjects recruitment for this study was
conducted in the neonatal intensive care unit at the Children’s Hospital, London Health
Sciences Center. Following parental consent, infants born less than 32 weeks GA and/or
weighing less than 1500 g were enrolled in the study and monitored for two six-hour
periods within the first 72-hours of life. The first period was conducted as soon as clinically
feasible following birth and resuscitation and the second at 48 hours post-natal age (PNA).
During each monitoring period, cUS was performed to diagnose cerebral hemorrhaging,
which was graded according to the Papile scale [31].
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4.2.2

Study Design

Once transferred to the NICU from the birthing suite, following acquisition of vitals by
nursing staff, the optical probes were secured to the scalp above the frontoparietal cortex
using a 3-D printed probe holder and adjustable strap (Figure 4.1, A). The optical fibers
were bent 90° at the point of contact on the head for ease of use, and the optical prober
holder was designed to be light, flexible and non-abrasive (Figure 4.1, B; 5×2×1 cm;
Flexible Resin, Form 2, Formlabs, Somerville, MA, USA). The design of the probe holder
enabled it to be used with infants requiring ventilation with continuous positive airway
pressure (CPAP) as it could be positioned under the CPAP cap and tube. The infant’s eyes
were shielded using phototherapy eye goggles as a precaution. Two optical fibers (B-NIRS
and DCS sources) directed light to the head, while a third (common detection) collected
diffusely reflected light. The source-detector distance (SDD) was 3 cm for B-NIRS and
2 cm for DCS. A smaller distance was chosen for DCS as it is inherently more sensitive to
the brain [32]. Light source power levels and spot size incident on the scalp were adjusted
to meet ANSI standards for skin exposure. Following the monitoring period, the probe
holder was removed and the skin immediately under was assessed for redness or irritation.
This workflow was repeated for the second day monitoring session.

Figure 4.1: A) Premature infant with optical probes secured to the forehead and
phototherapy eye shield, B) schematic of probe holder with NIRS (3-cm SDD) and
DCS (2-cm SDD) optical fibers with the common detection fiber shaded; probe
holder dimensions: 5×2×1 cm.
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4.2.3

Instrumentation

NNeMo is a multimodal optical device that combines B-NIRS and DCS. It incorporates a
multiplexing shuttering system to cycle between acquisitions from the two subsystems; the
details are described elsewhere [33,34]. For this study, NIRS and DCS data were each
acquired at sampling frequency of 4 Hz in consecutive 3-s intervals, resulting in full data
sets every 7 s (with a 0.5-s dead-time between techniques). For B-NIRS, a 20-W halogen
bulb (Hl-2000-HP, Ocean Optics, Delay Beach, FL, USA), filtered from 600 to 1000 nm,
and a spectrometer (iDus 420, Andor, Oxford Instruments, Abingdon, UK; 548–1085 nm
bandwidth; 1.65 nm resolution; P&P Optica, Waterloo, ON, Canada) were employed. An
optical fiber bundle (2.4 mm diameter, 30 µM core, 0.55 numerical aperture (NA), Loptek,
Berlin, Germany) directed light towards the subject, while a second set of fibers (three
linearly aligned 2 mm diameter fibers, 30 µm core, 0.55 NA, Loptek, Berlin, Germany)
collected light interrogating tissue. The DCS light source was a long-coherence laser
(DL785-100s, CrystaLaser, Reno, NV, USA) and a four-channel single-photon counting
module (SPCM-AQR-15-FC, Excelitas Technologies, Montreal, QC, Canada) was used
for detection. A DCS emission fiber (4 × 200 µm core diameter, 0.22 NA, Loptek, Berlin,
Germany) and a single-mode detection fiber (8 µm core diameter, 0.12 NA, Loptek, Berlin,
Germany) directed light towards and collected light from the scalp. A PCIe-6612 data
acquisition board collected the SPCM output which was processed using in-house
developed software (LabVIEW, MATLAB) [35,36].

4.2.4
4.2.4.1

Data Analysis
Quantifying StO2 and ΔoxCCO by B-NIRS

Each monitoring period began by measuring a dark signal, which was determined by taking
a measurement with the emission source turned off. A reference measurement was
collected prior to monitoring to characterize the spectral properties of the instrumentation.
The reference spectrum and the dark signal measurement were incorporated into the
analysis of measured light reflectance spectra. A derivative spectroscopy approach was
applied to reflectance spectra to quantify hemoglobin and water concentrations, while
accounting for light scatter contributions [26,37]. The first and second derivatives of
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reflectance spectra were fit to a solution of the diffusion approximation for a semi-infinite
homogeneous medium. A multi-parameter minimization fitting algorithm was utilized to
estimate the tissue water fraction, hemoglobin concentrations (oxy-, HbO2, and deoxyhemoglobin, Hb), and optical properties [38]. Baseline cerebral tissue oxygen saturation
(StO2b) was determined from the corresponding hemoglobin concentrations:
𝑆𝑡𝑂2 𝑏 =

𝐻𝑏𝑂2 𝑏

(4.1)

𝐻𝑏 𝑏 +𝐻𝑏𝑂2 𝑏

A modified Beer-Lambert Law approach based on the UCLn algorithm was utilized to
determine time-varying changes in the concentrations of HbO2, Hb, and oxCCO [28].
𝜀𝐻𝑏𝑂2 (λ1 )
∆𝐻𝑏𝑂2 (𝑡)
1
⋮
[ ∆𝐻𝑏(𝑡) ] = 𝐷𝑃 [
𝜀𝐻𝑏𝑂2 (λ1 )
∆𝑜𝑥𝐶𝐶𝑂(𝑡)

𝜀𝐻𝑏 (λ1 )
⋮
𝜀𝐻𝑏 (λ1 )

𝜀𝑜𝑥𝐶𝐶𝑂 (λ1 )
⋮
]
𝜀𝑜𝑥𝐶𝐶𝑂 (λ1 )

−1

×[

∆𝐴(λ1 , 𝑡)
⋮
]
∆𝐴(λ𝑛 , 𝑡)

(4.2)

where Δ denotes a change relative to baseline concentration, DP is the differential
pathlength (set to 4.9 based on previous literature [39,40]), ε is the molar extinction
coefficient of each chromophore, and A is the measured change in attenuation. Changes in
hemoglobin were calibrated using absolute values measured at baseline with the derivative
approach to provide continuous quantification of StO2. Metabolic changes were
represented by absolute changes in the concentration of oxCCO.

4.2.4.2

Monitoring CBF by DCS

To determine the cerebral blood flow index (CBFi), measured normalized intensity
autocorrelation data were converted to electric field autocorrelation data using the Siegert
relation [16,41]:
𝑔2 (𝜌, 𝜏) = 1 + 𝛽

|𝐺1 (𝜌,𝜏)|2
〈𝐼(𝜌,𝜏)〉2

,

(4.3)

where g2(ρ,τ) represents the measured normalized intensity autocorrelation as a function
of SDD and time (ρ,τ), G1(ρ,τ) is the electric field autocorrelation function, <I(ρ,τ)> is the
average intensity, and β is the coherence factor. G1 was fit with the solution to the diffusion
approximation for a semi-infinite homogenous medium while assuming pseudo-Brownian
motion of light scatterers [42,43]. The fitting was performed by incorporating changes in
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the absorption coefficient determined by B-NIRS and a constant scattering coefficient of
8 cm-1 [44]. All CBFi estimates were normalized to their respective baseline value to
generate a time series of relative changes in CBF.

4.2.5

Data Post-processing and Statistical Analysis

Time courses of StO2, CBFi, and oxCCO were filtered as a function of frequency using an
inverse wavelet transform with a Morlet wavelet (cwt MATLAB function) [45–47]. This
approach has been applied for time-frequency analysis of similar patient populations
[48,49]. To isolate relevant physiological frequencies, high (f > 0.01 Hz) and low
(f < 0.001 Hz) frequencies were removed. Next, time courses for each parameter were
corrected for motion artifacts using an algorithm utilizing a moving standard deviation and
spline interpolation [50,51].
Absolute StO2 measures as well as the standard deviation of CBFi and oxCCO values were
compared across day one and day three monitoring periods. The relationship between
saturation and perfusion was investigated to assess differences between these metabolic
markers. Both StO2 and CBFi were also compared to oxCCO measures to characterize the
impact of hemodynamic changes on metabolism. Comparisons were made by analyzing
correlations between CBFi/StO2, CBFi/oxCCO, and StO2/oxCCO and calculating
coherence and semblance across the frequency range (0.001-0.01 Hz). A measure of
coherence characterizes the strength of the relationship between variables, ranging from
0 to 1, while semblance describes the phase difference, ranging from -1 (antiphase) to 1 (in
phase) [48]. Coherence and semblance for all three combinations of optical measures were
compared across patients for both monitoring periods.
For data displayed in boxplots, statistical outliers were determined as points greater than
q3 + w × (q3 − q1) or less than q1 – w × (q3 − q1) where q is the quartile number and w is
the whisker length. All data are presented as mean ± standard deviation (range) unless
otherwise noted. Statistical analyses were conducted using a statistical toolbox (MATLAB)
and significance was defined as p < 0.05. A paired t-test was used to investigate differences
in measurements across days. In addition, regression analysis was conducted to assess the
relationships between CBFi, StO2 and oxCCO within a single day. A one-way repeated-
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measures analysis of variance was used to investigate differences in average coherence and
semblance values obtained from data measured in each subject across both monitoring
periods.

4.3

Results

Optical data were acquired in nine infants on the first and third days of life (6 male,
3 female, GA 28 ± 2 weeks, range: 24 weeks, 5 days to 31 weeks, one day). The first
monitoring period began on average at 5.9 ± 6.2 hours after birth (range: 1 to 18 hours) and
the second at 53.8 ± 8.2 hours (range: 44.5 to 61 hours). Data from the first subject were
excluded due to excessive ambient light that resulted in substantial signal artifacts. For
subsequent acquisitions, the optical probes were covered at the site of contact using a thin
blanket to reduce signal from ambient light. This was confirmed by quantifying the
spectrometer’s intensity output with the light source turned off. Data from the remaining
eight infants are reported in this work. Optical data acquired during significant patient
handling (e.g. vital signs, patient repositioning) or clinical intervention (e.g. x-ray, US
imaging) were omitted to avoid motion artifacts. On average, 233 ± 68 minutes
(range: 145 to 340 minutes) of data were analyzed on day one and 254 ± 36 minutes
(range: 210 to 290 minutes) on day three. Clinical parameters of patients enrolled are
displayed in Table 4-1.
Table 4-1: Patient demographics and clinical metrics.
Gestational age at birth (weeks + days)
Birth weight (g)
Sex (n)

28 ± 2 (24+5 – 31+1)
1123 ± 344
5 M; 3 F

Apgar score 5 min

6.4 ± 3.2 (1 – 9)

Apgar score 10 min

8.3 ± 1.0 (7 – 9)

Monitoring start time on day 1 (hours)

5.9 ± 6.2 (1 – 18)

IVH diagnosis (n, grade)

1, Grade II right/Grade I left

Optical parameters (StO2, ΔCBFi, and ΔoxCCO) were analyzed over the duration of the
monitoring period. An example of time courses obtained from one patient are displayed in
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Figure 4.2. In this dataset, a clear discrepancy is noted between CBFi values during the
first and third day of life. Large fluctuations in ΔCBFi were found during the first
monitoring period compared to the second. For StO2 and ΔoxCCO time courses, smaller
differences were observed across days.

Figure 4.2: Cerebral tissue saturation (StO2), change in cerebral blood flow index
(ΔCBFi), and change in oxidation state of cytochrome c oxidase (ΔoxCCO) of a
subject on the first (A) and third (B) day of life.
To illustrate the stability of time courses obtained in all subjects, absolute StO2 and the
standard deviation of ΔCBFi and ΔoxCCO across both days are presented in Figure 4.3.
Mean StO2 was 73.9 ± 11.6% on the first day of life and 79.7 ± 5.9% on the third day. For
relative ΔCBFi and ΔoxCCO measures, the standard deviation of time courses across
monitoring periods were found to decrease from 11.5 to 7.9% and 0.7 to 0.5 µM,
respectively; however, these changes were not statistically significant. While a trend is
apparent in StO2 and σCBFi values across days, much smaller changes were observed in
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σoxCCO. As oxCCO is measured as an absolute change, it is necessary to provide context
to characterize the extent of these fluctuations.

Figure 4.3: StO2, standard deviation of ΔCBFi , and standard deviation of ΔoxCCO
during day 1 and day 3; statistical outliers are indicated by +.
For each subject, time courses of optical metrics were analyzed using an inverse wavelet
transform to describe prevalent frequencies over the monitoring period. Figure 4.4 depicts
the heat maps for the same infant featured in Figure 4.2. A notable frequency band around
0.004 Hz was apparent in the CBFi data on day 1 and is highlighted for illustration
purposes only. By day 3, this oscillation was no longer present. A similar but less
pronounced effect was observed in the StO2 data that also dissipated by day 3. No
oscillations were evident in the corresponding oxCCO data.
Figures 4.5 and 4.6 display the coherence and semblance between optical parameters for
the same subject featured above. In both cases, there was notable coherence and semblance
only in the CBFi/StO2 relationship on day 1, which was less prominent on day 3.
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Figure 4.4: Frequency analysis of cerebral tissue saturation (StO2), cerebral blood
flow index (CBFi), and oxidation state of cytochrome c oxidase (oxCCO) on the first
(A) and third (B) day of life for one subject. The highlighted region isolates a
notable frequency band.

Figure 4.5: Coherence of cerebral tissue saturation (StO2), cerebral blood flow index
(CBFi), and oxidation state of cytochrome c oxidase (oxCCO) on the first (A) and
third (B) day of life for one subject.
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Figure 4.6: Semblance of cerebral tissue saturation (StO2), cerebral blood flow index
(CBFi), and oxidation state of cytochrome c oxidase (oxCCO) on the first (A) and
third (B) day of life for one subject.
Coherence and semblance measurements across all subjects are depicted in boxplots in
Figure 4.7. A significant difference was found between coherence of CBFi/StO2 compared
to coherence of CBFi/oxCCO on day 1. Semblance of CBFi/StO2 was significantly
different from the two semblances that included the metabolic marker oxCCO (i.e.,
CBFi/oxCCO and StO2/oxCCO) on both days.
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Figure 4.7: Boxplot showing coherence and semblance in all parameters across both
measurement days; statistical outliers are indicated by +.

4.4

Discussion

This study demonstrated the ability to monitor cerebral perfusion and metabolism
concurrently in preterms infants within the first critical 72 h of life. Numerous practical
challenges exist in monitoring premature infants so soon after birth. First, many births that
occur at this gestation are sudden or emergencies, which poses a challenge for patient
recruitment and obtaining consent. Clinical and research teams must communicate closely
to identify potential study participants and commence monitoring. Infants admitted to the
NICU are not only at risk of adverse neurological development, many have complications
with respiration, circulation, temperature control, or a number of other potential ailments,
which all require some form of intervention. As such, the period immediately following
birth has many events likely to produce artifacts in optical data from ambient light or
motion (e.g. phototherapy, imaging, patient handling). While each infant in this study was
monitored for 6 hours at a time, only 65% and 70% of the data sets on average were usable
on days one and three, respectively.
NNeMo provided continuous measures of StO2, CBFi, and oxCCO. These metrics each
provide a different perspective in terms of characterizing early brain development. Work
by Kissak et al. monitored OEF using NIRS in VLBW infants during the first three post-
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natal days and reported significant fluctuations in OEF in infants with IVH [52]. However,
NIRS measurements of StO2 and OEF alone have shown limited use as surrogate markers
of cerebral metabolism [53]. For example, a study monitoring premature infants following
administration of indomethacin (vasoconstrictor) for treatment of patent ductus arteriosus
found statistically significant decreases in CBF and corresponding significant increases in
the OEF. Despite these changes, no notable difference in cerebral metabolism was reported
[25]. It is therefore more useful to combine NIRS measures of oxygen content with CBF
and metabolic information to provide a more wholistic understanding of hemodynamic
fluctuations and their impact on energy production. A study by Noori et al monitored StO2
using NIRS and CBF with Doppler ultrasound in extremely premature infants during the
first three days of life [54]. This work reported a lower StO2 and an increased OEF in
infants who developed IVH compared to those who did not. The IVH group also
experienced a notable difference in cerebral hemodynamics; a fluctuating CBF was
observed and attributed to a hypoperfusion-reperfusion cycle that preceded the onset of
hemorrhaging. By adding a measure of metabolism, the impact of these fluctuations in CBF
could be further investigated and related to tissue viability and potential injury.
In our study, a large range of StO2 values as well as an increased standard deviation of
CBFi was found during the first day of life compared to the third (Figure 4.3). Much
smaller changes were observed in the standard deviation of oxCCO across the monitoring
periods. This implies that hemodynamic fluctuations were not significant enough to impede
energy metabolism. To place the oxCCO measure in context, animal experiments
conducted in adult rats estimate that the absolute concentration of CCO to be between
4.5 and 5.5 µM [27,55]. As metabolism in this animal model is higher than in humans, this
value should be considered an upper limit [28]. Furthermore, the total concentration of
CCO in neonates is likely less than the adult brain. Compared to the 0.7 µM standard
deviation in oxCCO observed on day much larger changes in oxCCO have been observed
in animal models prior to hypoxic ischemic injury [34] and following seizures in term
infants [56].
Frequency analysis using an inverse wavelet transform was implemented to characterize
the stability of optical parameters. Frequencies were limited between 0.001 – 0.01 Hz to
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isolate physiologically relevant signals [48,49]. Figure 4.4 illustrates the data from one
patient. For this infant, a consistent oscillation in CBFi and StO2 was observed only on day
one. By day three, a change in frequency components in this signal (i.e., a more balanced
distribution of fast and slow frequencies) left no disenable pattern. No prevailing frequency
was observed for metabolic measures. This observation was made for several subjects in
the study, as reflected in Figure 4.3.
To compare the interrelationship between saturation, perfusion, and metabolism, the
coherence and semblance for each pair was calculated. Figures 4.5 and 4.6 depict these
relationships for the same subject featured in Figure 4.2. Analyzing these metrics over all
subjects resulted in a significantly different coherence of CBFi/StO2 (Figure 4.7, A) from
CBFi/oxCCO on day one. Similarly, CBFi/StO2 semblance was significantly higher than
CBFi/oxCCO and StO2/oxCCO relationships on both monitoring periods (Figure 4.7, B).
In the healthy brain, a distinction between CBF and metabolic measures is expected, as
metabolism is heavily regulated and is largely independent [57]. A measure of metabolic
reactivity therefore has the potential to better characterize the impact of impaired CA on
the preterm brain. This relationship was shown to predict outcome in term infants with
hypoxic-ischemic encephalopathy as validated by metabolic measures of Lac/NAA levels,
using magnetic resonance spectroscopy, and a one-year neurodevelopmental outcome
check [48]. Within premature infants, CA is known to be frequently impaired; however, in
this work no significant relationship between metabolism and other optical measures was
observed, implying sufficient energy production. Fluctuations in StO2 and CBF had a
negligible influence on oxCCO measures.
In this study, only one subject was diagnosed with IVH and this scan took place prior to
optical monitoring on day 1. Due to this timing and the small sample size, no distinction
could be made between hemodynamic/metabolic instability and the onset of a bleed. In
addition, this study is limited in the amount of time monitored. Data from approximately
four hours was compared on the first and third day of life. Since CBFi is a relative measure
and oxCCO represents a change in concentration, trends in flow and metabolism could not
be compared across monitoring periods. Instead, data analysis focused on comparing the
standard deviations, as a marker of stability, within each monitoring period. Future work
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seeks to monitor changes continuously for the first 72 hours of life to better characterize
changes over this entire period. While frequency analysis provided valuable insight to the
relationship between hemodynamics and metabolism, a larger cohort is required to
determine if changes in oxCCO can be linked to IVH. Furthermore, NNeMo does not
provide any spatial resolution, having only a single B-NIRS/DCS interrogation site, and
therefore can only infer local changes. The one subject diagnosed with IVH experienced a
bilateral bleed (Grade II, right, Grade I, left). With the current system, discerning any
difference in hemodynamics across these two sites is not possible. Additional sourcedetector pairs could allow for hemispheric/regional monitoring.

4.5

Conclusion

This study demonstrates the feasibility of simultaneous bedside monitoring of cerebral
perfusion and metabolism following premature birth using a hybrid optical system
combining broadband-NIRS and DCS. Perfusion and metabolic stability on the first and
third day of life was demonstrated using frequency analysis with an inverse wavelet
transform. Prevalent oscillations in StO2 and ΔCBFi present on day one diminished by day
three. No accompanying changes were noted in ΔoxCCO. Coherence and semblance
analysis of optical parameters found a notable relationship between CBFi/StO2 only on the
first day while measures of metabolism were independent. Monitoring dynamic changes in
cerebral perfusion and its potential influence on metabolism could provide a clearer
indication of the impact of autoregulation in the newborn brain, sufficient energy
production, and tissue viability. Optical measures have potential as prognostic markers of
tissue damage and timely detection of injury could allow for corrective patient management
and improved clinical outcome.
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Chapter 5

5

Optical monitoring of cerebral perfusion and metabolism
in adults during cardiac surgery with cardiopulmonary
bypass

This chapter has been adapted from the publication titled “Optical monitoring of cerebral
perfusion and metabolism in adults during cardiac surgery with cardiopulmonary bypass”
published in Biomedical Optics Express in 2020 by Ajay Rajaram, Daniel Milej, Marianne
Suwalski, Lawrence C. M. Yip, Linrui R. Guo, Michael W. A. Chu, Jason Chui, Mamadou
Diop, John M. Murkin, and Keith St. Lawrence, volume 11, issue 10.

5.1 Abstract
During cardiac surgery with cardiopulmonary bypass (CPB), adequate maintenance of
cerebral blood flow (CBF) is vital in preventing postoperative neurological injury – i.e.,
stroke, delirium, cognitive impairment. Reductions in CBF large enough to impact cerebral
energy metabolism can lead to tissue damage and subsequent brain injury. Current methods
for neuromonitoring during surgery are limited. This study presents the clinical translation
of a hybrid optical neuromonitor for continuous intraoperative monitoring of cerebral
perfusion and metabolism in ten patients undergoing non-emergent cardiac surgery with
non-pulsatile CPB. The optical system combines broadband near-infrared spectroscopy (BNIRS) to measure changes in the oxidation state of cytochrome c oxidase (oxCCO) – a
direct marker of cellular energy metabolism – and diffuse correlation spectroscopy (DCS)
to provide an index of cerebral blood flow (CBFi). As the heart was arrested and the CPBpump started, increases in CBFi (88.5 ± 125.7%) and significant decreases in oxCCO
(−0.5 ± 0.2 µM) were observed; no changes were noted during transitions off CPB. Fifteen
hypoperfusion events, defined as large and sustained reductions in CPB-pump flow rate,
were identified across all patients and resulted in significant decreases in perfusion and
metabolism when mean arterial pressure dropped to 30 mmHg or below. The maximum
reduction in cerebral blood flow preceded the corresponding metabolic reduction by
18.2 ± 15.0 s. Optical neuromonitoring provides a safe and non-invasive approach to

136

assessing intraoperative perfusion and metabolism and has potential in guiding patient
management to prevent adverse clinical outcome.

5.2

Introduction

Cardiopulmonary bypass (CPB) has become a cornerstone of cardiac surgery since its
introduction in the 1950s. By taking over the physiological functions of the heart and lungs,
CPB provides surgeons with an operating field unobstructed by blood and free of cardiac
motion; however, there are numerous postoperative neurological complications associated,
including cognitive dysfunction [1–3], delirium, and stroke [4–6]. During CPB, procedural
changes in pump flow rate and unplanned fluctuations in cardiac output can produce
variations in cerebral blood flow (CBF) [7]. Given the high metabolic demands of the brain
and its reliance on a continuous supply of oxygen, changes in CBF that are large enough
to impact cerebral metabolism could lead to tissue damage and subsequent brain injury.
There is currently no established method for intraoperative monitoring of CBF and cerebral
metabolism during CPB. Traditionally, CBF was measured using Xenon-133, a
discontinuous method that requires an invasive injection via the arterial circulation [8].
Transcranial Doppler (TCD) ultrasound has also been used to measure CBF in major
cerebral arteries [9]; however, TCD embodies numerous drawbacks, including space
limitations when utilizing a large transducer probe, inconsistent acoustic windows due to
variations in thickness and porosity of the skull [10], and signal contamination from
electrocautery used during surgery [11]. Optical techniques are becoming more prevalent
for real-time monitoring due to their safety, low-cost, and ease of implementation [12].
Cerebral oximetry can continuously measure cerebral tissue saturation (StO2) during
surgery and provides valuable insight into cerebral hemodynamics but has proven
insufficient for monitoring oxygen utilization [13–15]. More advanced optical methods of
neuromonitoring have demonstrated the ability to measure microcirculatory blood flow and
cerebral metabolism continuously and noninvasively [16,17]. Broadband near-infrared
spectroscopy (B-NIRS) provides a means of directly monitoring cerebral energy
metabolism by measuring the oxidation state of cytochrome c oxidase (oxCCO). This
enzyme is involved in the electron transport chain and is vital to energy production via
oxidative phosphorylation [18]. In addition, diffuse correlation spectroscopy (DCS)
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provides continuous CBF monitoring by tracking the temporal correlation of light scatter
from red blood cells in the cerebral microvasculature [19–22].
This manuscript reports the clinical translation of a hybrid B-NIRS/DCS optical
neuromonitor to provide non-invasive and continuous monitoring of CBF and oxCCO
throughout cardiac surgery with CPB. The goal was to assess the system’s ability to
identify fluctuations in perfusion and metabolism, while determining the efficacy of CPB
in maintaining adequate oxygen supply and utilization. It was hypothesized that transitions
on and off CPB would impact CBF, based on the CPB-pump flowrate (FRCPB) chosen, but
fluctuations in flow would be insufficient to impact cerebral metabolism. It was also
expected that significant operational changes in FRCPB, while patients were fully reliant on
CPB, would directly influence cerebral hemodynamics, with large and sustained drops
leading to metabolic change.

5.3
5.3.1

Methods
Patient Population

This study was approved by the Western University Health Sciences Research Ethics
Board, which adheres to the guidelines of the Tri-Council Policy Statement: Ethical
Conduct for Research Involving Humans (REB #113650). After obtaining consent, patients
admitted to University Hospital’s Cardiac Surgical Unit in London, Ontario, were
monitored during non-emergent cardiac surgery with the use of non-pulsatile CPB.

5.3.2

Clinical Monitoring

Optical monitoring was conducted throughout surgery with CPB. Vital parameters were
recorded with a clinical unit (Intellivue MX800, Philips Healthcare, MA, USA) and
exported to the optical system. In accordance with clinical protocol, patients presenting
with an increased risk of postoperative cognitive effects were monitored with EEG and a
cerebral oximeter (SedLine®, Masimo, CA, USA). The optical probes were placed on the
right temporal region of the forehead following anesthetic induction, endotracheal
intubation, and placement of arterial and venous lines, but prior to skin incision. The probes
were secured using a 3D-printed probe holder (Fig. 5.1a) and medical tape. Two optical
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fibers delivered light from the DCS and B-NIRS sources onto the patient’s scalp. Diffusely
reflected light was collected from a common detection fiber bundle that corresponded to
source-detector distances (SDD) of 2 and 3 cm for DCS and B-NIRS, respectively (Fig.
5.1b), to ensure adequate brain interrogation. Prior to monitoring, broadband light spectra
were assessed to ensure negligible contamination from ambient light and the Masimo
oximeter (< 5% signal contribution). Optical source power levels were maintained within
ANSI limits for skin exposure.
B-NIRS and DCS measurements were acquired sequentially in a period of 3 s each. Within
each period, the integration time was 250 ms. A transition delay of 0.5 s was incorporated
between techniques to account for shutter transition times, achieving a cycle time of 7 s.
Data were continuously acquired during the entire surgical procedure, spanning the
transition on and off the CPB machine. Prior to and following CPB, DCS data were
acquired for a minimum of 10 seconds at an increased sampling rate (20 Hz) to capture
pulsatile waveforms.

Figure 5.1: A) Optical fiber probes and 3D-printed probe holder (5 × 2 × 1 cm) B)
Schematic of the probe holder showing near-infrared spectroscopy (NIRS, 3-cm
SDD) and diffuse correlation spectroscopy (DCS, 2-cm SDD) emission probes with a
common detection probe

5.3.3

Instrumentation

The development of a hybrid B-NIRS/DCS system has been previously reported and
demonstrated continuous monitoring of cerebral blood flow, cerebral oxygen saturation,
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and metabolism in both animal models and infants in the neonatal intensive care unit [1617].
The system was constructed by combining B-NIRS and DCS modalities using a
multiplexing shuttering system. The B-NIRS source (Hl-2000-HP, Ocean Optics, FL,
USA) was coupled into a custom optical fiber bundle (2.4 mm diameter active area, 30 µM
core, 0.55 numerical aperture (NA), Loptek, Germany) to guide light to the subject’s head.
Light that interrogated the head was collected by a detection fiber bundle (2 mm diameter
active area, 30 µm core, 0.55 NA, Loptek, Germany), and led to a custom-made
spectrometer (548 to 1085 nm bandwidth; 1.65 nm resolution; P&P Optica, ON, Canada).
Light from the DCS laser (DL785-100s, CrystaLaser, NV, USA) was similarly coupled
into a fiber bundle (4 × 200 µm core diameter, 0.22 NA, Loptek, Germany) and directed
towards the head. Diffusely reflected DCS light was collected with a bundle of four singlemode fibers (8 µm core diameter, 0.12 NA, Loptek, Germany) coupled to a four-channel
single-photon counting module (SPCM-AQR-15-FC, Excelitas Technologies, QC,
Canada). The output of the detectors was sent to a data acquisition board (PCIe-6612,
National Instruments, TX, USA) and processed by in-house developed software
(LabVIEW, National Instruments, TX, USA; MATLAB, MathWorks, MI, USA) [23,24].
Intensity autocorrelation curves at 50 delay times, ranging from 1 μs to 1 ms, were
generated for each detector.
For use in the operating room, the fibers were shielded to prevent ambient light
contamination from the bright surgical environment. The tips of the optical probes, in
contact with the scalp, were bent 90 degrees to maintain a low profile and held in placed
by a 3D-printed holder constructed from a lightweight, flexible material (5 × 2 × 1 cm;
Flexible Resin, Form 2, Formlabs, MA, USA).

5.3.4
5.3.4.1

Data Processing
B-NIRS Quantification of Baseline StO2

Prior to clinical monitoring, the spectral profile of the optical system was characterized by
acquiring a reference measurement. Once the probes were positioned on the scalp, a dark
count measurement was acquired while the light sources of the optical system were off. A
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reflectance measurement R(λ) was determined by correcting for both reference and dark
count measures as follows:
𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚 − 𝑑𝑎𝑟𝑘

𝑅(λ) = 𝑙𝑜𝑔10 (𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒λ − 𝑑𝑎𝑟𝑘λ )
λ

(5.1)

λ

where spectrumλ refers to the measured light intensity at wavelength λ. Reflectance data
were analyzed by fitting the first and second derivatives of R(λ) to solutions of the diffusion
approximation for a semi-infinite homogeneous medium [12,25,26]. As previously
reported, the tissue water fraction, oxy- and deoxy-hemoglobin (HbO2, Hb) concentrations,
and scattering parameters were estimated using a three-step multi-parameter fitting with a
constrained minimization algorithm based on the MATLAB function fminsearchbnd
[12,16,17]. Baseline tissue oxygen saturation (StO2b) was calculated from the estimated
hemoglobin concentrations:
𝑆𝑡𝑂2 𝑏 =

𝐻𝑏𝑂2 𝑏

(5.2)

𝐻𝑏 𝑏 +𝐻𝑏𝑂2 𝑏

where the superscript b denotes baseline values.

5.3.4.2

Monitoring StO2 and Absolute Change in Oxidative State of
Cytochrome c oxidase

Following a minimum five-minute baseline measurement, a modified Beer-Lambert Law
based on the UCLn algorithm (Equation 3) was used to calculate changes in Hb, HbO2,
and oxCCO concentrations [18].
−1

𝜀𝐻𝑏𝑂2 (𝜆1 ) 𝜀𝐻𝑏 (𝜆1 ) 𝜀𝑜𝑥𝐶𝐶𝑂 (𝜆1 )
∆𝐻𝑏𝑂2
1
⋮
⋮
⋮
[ ∆𝐻𝑏 ] = 𝐷𝑃 [
]
𝜀𝐻𝑏𝑂2 (𝜆𝑛 ) 𝜀𝐻𝑏 (𝜆𝑛 ) 𝜀𝑜𝑥𝐶𝐶𝑂 (𝜆𝑛 )
∆𝑜𝑥𝐶𝐶𝑂

∆𝐴(𝜆1 )
× [ ⋮ ]
∆𝐴(𝜆𝑛 )

(5.3)

where ΔHbO2, ΔHb, and ΔoxCCO are the relative changes from baseline in oxyhemoglobin, deoxy-hemoglobin, and the oxidation state of cytochrome c oxidase,
respectively. DP is the differential pathlength and ΔA is the measured change in
attenuation. DP was set to 6.26, based on previous literature representing measurements in
the adult head [27], and corrected for the wavelength dependency of the pathlength [28].
Relative measures determined by the modified Beer-Lambert approach were utilized in
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conjunction with absolute baseline values from the derivative approach. This method
provided absolute saturation values at faster computational speeds, allowing for real-time
data interpretation. Tissue saturation was determined as follows [17]:
(𝐻𝑏𝑂 𝑏 +∆𝐻𝑏𝑂 )

2
2
𝑆𝑡 𝑂2 = (𝐻𝑏𝑏+∆𝐻𝑏)+(𝐻𝑏𝑂
𝑏 +∆𝐻𝑏𝑂
2

5.3.4.3

2)

(5.4)

CBF Monitoring

Acquired DCS intensity data were normalized, autocorrelated, and converted to electric
field autocorrelation data following the Siegert relation [29,30]. Each autocorrelation
function was fit with the solution to the diffusion approximation for a semi-infinite
homogenous medium for SDD = 2 cm, dynamic µa measurements obtained by B-NIRS,
and a constant value for μs′ of 8 cm-1 [22]. Fitting resulted in an estimate of the cerebral
blood flow index (CBFi). CBFi data were normalized to baseline values to represent
relative changes [31].

5.3.5

Statistical Analysis

All data are presented as mean ± standard deviation and statistical significance is defined
as p < 0.05. CPB transition periods were defined as the minimum time to increase the CPBpump flow rate (FRCPB) from zero to values sustained throughout the procedure, and viceversa. To characterize this impact, data were averaged over 5-minute periods immediately
surrounding CPB transitions and displayed in boxplots. An additional 5-minute period was
analyzed 15 minutes into CPB and compared to baseline values. Outliers were defined as
points greater than q3 + w × (q3 – q1) or less than q1 – w × (q3 – q1), where w represents
the whisker length and q indicates quartile number. A two-tailed paired t-test was
conducted to determine significance following the onset/end of CPB. Intraoperative
hypoperfusion events were identified, defined as sudden and large decreases in FRCPB
lasting a minimum of 30 s. Changes in optical parameters during these events were binned
into 10-mmHg MAP intervals and plotted. A multivariate ANOVA was used to determine
statistical significance in optical parameters compared to baseline values. For each
hypoperfusion event, the maximum reductions in CBFi and oxCCO were compared.
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5.3.6

Results

Optical measurements were acquired in ten adult patients (nine male, one female, aged
34 to 76 years, mean age = 58.1 ± 13.8 years). Data from the first three patients had to be
excluded due to excessive ambient light from the bright surgical environment. Additional
shielding, in the form of an optical blackout cloth (Thorlabs, NJ, USA), was implemented
following these subjects to minimize artifacts from external light sources (< 5% signal
contribution). Data from the fourth and seventh patients were limited to hypoperfusion
events due to excessive motion during CPB transitions. The fourth subject experienced the
onset of a bleed in the chest cavity resulting in a severely deteriorating condition and
ultimately death. Remaining data sets were analyzed for changes in CBFi, StO2, and
oxCCO. Table 5-1 displays patient demographics.
Table 5-1: Demographic and procedural variables.
Sex (n)
Age (year)
Duration of surgery (min)
Duration of CPB (min)
Procedure (n)
- CABG
- CABG + AVR
- Aortic arch repair
- Bentall
- Bentall + MVR
Patient death (n)

F = 1, M= 6
58.1 ± 13.8
409.4 ± 191.4
191.9 ± 177.3
3
1
1
1
1
1

CABG: Coronary artery bypass graft; AVR: Aortic valve replacement; MVR: Mitral
valve replacement. Values are represented as mean ± standard deviation.
Fig. 5.2 displays time courses from one patient during the transition on (Fig. 5.2 A) and off
(Fig. 5.2 B) CPB; the FRCPB, mean arterial pressure (MAP), and optical measurements –
ΔCBFi, StO2, and ΔoxCCO – are displayed. The FRCPB was measured by the CPB machine
and MAP with the clinical Philips monitor from a radial artery site.
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Figure 5.2: Cerebral hemodynamics during transition A) on cardiopulmonary
bypass (CPB) and B) off CPB. Figure shows a continuous measure of CPB-pump
flowrate (FRCPB), mean arterial pressure (MAP), change in the cerebral blood flow
index (ΔCBFi), cerebral tissue saturation (StO2), and changes in the oxidation state
of cytochrome c oxidase (ΔoxCCO). ΔCBFi scales are adjusted across plots for data
visualization.
As each patient was transitioned onto CPB, as indicated by the increase in the FR CPB, and
the heart was arrested using a potassium solution, blood flow changed from a pulsatile to
non-pulsatile state. This is apparent in the standard deviation of CBFi; pulsatile flow
produced a larger range of values (Fig. 5.2 A < 8 min) compared to on-pump flow. The
reverse effect was evident during the transition off CPB (Fig. 5.2 B > 10 min) as the heart
was restarted. Averaged values across all subjects during pre-, on-, and post-CPB periods
are displayed in Table 5-2. Data represented as a change (Δ) were acquired for 5-minute
intervals immediately surrounding the transition on CPB, 15 minutes into CPB, and
immediately surrounding the transition off CPB. CPB transitions are represented in
boxplots in Fig. 5.3. The average transition time on CPB was 202 ± 111 s, and off CPB
was 230 ± 160 s. During the on-CPB transition, subjects showed a notable increase in CBFi
and a statistically significant decrease in MAP and ΔoxCCO. No significant change
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persisted 15 minutes into CPB. Following CPB, MAP increased, while CBFi and ΔoxCCO
displayed no significant change. StO2 remained stable throughout the procedure.
Table 5-2: Hemodynamic parameters throughout cardiopulmonary bypass (CPB).
Parameter
tHb (g/L)
pH
PaCO2 (mmHg)
Temperature (ºC)
Parameter
ΔMAP (mmHg)
ΔCBFi (%)
ΔStO2 (%)
ΔoxCCO (µM)

Pre-CPB
112.6 ± 20.8
7.41 ± 0.06
41.1 ± 3.9
35.6 ± 0.4
Transition on CPB
-18.8 ± 11.3*
88.5 ± 125.7
1.2 ± 5.2
-0.5 ± 0.2*

On-CPB
85.0 ± 13.0*
7.33 ± 0.02*
35.3 ± 6.2
33.6 ± 2.4
Mid-CPB
-6.0 ± 9.5
51.9 ± 91.4
-2.8 ± 5.7
-0.3 ± 0.5

Post-CPB
111.8 ± 42.8
7.38 ± 0.03
38.8 ± 1.5
36.3 ± 0.5
Transition off CPB
11.0 ± 21.8
-3.3 ± 17.2
1.4 ± 3.1
0.2 ± 0.3

tHb: total Hemoglobin, PaCO2: partial pressure of carbon dioxide. ‘Transition on CPB’
data were acquired as a change immediately surrounding CPB onset; ‘Mid CPB’ data
were acquired 15 min following CPB onset and compared to pre-CPB data; ‘Transition
off CPB’ data were acquired as a change immediately surrounding the end of CPB. Data
were averaged over 5-minute intervals; * indicates statistical significance (p < 0.05).
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Figure 5.3: Box plots showing average change across subjects during transitions
onto the CPB pump (ON CPB) and off of the pump (OFF CPB). Absolute StO2
values are shown for periods immediately before and after each transition. Data
were averaged for 5-minute durations immediately surrounding the transition
period; + indicates statistical outliers and * indicates a statistically significant
difference across the transition. Average transition time on CPB was 202 ± 111 s,
and off CPB was 230 ± 160 s.
CBFi data were also acquired at increased acquisition rate (20 Hz) prior to and following
CPB. Fig. 5.4 depicts fast blood flow monitoring in an aortic valve replacement (AVR)
patient before (Fig. 5.4 A) and following (Fig. 5.4 B) replacement of the defective valve.
The increased sampling rate allowed for depiction of pulsatile waveforms within the CBFi
measure. Following AVR, the range of CBFi values increased for each ejection and a
change in the shape of the secondary peak – which represents a change in pressure due to
vascular elastic recoil following AV closure – became apparent, indicating a potential
improvement in flow and pressure dynamics within the heart [23,32].
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Figure 5.4: Pulsatile waveforms observed in cerebral microcirculation measured at
20 Hz A) pre and B) post aortic valve replacement.
Across the seven patient data sets, 15 hypoperfusion events, defined as large decreases in
FRCPB (mean change 2.8 ± 1.4 L/min, 70.6 ± 28.8%) and lasting a minimum of 30 seconds
in duration (mean duration 93.9 ± 52.5 s), were observed. Fig. 5.5 displays data acquired
in subject four during a stable period (Fig. 5.5 A) and when experiencing successive drops
in FRCPB (Fig. 5.5 B). With a stable FRCPB, no significant changes were detected in the
optical parameters. In Fig. 5.5 B, the drop in ΔCBFi (~2.5-minute mark) coincides with the
onset of a significant bleed during surgery. This event prompted immediate reductions in
FRCPB to allow for surgical correction. MAP and optical measures were found to mirror
changes in FRCPB, with StO2 and ΔoxCCO displaying a delayed response compared to
ΔCBFi.
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Figure 5.5: Cerebral hemodynamics in subject 4 during A) a stable period and B)
successive FRCPB-driven hypoperfusion events. Each graph includes a continuous
measure of CPB-pump flow rate (FRCPB), mean arterial pressure (MAP), change in
cerebral blood flow (ΔCBFi), cerebral tissue saturation (StO2), and changes in the
oxidation state of cytochrome c oxidase (ΔoxCCO). Data were temporally averaged
(7-s window) for visualization.
Correlation plots of hypoperfusion events, showing changes in optical parameters as a
function of MAP, are displayed in Fig. 5.6; statistical outliers are depicted by red crosses.
Statistically significant changes in ΔCBFi occurred below MAP values of 30 mmHg, in
StO2 below 20 mmHg, and in ΔoxCCO between 30 to 20 mmHg and below 10 mmHg.
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Figure 5.6: Correlation boxplots of ΔCBF, StO2, and ΔoxCCO as a function of
MAP; + indicates statistical outliers and * indicates a statistically significant
difference from baseline values.
The maximum changes in oxCCO during each hypoperfusion event were plotted against
the maximum change in CBFi in Fig. 5.7. A temporal delay of 18.2 ± 15.0 s was found
between nadirs of ΔCBFi and ΔoxCCO. A delayed metabolic response in relation to flow
has been previously reported [16,17,33,34]. Changes in CBFi greater than 70% resulted in
large decreases in oxCCO.

Figure 5.7: Correlation plot showing the relationship between the maximum
reductions in ΔCBFi and ΔoxCCO. On average, the ΔoxCCO nadir occurred
18.2 ± 15.0 s after the corresponding ΔCBFi nadir.
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5.4

Discussion

For patients undergoing cardiac surgery with the use of CPB, current clinical standards are
either completely absent of brain specific monitoring or reliant on commercial oximetry
devices to provide regional cerebral oxygen saturation measurements. While oximetry has
advanced to provide robust continuous measures, saturation alone has proven insufficient
in describing metabolism and predicting neurological outcome [15,35]. The goal of this
study was to test the feasibility of a newly developed optical brain monitor to provide
intraoperative measurements of cerebral hemodynamics and metabolism during CPB.
In seven patients undergoing cardiac surgery with CPB, the hybrid optical device provided
continuous monitoring of cerebral blood flow based on the DCS blood flow index (CBFi)
and metabolism using B-NIRS to measure changes in the oxidation state of cytochrome c
oxidase (ΔoxCCO). During transitions onto CPB (Fig. 5.2 A), the FRCPB was increased to
provide adequate perfusion as the heart was arrested. The CPB pump was initially filled
with a crystalloid solution in its reserve; when the pump was started, the first cycle was
devoid of blood. As it continued, the crystalloid solution and blood mixed, resulting in a
hemodilution effect that gradually diminished. From the perspective of the B-NIRS
acquisition, there was a sudden change in the optical properties which may have
contributed to the observed change in oxCCO. While Fig. 5.3 shows a statistically
significant drop in ΔoxCCO, implying inadequate oxygen utilization across the on-CPB
transition, the influence of hemodilution during this transition phase must be considered.
It is also noteworthy that a significant increase in MAP was observed across this period
and that no significant change in oxCCO persisted 15 minutes into CPB. Studies by
Lassnigg et al. and Talpahewa et al. both reported similar changes in oxCCO following
CPB-onset while noting contributions from hemodilution effects [36,37]. While
hemodilution also results in a reduced number of moving light scatterers (e.g., red blood
cells), it did not appear to have the same impact on DCS, since the CBFi measure relies on
the temporal correlation of dynamic light scatter. Instead, CBFi was influenced to a greater
extent by the FRCPB. The clinically chosen FRCPB was generally within a limited range from
2.0 to 2.5 L/min/m2, using an estimated surface area for each patient [38–40]. Fig. 5.3
displays a large range of ΔCBFi following CPB onset, with an average increase of
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88.5 ± 125.7%. This shows that pump-flow rates were consistently overestimated, in
relation to baseline values. While this ensures sufficient perfusion, intraoperative blood
flow monitoring has potential in allowing for patient specific flow rates. Following the
procedure, no significant changes were observed coming off CPB, suggesting no loss of
oxygen supply or utilization when restarting the heart. Similarly, no change in StO 2 was
observed across either transition. Patients also experienced significant drops in total
hemoglobin and pH during CPB, while no significant changes in temperature and PaCO2
were observed.
Fig. 5.4 demonstrates the system’s ability to capture pulsatile waveforms in the cerebral
microcirculation. A patient presented with a bicuspid aortic valve (Fig. 5.4 A), which was
replaced with an artificial valve (Fig. 5.4 B). In the pulse pressure waveform, the first and
largest peak represents the systolic phase, corresponding to the aortic valve opening and
left ventricular ejection. The second peak visualized represents the vascular elastic recoil
following aortic valve closure [32]. After valve replacement, alterations in the height of the
curve and shape of the secondary peak were observed. These changes could represent
improvements in stroke volume and aortic pressure from cardiac pathologies (e.g., the
progressive decrease in aortic pressure due to aortic stenosis) or surgical repairs (e.g. valve
integrity) and could provide more insight on the impact of cardiac output on CBF. CPB
produces a non-pulsatile blood flow while the heart is arrested. Pulsatile flow has been
shown to significantly enhance organ perfusion (i.e., in kidneys) prior to transplant [41],
and recent studies investigating non-pulsatile versus pulsatile CPB in major cerebral
arteries suggest the potential benefit of cerebral pulsatility [42]; however, there is currently
insufficient evidence to necessitate the clinical implementation of pulsatile CPB.
Continuous monitoring of CBF and oxCCO could be used to assess the effects of pulsatile
versus non-pulsatile CPB on cerebral health.
Throughout surgery, numerous hypoperfusion events caused by large and sustained drops
in FRCPB were observed. While on CPB, oxygen supply is solely dependent on the CPBpump flow rate; reducing FRCPB therefore directly impacts cerebral perfusion and could
lead to adverse neurological outcome. Fig. 5.5 displays an example dataset acquired from
a patient during a stable period (Fig. 5.5 A, no notable changes in FRCPB) and during
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multiple successive drops in FRCPB. Optical metrics during 15 hypoperfusion events (mean
drop in FRCPB of 70.6 ± 28.8% for 93.9 ± 52.5 s) are summarized in Fig. 5.6 as a function
of MAP. As MAP decreased with reduced FRCPB, correlation plots show a consistent
decrease in cerebral perfusion, saturation, and metabolism. Statistically significant
differences were found for MAP values below 30 mmHg. ΔCBFi showed the earliest
response with delayed responses in StO2 and ΔoxCCO. For each event, the maximum
change in oxCCO was plotted as a function of the corresponding largest change in CBFi
(Fig. 5.7). Mild-to-moderate reductions in CBFi (< 70%) resulted in small decreases in
oxCCO; similar reductions were reported in patients undergoing transaortic valve
replacements [43], and in healthy volunteers undergoing hypoxia and hypocapnia
challenges [44,45]. Reductions in CBFi > 70% instigated larger changes in metabolism
comparable to reductions observed in infants with brain injury [46]. The adult brain is
assumed to have a total CCO concentration of approximately 5.5 µM [18]. The largest
observed drop (−1.5 µM) represents an approximate 27% change in oxCCO within the
brain. Furthermore, an 18.2 ± 15.0-s delay was observed between metabolic and flow
nadirs. Previous studies have shown similar delays in piglets [17,47] and infants [16,33].
Reductions in CBF are likely met by increases in oxygen extraction to maintain stable
metabolic levels. Following large and sustained drops in CBF, this compensatory
mechanism could become overwhelmed and metabolism impacted. The variability in
oxCCO is therefore influenced by the duration of hypoperfusion events observed. While
shorter events can elicit similar CBF responses, they may not last long enough to cause the
maximum reduction in oxCCO. Further investigations are required to establish clinical
thresholds for changes in CBFi and oxCCO in order to understand when values become
clinically relevant. Previous work has utilized continuous CBF monitoring to determine a
patient-specific lower limit of autoregulation (LLA) [11]. Future work will look to
determine the relationship of the LLA with changes in cerebral metabolism.
When translating the optical system to the cardiac operating room, the bright ambient light
in the surgical suite was initially a significant source of signal contamination. In this
environment, additional shielding in the form of an optical blackout cloth was essential.
Further, frequent bed motion and patient repositioning/intervention (i.e., head-cooling with
ice, manipulating the transesophageal echocardiography probe) during surgical procedures

152

necessitated strong contact between the optical probes and the surface of the skin. This was
achieved by anchoring the optical fibers at a point above the patient, minimizing weight
and providing leeway for motion. An additional challenge of the current set-up is the
inherent depth sensitivity of the optical technology. The SDDs chosen for B-NIRS and
DCS have proven sufficient to interrogate the brain in adult populations [43,48,49];
however, previous work has shown the large contribution from the scalp for NIRS
measures [50–52]. While StO2 is susceptible to this effect, oxCCO is less impacted since
CCO concentrations are considerably higher in the brain than in extracerebral tissues [18].
To further address depth sensitivity, future work will implement multi-distance
measurements to simultaneously acquire scalp perfusion and metabolism and correct for
their influence. Previous reports have elaborated on the benefits of measuring extracerebral
layers in discerning this contribution [43,49,53,54]. Another future direction will be to
modify the system to enable measurements from multiple vascular territories. A limitation
with the current system was that the single probe only afforded monitoring in one brain
region. In this study, a patient had an intraoperative ischemic stroke in the M1 branch of
the right middle cerebral artery, which was not detected by the probes placed on the right
side of the forehead. With advancements in lower-cost detector technology, implementing
multiple source-detection pairs would enable monitoring across multiple vascular
territories [12,55].

5.5

Conclusion

This study presents the clinical translation and feasibility of an optical neuromonitor
capable of continuous measurement of cerebral perfusion and metabolism during cardiac
surgery with CPB. Temporal resolution was sufficient to capture physiological responses
to transitions on and off the CPB pump and intraoperative hypoperfusion events. Increases
in CBFi and significant decreases in MAP and oxCCO were noted during transitions on
CPB, with no change during transitions off. Large reductions in CPB-pump flowrate
resulted in significant drops in CBFi and oxCCO when MAP decreased below 30 mmHg.
The findings regarding metabolic change are supported by previous literature using similar
methodologies. The optical system described provides a safe and non-invasive approach
for real-time assessment of cerebral hemodynamics and metabolism. More studies are
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required to determine if direct intraoperative monitoring of CBFi and oxCCO could aid
clinicians in patient management and possibly provide insight into the impact of CPB on
postoperative cognitive decline and brain injury.
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Chapter 6

6

Conclusion and Future Directions

This section revisits the overarching aims of this dissertation and summarizes findings from
each chapter. Limitations are discussed to address notable drawbacks within this work
along with potential solutions and future directions in this field.

6.1

Research Objectives

Infants born prematurely (i.e., a gestational period fewer than 37 weeks) have an increased
risk of adverse neurological outcome. The shorter the gestation, and the less infants weigh
at birth, the higher the risk of developing a brain injury. For example, 25-50% of very low
birth weight infants (< 1500 g) experience cognitive/behaviour deficits, and 5-10% develop
major disorders such as cerebral palsy [1]. A common brain injury among this population
is intraventricular hemorrhaging (IVH), which describes bleeding in the germinal matrix
and surrounding white matter. Due to an underdeveloped vascular bed in this region,
infants are particularly susceptible to hemorrhaging, particularly within the first 48 hours
after birth [2]. Severe bleeding can trigger an inflammatory response and subsequent
fibrosis, which can prevent drainage of cerebrospinal fluid (CSF) from the brain’s
ventricles. Significant build-up of CSF can cause increases in intracranial pressure and
result in ventricle enlargement; this is referred to as post-hemorrhagic ventricle dilatation
(PHVD) [3,4]. PHVD is a common complication in high-grade IVH, both of which place
infants at a higher risk of developing brain damage and long-term cognitive deficits.
Currently, diagnosis of IVH and PHVD is conducted using cranial ultrasound (cUS) to
visually grade/assess hemorrhages and ventricular dilatation [4,5]. Ultrasound is limited in
its ability to longitudinally monitor and acquired images can only be used to assess damage
that has already occurred. Advancements in optical technologies have shown potential in
providing non-invasive monitoring of physiological markers of brain injury. Broadband
near-infrared spectroscopy (B-NIRS) exploits light absorption properties of tissue
constituents, such as hemoglobin, to quantify their concentrations [6]. This technique can
therefore provide continuous monitoring of cerebral tissue saturation (StO2). Due to the
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wide range of wavelengths implemented using B-NIRS, a measure of cytochrome c oxidase
(CCO) can also be acquired. CCO is an enzyme in the mitochondria vital to oxidative
phosphorylation (i.e., cellular energy production). Through monitoring CCO’s oxidation
state (oxCCO), B-NIRS can provide a direct measure of metabolism [7]. Diffuse
correlation spectroscopy (DCS) is a relatively newer optical technique that can provide
continuously monitoring of cerebral blood flow (CBF). Whereas B-NIRS can quantify
StO2 through measuring light absorption, DCS can provide a measure of blood flow by
analyzing light scattered off of red blood cells (RBC) [8,9]. As RBC are the primary
moving scatterers in tissue, changes in light scatter reflect RBC motion [10]. Using a stable
long-coherence laser, DCS can directly monitoring CBF in the microvasculature.
The overarching goal of this dissertation was to develop an optical system combining BNIRS and DCS techniques to provide a simultaneous acquisition of CBF and oxCCO.
Bedside monitoring of perfusion and metabolism could act as a prognostic tool to provide
insight into physiological precursors of brain injury before significant damage occurs. This
thesis sought to achieve this through the following aims:
1. Develop and validate a hybrid B-NIRS and DCS neuromonitor to simultaneously
acquire CBF and oxCCO at the bedside (Chapter 2).
2. Assess system feasibility in PHVD infants in the neonatal intensive care unit
(Chapter 3).
3. Investigate cerebral perfusion and metabolic stability during early brain
development in premature infants soon after birth (Chapter 4).
4. Investigate the impact of significant changes in CBF on cerebral energy metabolism
(Chapter 5).

6.2
6.2.1

Summary of Individual Chapters
Development of a hybrid broadband NIRS and DCS device
for concurrent measurements of cerebral perfusion and
cytochrome c oxidase

Chapter 2 presented a novel optical system combining B-NIRS, to monitor cerebral tissue
saturation and oxidative metabolism (via the marker cytochrome c oxidase), with DCS to
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provide measures of blood flow in the cerebral microvasculature. Though implementing a
multiplexing shuttering system, B-NIRS and DCS techniques were acquired in quick
succession while avoiding system crosstalk as demonstrated in a phantom model. Dynamic
measurements of StO2, CBF, and oxCCO were reported in a piglet model of neonatal
hypoxia-ischemia, achieved through clamping carotid arteries and reducing oxygen
content. StO2 and CBF were found to react immediately to the onset of injury, while a delay
in metabolism was observed. The hybrid system presented showed potential for real-time
bedside monitoring of hemodynamics and metabolism as a prognostic tool to indicate
injury.

6.2.2

Monitoring changes in cerebral blood flow and metabolism in
infants with post-hemorrhagic ventricular dilatation during
ventricular taps

Chapter 3 describes the clinical translation of NNeMo (Neonatal NeuroMonitor), a hybrid
B-NIRS/DCS device for bedside characterization of cerebral perfusion and metabolism. In
this work, StO2, CBF, and oxCCO were monitored in term infants with post-hemorrhagic
ventricular dilatation while receiving ventricular taps to drain excessive cerebrospinal fluid
and alleviate intracranial pressure. The minimal optical fiber and probe holder design
allowed for convenient longitudinal monitoring. Across 14 ventricular taps, an
approximately 15% increase in CBF was reported following the procedure, which was
supported by previous investigations. Much smaller changes in metabolism were noted
over this same period. NNeMo’s ability to provide bedside monitoring of perfusion and
metabolism showed potential for numerous neuromonitoring applications in the neonatal
intensive care unit.

6.2.3

Monitoring cerebral hemodynamic, oxygenation and
metabolic stability in premature infants following birth using a
hybrid broadband NIRS/DCS optical brain monitor

Chapter 4 reports the clinical translation of NNeMo to monitor the brains of eight
premature infants soon after birth. Perfusion and metabolic stability were demonstrated on
the first and third days of life. No significant differences in measurement stability was
reported between days. Continuous wavelet transforms were applied to perform frequency
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analysis and characterize prevailing oscillations during these monitoring periods. Apparent
oscillations were found in StO2 and CBF markers on day 1, which diminished by day 3.
Coherence and semblance were calculated to determine the relationship between optical
measures of StO2, CBF, and oxCCO. The semblance of CBF/StO2 was found to
significantly differ from relationships with oxCCO, suggesting that persistent fluctuations
in CBF and StO2 did not influence the metabolism.

6.2.4

Changes in cerebral blood flow and metabolism in response
to hypoperfusion events in adults during surgery with
cardiopulmonary bypass

Chapter 5 demonstrates similar perfusion and metabolic measures in seven adults during
cardiac surgery with cardiopulmonary bypass. This patient population experiences large
intraoperative fluctuations in perfusion, as dictated by the bypass pump, to allow for
surgical intervention. During the transition on bypass CBF increased by an average of
approximately 89%. During this same period, a statistically significant drop in oxCCO was
noted (0.5 µM), which was in part due to a hemodilution effect as the pump was turned on.
Across all subjects, fifteen hypoperfusion events characterized by large and sustained drops
in CBF were identified. During these periods, significant reductions in CBF and oxCCO
were reported when mean arterial pressure dropped below 30 mmHg. Changes in CBF
were found to precede metabolic response during these events. Optical neuromonitoring
showed strong potential to aid in assessing hemodynamics intraoperatively, determining
the presence of autoregulation, and in guiding patient management.

6.3

Limitations

This section describes limitations with respect to each chapter. General limitations
common to all of the work discussed in addition to study specific limitations. A more
detailed discussion of limitations for each body of work is presented within each chapter.

6.3.1

General Limitations

In the work presented, NNeMo utilizes a single source-detector pair for both B-NIRS and
DCS techniques. This geometry limits data acquired to represent local changes in
hemodynamics and metabolism as a representation of the global environment. In neonatal

165

studies, this prevented characterizing hemispheric differences which are often prevalent.
For example, in chapter 3, the one subject who experienced IVH was diagnosed with a
Grade II on the right and Grade I on the left. While hemorrhaging will likely affect the
brain globally, a single acquisition site prevents characterizing the differences between
these bleeds. Similarly, in the cardiac operating room, a patient in our study experienced
an intraoperative ischemic stroke away from the site of monitoring. Due to the single
source-detector pair, any influence on perfusion/metabolism from this event would be
indistinguishable from global changes. NNeMo also utilizes only a single source-detector
distance for B-NIRS and DCS measures, which limits depth sensitivity. While, in neonatal
studies, signal contamination from extracerebral layers is minimal, increased depth
sensitivity could aid in capturing changes in deeper brain regions where IVH originates.

6.3.2

Study Specific Limitations

Chapter 2: The work in this section describes the first combination of B-NIRS and DCS
using a multiplexing shuttering system to avoid signal cross talk. Shutters were
implemented, opposed to optical filters, since the DCS emission source (785 nm) overlaps
with HbO2’s (680-845 nm) and oxCCO’s (780-900 nm) broad absorption spectra.
Therefore, this acquisition was not truly simultaneous with each technique acquired in
quick succession. As such, the system was limited in its temporal resolution, only achieving
a full data set once every 14 seconds. The piglet model of hypoxia-ischemia involved
clamping carotid arteries and reducing oxygen content to produce injury. When piglets
were initially occluded, sudden and extreme changes in CBF resulted. The temporal
resolution of the system limited the ability to resolve changes during this initial drop and
compare metabolic response to moderate changes in CBF, opposed to the large changes
that the occluders ultimately produced.
Chapter 3: Subjects in this study underwent ventricular taps to drain cerebrospinal fluid
directly from the brain’s ventricles. Due to sterilization of the site of interest prior to the
procedure, and patient repositioning following, motion artifacts were prevalent
surrounding the immediate monitoring period. As a result, data analysis was limited to 2mintute windows before needle insertion and removal. Changes in hemodynamics and
metabolism therefore only represented the immediate effects of the ventricular tap, while
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further changes likely persisted in the hours or days following. Data in this work were also
prone to signal contamination from ambient light sources due to the increased lighting to
aid surgeons in inserting the needle and the proximity of the optical probes to the site of
insertion.
Chapter 4: This section describes optical neuromonitoring with NNeMo soon after
premature birth and analyzed an average of approximately 4 hours of data from each 6hour period of data acquired. This discrepancy was largely due to the abundance of patient
handling and medical intervention during this early time frame, leading to excessive motion
artifacts. The relative nature of CBF and oxCCO measures, prevented direct comparison
of perfusion and metabolism between the first and third day of life. Instead, analysis was
limited to signal stability (i.e., standard deviation), frequency analysis, and comparison
between optical measures acquired concurrently. The small number of subjects monitored
in this investigation also prevented correlation of measurement stability/prevailing
frequencies to the onset of IVH, as only a single subject experienced a bleed.
Chapter 5: This study demonstrated the translation of NNeMo to monitor adults during
cardiac surgery with cardiopulmonary bypass. The data presented in this work was also
quite susceptible to ambient light and motion artifacts. The former produced by the
extremely bright environment in the operating suite and the latter from frequent bed
motion, patient repositioning, movement of the transesophageal echocardiography probe,
etc. Data collected as patients were transitioned onto bypass was influenced by a
hemodilution effect, caused by the ‘first pass’ of the bypass pump which was initially filled
with a crystalloid solution. This apparent decrease in hemoglobin concentration
contributed in part to the significant drop in metabolism reported. Compared to previous
work in piglets and neonates, the data presented in this study was limited in terms of depth
sensitivity and had a larger influenced by scalp contribution. This likely impacted StO2 to
the greatest extent since oxCCO is naturally more abundant in cerebral tissue due to higher
metabolic demands [7] and CBF has an inherent greater depth sensitivity than NIRS
measures [11].
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6.4

Future Work

To address the limitations discussed, future work seeks to modify NNeMo to allow for both
multi-distance and regional measurements. For the former, the addition of a shorter sourcedetector separation for B-NIRS would provide an estimate of extracerebral tissue
saturation. This approach is well established for commercial NIRS devices to control for
scalp effects. For the B-NIRS measure of metabolism this similarly useful, although to a
lesser extent. Work by Nguyen et al. utilizing multi-distance measures of oxCCO in cardiac
arrest patients showed a discrepancy in oxCCO response over 1-cm and 3-cm SDDs,
supporting oxCCO’s inherent depth sensitivity. Multi-distant DCS measures have shown
strong potential in separating flow responses from the brain and scalp [12], and have been
utilized to quantify optical properties, allowing for DCE measurements and quantitative
measures of CBF [13].
Regional measurements can be achieved by bifurcating optical fibers for emission sources
and employing additional detectors. Alternatively, by utilizing optical shutters, light
interrogating different regions can be collected and sent to the same detector in succession.
This will allow for analysis from both regions without additional components but with a
trade-off in a decreased temporal resolution. For B-NIRS detection, a spectrometer’s
detection plane can be digitally sectioned and light incident on different regions can be
separately analyzed. This requires an optical fiber detection bundle which spatially
separates light from different regions when entering the spectrometer. An area of dead
space between different sources is needed to avoid signal crosstalk; this approach allows
for simultaneous B-NIRS acquisition and analysis from different sites. In neonatal
populations, regional measurements have reported significant differences in cerebral
saturation, flow, and metabolism across hemispheres, with the right hemisphere
consistently reporting greater values [14]. Monitoring regional changes has potential to
indicate local hemorrhaging or stroke.
The recent development of supercontinuum lasers has allowed for combined B-NIRS and
TR-NIRS techniques using a single source [15]. This approach is able to collect time-offlight information, through a temporal point spread function, for photons across a wide
wavelength range. This would allow for TR-NIRS acquisition of the broad oxCCO spectra.

168

By isolating later arriving photons, an increased depth sensitivity can also be achieved
compared to traditional B-NIRS approaches. Similarly, time-resolved DCS technology has
proven capable of acquiring time-of-flight information in addition to measuring the
autocorrelation function [16]. This allows for CBF monitoring with increased depth
sensitivity by differentiating between photon pathlengths.
Chapter 2 describes the development of the hybrid B-NIRS/DCS system using optical
shutters. This approach was chosen since the wavelength of the DCS laser implemented
overlapped with the absorption spectra of HbO2 and oxCCO. Recent work by Carp et al.
has demonstrated DCS acquisition using an emission source at 1064 nm [17]. Using this
approach, high/low-pass optical filters could be implemented to shield detectors from
opposing sources, allowing for a truly simultaneous acquisition, significantly improving
temporal solution. A similar approach has been demonstrated when combining TR-NIRS
and DCS techniques [18].
Chapter 3 describes hemodynamics and metabolism during ventricular taps in PHVD
infants. Future investigation seeks to monitor infants at risk of CSF accumulation in the
days and weeks preceding potential intervention with the aim of assessing perfusion and
metabolism as prognostic markers. This will be achieved through correlating fluctuations
and longitudinal changes in CBF and oxCCO to changes in ventricle volume and
intracranial pressure prior to and following CSF drainage. Current practice relies on
measurements of head circumference, and in some centers ventricular volume, to dictate
intervention. Optical monitoring could provide a clearer indication of the when to intervene
and/or how much CSF to drain in order to maintain sufficient cerebral metabolism and
avoid tissue damage.
Chapter 4 similarly discusses fluctuations in perfusion and metabolism as potential
prognostic markers of IVH in premature infants. Firstly, a larger patient cohort will allow
for stratification of subjects without prevailing injury and those with mild to severe IVH.
Infants with IVH upon birth, as diagnosed by a day-one cranial ultrasound scan, can be
further separated from infants who initially present without a bleed and subsequently
experience hemorrhaging. The goal of this work will be to establish clinical thresholds of
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perfusion and metabolic change that are indicative of subsequent injury. This will be
achieved by monitoring infants continuously over the first few days of life and correlating
optical measures to clinical outcome.
Chapter 5 demonstrates CBF and oxCCO measures in adults undergoing surgery with
cardiopulmonary bypass. Numerous large reductions in CBF were noted within this small
patient cohort and were found to impact cerebral metabolism at low mean arterial
pressures. Similar to chapter 4, fluctuations in optical measures will be utilized to establish
clinical thresholds of neurological injury. In this study, patient specific thresholds can be
achieved by determining a real-time measure of cerebral autoregulation. This is possible
with an accompanying measure of MAP, which is absent in most neonatal populations. In
addition, regional measurements of optical parameters will allow for an increased spatial
resolution which has potential to identify local hemodynamic events such as strokes.

6.5

Conclusion

In conclusion, this dissertation provides a fundamental understanding of optical techniques
and their applications in neuromonitoring, with a particular focus on the neonatal brain.
NNeMo, a novel optical brain monitor, is presented combining B-NIRS and DCS
technology to simultaneously characterize cerebral perfusion and metabolism at the
bedside. The studies described in this thesis show potential for optical measures of flow
and metabolism to act as prognostic markers of brain injury in both the NICU and cardiac
operating room. Real-time monitoring of cerebral hemodynamics and energy production
has potential to aid clinicians in patient management, mitigate adverse neurological injury,
and ultimately improve long-term clinical outcome.
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research excellence
Provincial ($15,000) declined

2018

3rd place oral presentation – ImNO conference
Imaging Network Ontario, London, Ontario
Awarded for scientific presentation
Provincial ($200)

2019

Doctoral Excellence Research Award
Department of Medical Biophysics, Western University
Recognized for having a tri-agency doctoral scholarship (NSERC)
Institutional ($3,000)

2019

Western Graduate Research Scholarship
Department of Medical Biophysics, Western University
Awarded to graduate students who maintain an average of 80% or
more
Institutional ($4,500)

2018

Ontario Graduate Scholarship (OGS)
Government of Ontario
Merit based scholarship awarded for academic achievement and
research excellence
Provincial ($15,000)
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2018

2nd place poster – Lawson Imaging Discovery Day
London Health Sciences
Awarded for scientific poster presentation
Institutional

2018

Western Graduate Research Scholarship
Department of Medical Biophysics, Western University
Awarded to graduate students who maintain an average of 80% or
more
Institutional ($4,500)

2017

Ontario Graduate Scholarship (OGS)
Government of Ontario
Merit based scholarship awarded for academic achievement and
research excellence
Provincial ($15,000)

2017

CIHR Travel Award,
Canadian Institutes of Health Research (CIHR)
Awarded based on research proposal and scientific merit
National ($1,000)

2017

MexNIRS Travel Award,
Mexican Symposium on Neuroimaging, Mexico
Awarded based on research abstract
International ($900)

2017

1st place poster – Newborn Brain conference
Brain monitoring and Neuroprotection in the Newborn, Ireland
Awarded based on scientific poster presentation
International ($375)

2017

Western Graduate Research Scholarship
Department of Medical Biophysics, Western University
Awarded to graduate students who maintain an average of 80% or
more
Institutional ($4,500)

2016

Ontario Graduate Scholarship (OGS)
Government of Ontario
Merit based scholarship awarded for academic achievement and
research excellence
Provincial ($15,000)
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2016

2nd place 3-Minute Thesis Competition
Western University
Awarded for delivering a concise and engaging lay research
presentation
Institutional ($500)

2016

Western Graduate Research Scholarship
Department of Medical Biophysics, Western University
Awarded to graduate students who maintain an average of 80% or
more
Institutional ($4,500)

2015

Western Graduate Research Scholarship
Department of Medical Biophysics, Western University
Awarded to graduate students who maintain an average of 80% or
more
Institutional ($4,500)

2014

Harold E. John’s Medical Physics Studentship Award
Cancer Care Ontario
Cancer Center of Southeastern Ontario, Kingston, Ontario
Awarded based on academic achievement, funding a co-operative
placement at a cancer center in Ontario
Institutional ($9,600)

2014

Harold E. John’s Medical Physics Studentship Award
Cancer Care Ontario
Juravinski Cancer Center, Hamilton, Ontario
Awarded based on academic achievement, funding a co-operative
placement at a cancer center in Ontario
Institutional ($9,600)

2013-2015

Dean’s Honour List
McMaster University
Awarded for academic achievement
Institutional

ACADEMIC AND RESEARCH POSITIONS
2018-2020
(4 terms)

Teaching Assistant Graduate Biophysics Communications
BIOPHYS 9513/9514, Western University, London, Ontario
Lectured MSc and PhD candidates on scientific presentations and
assessed student work
Supervisor: Dr. Matthew Teeter
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2016-2017
(2 terms)

Teaching Assistant Undergraduate Physics
PHYS 1028/1029, Western University, London, Ontario
Led physics laboratory sessions for first year undergraduates and
assessed student work
Supervisor: Dr. Kanthi Kaluarachchi

2015

Research Assistant
Lawson Health Research Institute, London, Ontario
Supervisors: Dr. Keith St. Lawrence & Dr. Mamadou Diop
Project: Optical monitoring of hemodynamics and inflammation in
an animal model of rheumatoid arthritis

2014

Research Assistant
Cancer Center of Southeastern Ontario, Kingston, Ontario
Supervisors: Dr. John Schreiner
Project: Development of a radiochromic film dosimetry imaging
system

2014

Research Assistant
Juravinski Cancer Center, Hamilton, Ontario
Supervisors: Dr. Gordon Chan
Project: Orthovoltage dosimetric measurements using
radiochromic film

2013

Research Assistant
Grand River Regional Cancer Center, Waterloo, Ontario
Supervisors: Dr. Runqing Jiang
Project: Linear accelerator quality assurance; Radiation deposition
in whole breast radiotherapy versus accelerated partial breast
irradiation

COMMITTEE PARTICIPATION
2020

National Scholarship Ranking Committee
Western University
Assessed scholarship for incoming undergraduate students

2016-2020

Medical Biophysics Graduate Recruitment Committee
Department of Medical Biophysics, Western University
Presented at graduate fairs and recruitment nights

2013-2015

President - McMaster Medical Physics Undergraduate Society
McMaster University
Led executive team in organizing academic and recreational events
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INVITED LECTURES
2021

AC Burton Day
Department of Medical Biophysics, Western University
Institutional

2020

Fetal Neonatal Neuroimaging Developmental Science Center
Lecture Series
Harvard Medical School, Boston Children’s Hospital
International

2019

Talks on Friday
Lawson Health Research Institute Lecture Series
St Joseph Hospital, London, Ontario
Institutional

2019

AC Burton Day
Department of Medical Biophysics, Western University
Institutional

2018

Illuminating Innovation – Children’s Hospital Philanthropic
Event
Victoria Hospital, London, Ontario
Local

2018

Neonatology Grand Rounds
Victoria Hospital, London, Ontario
Local

2018

Talks on Friday
Lawson Health Research Institute Lecture Series
St Joseph Hospital, London, Ontario
Institutional

2017

Talks on Friday
Lawson Health Research Institute Lecture Series
St Joseph Hospital, London, Ontario
Institutional

2016

Neonatology Grand Rounds
Victoria Hospital, London, Ontario
Local
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ACADEMIC REVIEWING ACTIVITES
Scientific Reports
Biomedical Optics Express
Neurophotonics
Neuroscience Methods
University of Western Ontario Medical Journal
CONFERENCE JUDGING
2019

Imaging Network Ontario (Platform & Posters)
London, Ontario

2019

London Health Research Day (Posters)
London, Ontario

2017-2019

Thames Valley Science and Engineering Fair (Posters)
London, Ontario

PUBLICATIONS AND PRESENTATIONS
Peer-reviewed Journal Manuscripts:
(11 published/in-press; 1 in review; 4 first-author)
1.

A. Rajaram, D. Milej, M. Suwalski, L. Yip, L. Guo, M. Chu, J. Chui, M. Diop, J.
Murkin, K. St. Lawrence. “Optical monitoring of cerebral perfusion and metabolism
in adults during cardiac surgery with cardiopulmonary bypass” Biomed. Optics Exp.,
11(10), 5967-5981 (2020) DOI:10.1364/BOE.404101

2.

A. Mendleson, A. Rajaram, D. Bainbridge, K. St. Lawrence, T. Bentall, M. Sharpe,
M. Diop, C. Ellis “Dynamic tracking of microvascular hemoglobin content for
continuous perfusion monitoring in the intensive care unit: a pilot study.” Journal of
Clinical Monitoring and Computing (2020) DOI:10.1007/s10877-020-00611-x

3.

D. Milej, A. Abdalmalak, A. Rajaram, K. St. Lawrence “Direct Assessment of
Extracerebral Signal Contamination on Optical Measurements of Cerebral Blood
Flow, Oxygenation, and Metabolism” Neurophotonics, 7(4) 045002 (2020)
DOI:10.1117/1.NPh.7.4.045002
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4.

A. Rajaram, L. Yip, D. Milej, M. Suwalski, M. Kewin, M. Lo, J. Carson, V. Han, S.
Bhattacharya, M. Diop, S. de Ribaupierre, K. St. Lawrence “Perfusion and Metabolic
Neuromonitoring during Ventricular Taps in Infants with Post-hemorrhagic
Ventricular Dilatation” Brain Sci., 10(7) (2020) DOI:10.3390/brainsci10070452

5.

D. Milej, M. Shahid, A. Abdalmalak, A. Rajaram, M. Diop, K. St. Lawrence
“Characterizing Dynamic Cerebral Vascular Reactivity using a Hybrid System
Combining Time-Resolved Near-Infrared and Diffuse Correlation Spectroscopy”
Biomed. Optics Exp. 11(8), 4571-4585 (2020) DOI:10.1364/BOE.392113

6.

G. Bale, A. Rajaram, M. Kewin, L. Morrison, A. Bainbridge, L. Liu, U. Anazodo, M.
Diop, K. St. Lawrence, I. Tachtsidis. “Multimodal measurements of brain tissue
metabolism and perfusion in a neonatal model of hypoxic-ischaemic injury” Accepted
for publication in Oxygen Transport to Tissue XLII, Springer International Publishing
(2020)

7.

M. Kewin, A. Rajaram, D. Milej, A. Abdalmalak, L. Morrison, M. Diop, K. St
Lawrence “Evaluation of hyperspectral NIRS for quantitative measurements of tissue
oxygen saturation by comparison to time-resolved NIRS” Biomed. Optics Exp., 10(9),
4789-4802 (2019) DOI:10.1364/BOE.10.004789

8.

M. Khalid, D. Milej, A. Rajaram, A. Abdalmalak, L. Morrison, M. Diop, K. St.
Lawrence “Development of a stand-alone DCS system for monitoring absolute
cerebral blood flow” Biomed. Optics Exp., 10(9), 4607-4620 (2019)
DOI:10.1364/BOE.10.004607

9.

A. Rajaram, G. Bale, M. Kewin, L. Morrison, I. Tachtsidis, K. St. Lawrence, M. Diop
“Simultaneous monitoring of cerebral perfusion and cytochrome c oxidase by
combining broadband near-infrared spectroscopy and diffuse correlation
spectroscopy”
Biomed.
Optics
Exp.
9(6),
2588-2603
(2018)
DOI:10.1364/BOE.9.002588

10. G. Bale, A. Rajaram, M. Kewin, L. Morrison, A. Bainbridge, M. Diop, K. St
Lawrence, I. Tachtsidis “Broadband NIRS cerebral cytochrome-c-oxidase response
to anoxia before and after neonatal hypoxic-ischemic injury in piglets.” Oxygen
Transport to Tissue XL, O. Thews, J.C. LaManna, and D.K. Harrison, eds. Springer
International Publishing, 151-156 (2018) DOI: 10.1007/978-3-319-91287-5_24
11. A. Rajaram, S. Ioussoufovitch, L. Morrison, K. St Lawrence, T.Y. Lee, Y. Bureau,
M. Diop “Joint blood flow is more sensitive to inflammatory arthritis than
oxyhemoglobin, deoxyhemoglobin, and oxygen saturation.” Biomed. Optics Exp
7(10), 3843-3845 (2016) DOI: 10.1364/BOE.7.003843
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In review:
12. D. Milej, A. Abdalmalak, A. Rajaram, A. Jhajj, A. Owen, K. St. Lawrence “Using
regression analysis to improve the reconstruction of cerebral hemodynamic responses
acquired by time-resolved near-infrared spectroscopy” Submitted to Journal of
Biomedical Optics (JBO 210070), Mar 2021
In preparation:
1. A. Rajaram, D. Milej, M. Suwalski, L. Kebaya, M. Kewin, L. C. M. Yip, , S. de
Ribaupierre, S. Bhattacharya, M. Diop, and K. St. Lawrence “Monitoring cerebral
hemodynamic, oxygenation and metabolic stability in premature infants following
birth using a hybrid broadband NIRS/DCS optical brain monitor”
Peer-reviewed Conference Proceedings & Published Abstracts:
(12 published; 4 first-author)
1. D. Milej*, A. Abdalmalak, A. Rajaram, K. St. Lawrence. “Assessing the ability to
monitor cerebral blood flow and oxygen consumption by combining time-resolved
near-infrared and diffuse correlation spectroscopy” SPIE Proceedings vol 11639
Optical Tomography and Spectroscopy of Tissue XIV; 1163918 SPIE BiOS, (Online,
2021) DOI:10.1117/12.2577933
2. D. Milej*, A. Abdalmalak, A. Rajaram, M. Suwalski, K. St. Lawrence. “Combining
time-resolved near-infrared spectroscopy with regression analysis to improve the
reconstruction of cerebral hemodynamic responses” SPIE Proceedings vol 11639
Optical Tomography and Spectroscopy of Tissue XIV; 116390R SPIE BiOS, (Online,
2021) DOI:10.1117/12.2577237
3. L. Mawdsley*, A. Rajaram, L. Yip, N. Abayomi, S. Milkovich, K. St. Lawrence, J.
Carson, C. Ellis, M. Diop. “Using near infrared spectroscopy and diffuse correlation
spectroscopy to determine the microvascular effects of phenylephrine in vivo” SPIE
Proceedings vol 11639 Optical Tomography and Spectroscopy of Tissue XIV;
116390Z SPIE BiOS, (Online, 2021) DOI:10.1117/12.2577237
4. L. Mawdsley*, A. Rajaram, L. Yip, C. Ellis, M. Diop. “Using near infrared
spectroscopy, diffuse correlation spectroscopy, and intravital video microscopy to
monitor skeletomuscular and cerebral microcirculation” Experimental Biology 2020
Proceedings FASEB Journal 34 (S1), 1-1 (San Diego, CA, 2020)
DOI:10.1096/fasebj.2020.34.s1.02980
5. A. Rajaram*, L. Yip, M. Kewin, L. Morrison, M. Diop, K. St. Lawrence.
“Development of a neonatal neuromonitor for concurrent measurements of
cytochrome c oxidase and CMRO2” Brain & Brain PET Proceedings PB01-D04
(Yokohama, Japan, 2019) DOI:10.1177/0271678X19851020
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6. G. Bale*, A. Rajaram, M. Kewin, L. Morrison, A. Bainbridge, M. Diop, K. St.
Lawrence, I. Tachtsidis. “Multimodal measurements of brain tissue metabolism and
perfusion in a neonatal model of hypoxic-ischaemic injury” European Conference on
Biomedical Engineering Proceedings 11074_38 (Munich, Germany, 2019)
DOI:10.1117/12.2526729
7. D. Milej, A. Rajaram, A. Abdalmalak, M. Khalid, M. Shahid, M. Kewin, K. St.
Lawrence*. “Assessing extracerebral signal contamination in optical measurements of
cerebral blood flow and oxygenation” European Conference on Biomedical
Engineering
Proceedings
11074_90
(Munich,
Germany,
2019)
DOI:10.1117/12.2527150
8. A. Rajaram, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop*. “Hybrid
broadband NIRS/Diffuse correlation spectroscopy system for simultaneous monitoring
of cerebral perfusion and cytochrome c oxidase.” Optical Society of America
Proceedings JW3A.50 (Hollywood, FL, 2018)
DOI:10.1364/TRANSLATIONAL.2018.JW3A.50
9. M. Kewin*, D. F Milej, A. Abdalmalak, A. Rajaram, M. Diop, S. de Ribaupierre, K.
St Lawrence. “Validation of a Hyperspectral NIRS Method for Measuring Oxygen
Saturation by Comparison to Time-Resolved NIRS.” Optical Society of America
Proceedings OW4C.4 (Hollywood, FL, 2018) DOI:10.1364/OTS.2018.OW4C.4
10. M. Khalid*, D. F Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St Lawrence. “Selfcalibrated DCS for monitoring absolute cerebral blood flow.” Optical Society of
America Proceedings JTu3A.63 (Hollywood, FL, 2018)
DOI:10.1364/TRANSLATIONAL.2018.JTu3A.63
11. A. Rajaram*, K. St. Lawrence, M. Diop. “Development of a hybrid broadband
NIRS/diffusion correlation spectroscopy system for real-time monitoring of cerebral
perfusion and oxygenation in preterm brain injury.” SPIE BiOS Photonics West
Proceedings 100540T (San Francisco, CA, 2017) DOI:10.1117/12.2253358
12. A. Rajaram, K. St. Lawrence, M. Diop*. “Monitoring vascular markers of joint
inflammation in a rabbit model of rheumatoid arthritis with time-resolved nearinfrared spectroscopy.” Optical Society of America & Proceedings JTu3A.30 (Ft.
Lauderdale, FL, 2016) DOI:10.1364/CANCER.2016.JTu3A.30
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Peer-reviewed Conference Abstracts/Presentations:
(50 total; 20 first-author; 26 oral presentations; 24 international conferences)
* indicates presenting author
1. SPIE BiOS Photonics West: International/Online Oral presentation
A. Rajaram*, L. Yip, M. Suwalski, D. Milej, L. Kebaya, M. Kewin, M. Diop, S. de
Ribaupierre, S. Bhattacharya, K. St. Lawrence. “NNeMo (Neonatal NeuroMonitor): A
non-invasive brain monitor for continuous acquisition of cerebral blood flow and
cytochrome c oxidase in the premature brain” (Online, 2021)
2. SPIE BiOS Photonics West: International/Online Oral presentation
A. Rajaram*, M. Suwalski, D. Milej, L. Yip, L. Guo, M. Chu, J. Chui, M. Diop, J.
Murkin, K. St. Lawrence. “Cerebral perfusion and metabolic neuromonitoring during
cardiopulmonary bypass” (Online, 2021)
3. SPIE BiOS Photonics West: International/Online Oral presentation
D. Milej*, A. Abdalmalak, A. Rajaram, M. Suwalski, K. St. Lawrence. “Combining
time-resolved near-infrared spectroscopy with regression analysis to improve the
reconstruction of cerebral hemodynamic responses” (Online, 2021)
4. SPIE BiOS Photonics West: International/Online Oral presentation
D. Milej*, A. Abdalmalak, A. Rajaram, K. St. Lawrence. “Assessing the ability to
monitor cerebral blood flow and oxygen consumption by combining time-resolved
near-infrared and diffuse correlation spectroscopy” (Online, 2021)
5. SPIE BiOS Photonics West: International/Online Oral presentation
L. Mawdsley, N. Abayomi, A. Rajaram, L. Yip, S. Milkovich, C. Ellis, M. Diop.
“Using Hyperspectral Near Infrared Spectroscopy and Diffuse Correlation
Spectroscopy to Monitor the Microvascular Effects of Phenylephrine in vivo” (Online,
2021)
6. Experimental Biology: International/Online Oral presentation
L. Mawdsley*, A. Rajaram, L. Yip, N. Adayomi, N. Li, S. Milkovich, J. Carson, K.
St. Lawrence, C. Ellis, M. Diop. “Simultaneous Monitoring of the Cerebral and
Skeletomuscular Microcirculation using Hyperspectral Near Infrared Spectroscopy
and Intravital Video Microscopy” (Online, 2021)
7. Children’s Health Research Day: Local/Online Oral Presentation
A. Rajaram*, D. Milej, M. Kewin, L. Kebaya, L. Yip, M. Lo, M. Suwalski, M. Diop,
S. De Ribaupierre, S. Bhattacharya, K. St. Lawrence. “Cerebral blood flow and
metabolic neuromonitoring immediately following premature birth” (Online, 2020)
8. Canadian Anesthesiologists’ Society: National/Online Poster Presentation
J. Murkin*, J. Chui, A. Rajaram, D. Milej, M. Chu, R. Guo, J. Morriseau, M. Diop,
K. St. Lawrence. “Non-invasive Monitoring of CBF and Brain Oxidative Metabolism
During Cardiopulmonary Bypass: A Novel Feasibility Study” (Online, 2020)
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9. Optical Society of America: International/Online Poster Presentation
Z. Fang, M. O’Neil, A. Rajaram, A. Mendelson, K. St. Lawrence, C. Ellis, M. Diop*.
“Real-Time Monitoring of Muscle Blood Flow Regulation in Cardiac Surgery Patients
with Near-Infrared Spectroscopy” (Online, 2020)
10. Experimental Biology 2020: International/Online Oral Presentation
L. Mawdsley*, A. Rajaram, L. Yip, C. Ellis, M. Diop. “Using near infrared
spectroscopy, diffuse correlation spectroscopy, and intravital video microscopy to
monitor skeletomuscular and cerebral microcirculation” (Online, 2020)
11. Brain & Brain PET: International/Oral Presentation
A. Rajaram*, L. Yip, M. Kewin, L. Morrison, M. Diop, K. St. Lawrence.
“Development of a neonatal neuromonitor for concurrent measurements of
cytochrome
c
oxidase
and
CMRO2”
(Yokohama,
Japan,
2019)
doi:10.1177/0271678X19851020
12. Lawson Imaging Discovery Day: Local/Oral Presentation
M. Shahid*, D. Milej, A. Abdalmalak, A. Rajaram, M. Khalid, M. Diop, K. St.
Lawrence. “Developing an optical device for simultaneous monitoring of oxygenation
and blood flow dynamics in the adult brain” (London, ON, 2019)
13. London Health Research Day: Local/Oral Presentation
A. Rajaram*, L. Yip, M. Kewin, L. Morrison, M. Diop, K. St. Lawrence. “Optical
neuromonitoring for continuous quantification of cerebral blood flow and energy
metabolism in the developing brain” (London, ON, 2019)
14. London Health Research Day: Local/Poster Presentation
M. Shahid*, D. Milej, A. Abdalmalak, A. Rajaram, M. Khalid, M. Diop, K. St.
Lawrence. “Developing a non-invasive optical system for monitoring oxygenation and
blood flow dynamics in the adult brain” (London, ON, 2019)
15. London Health Research Day: Local/Poster Presentation
L. Mawdsley*, A. Rajaram, M. Diop, C. Ellis “The effect of sepsis on skeletomuscular
and cerebral microvascular blood flow” (London, ON, 2019)
16. European Conference on Biomedical Engineering: International/Oral Presentation
G. Bale*, A. Rajaram, M. Kewin, L. Morrison, A. Bainbridge, M. Diop, K. St.
Lawrence, I. Tachtsidis. “Multimodal measurements of brain tissue metabolism and
perfusion in a neonatal model of hypoxic-ischaemic injury” (Munich, Germany, 2019)
17. European Conference on Biomedical Engineering: International/Poster Presentation
D. Milej, A. Rajaram, A. Abdalmalak, M. Khalid, M. Shahid, M. Kewin, K. St.
Lawrence*. “Assessing extracerebral signal contamination in optical measurements of
cerebral blood flow and oxygenation” (Munich, Germany, 2019)
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18. Imaging Network Ontario: Provincial/Oral Presentation
A. Rajaram*, L. Yip, M. Kewin, L. Kebaya, V. Han, S. Bhattacharya, M. Diop, K. St.
Lawrence. “NNeMo (Neonatal NeuroMonitor): A non-invasive optical device for
assessing the coupling of cerebral blood flow and energy metabolism in the developing
brain” (London, ON, 2019)
19. Imaging Network Ontario: Provincial/Poster Presentation
M. Kewin*, A. Rajaram, D. Milej, M. Diop, S. de Ribaupierre, K. St. Lawrence
“Confirmation of a Derivative Hyperspectral NIRS Method to Measure Oxygen
Saturation” (London, ON, 2019)
20. Imaging Network Ontario: Provincial/Poster Presentation
D. Milej*, A. Rajaram, A. Abdalmalak, M. Khalid, M. Shahid, M. Kewin, K. St.
Lawrence “Characterization of scalp signal contamination for noninvasive optical
brain monitoring” (London, ON, 2019)
21. Imaging Network Ontario: Provincial/Poster Presentation
M. Shahid*, D. Milej, A. Abdalmalak, A. Rajaram, M. Khalid, M. Diop, K. St.
Lawrence. “Developing a Time-Resolved Near-Infrared/Diffuse Correlation
Spectroscopy System for Monitoring Oxygenation and Blood Flow Dynamics in the
Adult Brain” (London, ON, 2019)
22. SPIE BiOS Photonics West: International/Oral Presentation
M. Shahid*, D. Milej, A. Abdalmalak, A. Rajaram, M. Khalid, M. Diop, K. St.
Lawrence. “Development of a hybrid optical system to study dynamic blood
flow/oxygenation regulation in the human brain.” (San Francisco, CA, 2019)
23. Critical Care Canada Forum: National/Oral Presentation
A. Mendelson*, A. Rajaram, D. Bainbridge, K. St. Lawrence, T. Bentall, M. Sharpe,
M. Diop, C. Ellis. “Dynamic tracking of microvascular hemoglobin content in skeletal
muscle of ICU patients with a custom near-infrared spectroscopy system,” (Toronto,
ON, 2018)
24. Critical Care Canada Forum: National/Poster Presentation
L. Mawdsley*, A. Rajaram, M. Diop, C. Ellis “The effect of sepsis on skeletomuscular
and cerebral microvascular blood flow” (London, ON, 2019) (Toronto, ON, 2018)
25. Functional-NIRS Tokyo: International/Poster Presentation
D. Milej*, A. Abdalmalak, M. Khalid, M. Shahid, A. Rajaram, M. Kewin, M. Diop,
K. St. Lawrence. “Assessing extracerebral signal contamination in NIRS and DCS”
(Toyko, Japan, 2018)
26. Lawson Imaging Discovery Day: Local/Oral Presentation
A. Rajaram*, G. Bale, M. Kewin, L. Morrison, I. Tachtsidis, K. St. Lawrence, M.
Diop. “A bedside optical neuromonitor for quantification of cerebral perfusion and
metabolism in preterm brain injury.” (London, ON, 2018)
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27. Lawson Imaging Discovery Day: Local/Oral Presentation
M. Shahid*, D. Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St. Lawrence.
“Development of a hybrid optical system to study dynamic regulation of blood
flow/metabolism in the human brain.” (London, ON, 2018)
28. London Health Research Day: Local/Poster Presentation
A. Rajaram*, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. “A novel
optical neuromonitor for simultaneous quantification of cerebral perfusion and
metabolism in preterm brain injury.” (London, ON, 2018)
29. London Health Research Day: Local/Oral Presentation
M. Shahid*, A. Abdalmalak, A. Rajaram, M. Diop, K. St. Lawrence. “Development
of a hybrid optical system for studying the dynamic regulation of blood
flow/metabolism in the human brain.” (London, ON, 2018)
30. London Health Research Day: Local/Poster Presentation
M. Kewin*, D. Milej, A. Abdalmalak, A. Rajaram, M. Diop, S. de Ribaupierre, K. St
Lawrence. “Confirmation of a Derivative Hyperspectral NIRS Method for Measuring
Oxygen Saturation by Comparison to Time-Resolved NIRS.” (London, ON, 2018)
31. London Health Research Day: Local/Poster Presentation
M. Khalid*, D. F Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St Lawrence.
“Monitoring absolute cerebral blood flow using a self-calibrated software-based DCS
system.” (London, ON, 2018)
32. London Health Research Day: Local/Poster Presentation
K. Selvan*, A. Mendelson, A. Rajaram, K. St. Lawrence, C. Ellis, M. Diop.
“Monitoring Tissue Oxygenation in ICY patients using Hyperspectral NIRS” (London,
ON, 2018)
33. Imaging Network Ontario: Provincial/Oral Presentation
A. Rajaram*, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. “A novel
optical neuromonitor for simultaneous and real-time quantification of cerebral
saturation, perfusion, and metabolism at the bedside.” (Toronto, ON, 2018)
34. Imaging Network Ontario: Provincial/Poster Presentation
M. Kewin*, D. F Milej, A. Abdalmalak, A. Rajaram, M. Diop, S. de Ribaupierre, K.
St Lawrence. “Confirmation of a Derivative Hyperspectral NIRS Method for
Measuring Oxygen Saturation by Comparison to Time-Resolved NIRS.” (Toronto, ON,
2018)
35. Imaging Network Ontario: Provincial/Poster Presentation
M. Khalid*, D. Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St Lawrence.
“Development of a self-calibrated DCS for tracking absolute cerebral blood flow.”
(Toronto, ON, 2018)
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36. Optical Society of America: International/Poster presentation
A. Rajaram, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop*. “Hybrid
broadband NIRS/Diffuse correlation spectroscopy system for simultaneous monitoring
of cerebral perfusion and cytochrome c oxidase.” (Hollywood, FL, 2018)
37. Optical Society of America: International/Oral presentation
M. Kewin*, D. F Milej, A. Abdalmalak, A. Rajaram, M. Diop, S. de Ribaupierre, K.
St Lawrence. “Validation of a Hyperspectral NIRS Method for Measuring Oxygen
Saturation by Comparison to Time-Resolved NIRS.” (Hollywood, FL, 2018)
38. Optical Society of America: International/Poster presentation
M. Khalid*, D. F Milej, A. Rajaram, A. Abdalmalak, M. Diop, K. St Lawrence. “Selfcalibrated DCS for monitoring absolute cerebral blood flow.” (Hollywood, FL, 2018)
39. Mexican Symposium on Neuroimaging: International/Oral presentation
A. Rajaram*, G. Bale, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. “A novel
hybrid broadband near-infrared/diffuse correlation spectroscopy neuromonitor for
simultaneous and real-time quantification of cerebral saturation, perfusion, and
metabolism at the bedside.” (Puebla, Mexico, 2017)
40. Brain Monitoring, Neuroprotection in the Newborn: International/Poster presentation
A. Rajaram*, G. Bale, M. Kewin, I. Tachtsidis, M. Diop, K. St. Lawrence. “A bedside
optical neuromonitor for real-time monitoring of cerebral perfusion/oxidative
metabolism.” (Killarney, Ireland, 2017)
41. Functional-NIRS UK: International/Poster presentation
A. Rajaram, G. Bale*, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop.
“Development of a hybrid broadband NIRS/diffuse correlation spectroscopy system for
simultaneous monitoring of cytochrome c oxidase and cerebral perfusion.” (London,
United Kingdom, 2017)
42. Internat. Society on Oxygen Transport to Tissue: International/Poster Presentation
A. Rajaram, G. Bale*, M. Kewin, I. Tachtsidis, K. St. Lawrence, M. Diop. “A novel
bedside optical neuromonitor for real-time measurements of cerebral
perfusion/metabolism.” (Halle, Germany, 2017)
43. Internat. Society on Oxygen Transport to Tissue: International/Oral presentation
G. Bale*, A. Rajaram, M. Kewin, L. Morrison, K. St. Lawrence, M. Diop, I.
Tachtsidis. “Broadband NIRS cerebral cytochrome-c-oxidase response to anoxia
before and after neonatal hypoxic-ischemic injury.” (Halle, Germany, 2017)
44. SPIE BiOS Photonics West: International/Oral Presentation
A. Rajaram*, K. St. Lawrence, M. Diop. “Development of a hybrid broadband
NIRS/diffusion correlation spectroscopy system for real-time monitoring of cerebral
perfusion and oxygenation in preterm brain injury.” (San Francisco, CA, 2017)

195

45. London Health Research Day: Local/Poster Presentation
A. Rajaram*, D. Lee, K. St. Lawrence, M. Diop. “Development of a hybrid broadband
NIRS/diffusion correlation spectroscopy system for real-time monitoring of cerebral
perfusion and oxygenation in preterm brain injury.” (London, ON, 2017)
46. Imaging Network Ontario: Provincial/Poster presentation
A. Rajaram*, D. Lee, K. St. Lawrence, M. Diop. “Development of a hybrid broadband
NIRS/diffusion correlation spectroscopy system for real-time monitoring of cerebral
perfusion and oxygenation in preterm brain injury.” (London, ON, 2017)
47. Canadian Bone and Joint Conference: National/Oral Presentation
A. Rajaram*, L. Morrison, K. St. Lawrence, T.Y. Lee, M. Diop. “Monitoring vascular
markers of joint inflammation in a rabbit model of rheumatoid arthritis with timeresolved NIRS.” (London, ON, 2016)
48. Optical Society of America: International/Poster presentation
A. Rajaram, K. St. Lawrence, M. Diop*. “Monitoring vascular markers of joint
inflammation in a rabbit model of rheumatoid arthritis with time-resolved nearinfrared spectroscopy.” (Ft. Lauderdale, FL, 2016)
49. London Health Research Day: Local/Oral Presentation
A. Rajaram*, L. Morrison, K. St. Lawrence, T.Y. Lee, M. Diop. “Monitoring vascular
markers of joint inflammation in a rabbit model of rheumatoid arthritis with timeresolved near-infrared spectroscopy.” (London, ON, 2016)
50. IUPESM World Congress: International/Oral Presentation
K. Alexander*, A. Rajaram, J. Schreiner. “Development of a Radiochromic Film
Dosimetry Imaging System” (Toronto, ON, 2015)

